CURRICULUM VITAE NAME: Conrad Vincent Fernandez, MD, … · CV – Conrad Fernandez, MD, FRCP(C) 2...
Transcript of CURRICULUM VITAE NAME: Conrad Vincent Fernandez, MD, … · CV – Conrad Fernandez, MD, FRCP(C) 2...
CURRICULUM VITAE
NAME: Conrad Vincent Fernandez, MD, FRCP(C), Hon BSc (Genetics)
Head, Division of Pediatric Hematology/Oncology
Professor, Department of Pediatrics
Cross-appointee: Departments of Bioethics, Postgraduate Studies, and Medicine
Senior Scientist, Beatrice Hunter Cancer Research Institute
Pediatric Hematologist/Oncologist
IWK Health Centre, Dalhousie University
ADDRESS: Work
IWK Health Centre
5850 University Avenue
P. O. Box 9700
Halifax, Nova Scotia B3K 6R8 Canada
Phone: 902-470-6839/or 6988
Fax: 902-470-7216 (administrative)
Fax: 902-470-7208 (clinical - secure)
E-mail: [email protected]
PERSONAL: Canadian Citizen
Married, 2 children
Fluent: English, German (non-medical knowledge)
Conrad V. Fernandez, Hon BSc, MD, FRCP(C)
Last Updated: 13 August 2018
CV – Conrad Fernandez, MD, FRCP(C)
2
EDUCATION:
1997 Bone Marrow Transplantation, Clinical Fellowship, BC Cancer Agency, Vancouver,
British Columbia. Canada.
1994 - 1996 Pediatric Hematology/Oncology Fellowship, BC Children's Hospital, Vancouver,
British Columbia. Canada.
1989 - 1993 Pediatric Residency, Izaak Walton Killam Children's Hospital, Dalhousie University,
Halifax, Nova Scotia. Canada.
1985 - 1986 Rotating Internship, McMaster University, Hamilton, Ontario, Canada.
1982 - 1985 McMaster University Medical School, MD 1985, McMaster University, Hamilton,
Ontario, Canada.
1978 - 1982 University of Western Ontario, Hon BSc (Genetics), Dean's List. London, Ontario,
Canada.
1975 - 1978 Lisgar Collegiate Institute, Ontario Scholar 1978, Ottawa, Ontario, Canada.
HOSPITAL APPOINTMENTS:
2014 - Capital District Health Authority (now Nova Scotia Health Authority). Consultant
staff. Halifax, Nova Scotia.
1998 - IWK Grace Health Centre (now IWK Health Centre), Active Staff, Halifax, NS.
1996 - 1998 British Columbia's Children's Hospital, Courtesy Staff, Vancouver, British Columbia.
1993 Izaak Walton Killam Children's Hospital, Courtesy Staff, Halifax, Nova Scotia.
1993; 2007 Moncton City Hospital & George L. Dumont Hospital, Courtesy Staff. Moncton, New
Brunswick.
1988 - 1989 Sioux Lookout General Hospital, Associate Staff, Sioux Lookout, Ontario, Canada.
1988 - 1989 Sioux Lookout Zone Hospital, Courtesy Staff, Sioux Lookout, Ontario, Canada.
LICENCES and SPECIALITY RECOGNITION:
2002 - New Brunswick Provincial Medical Board, Courtesy Licence: 90415.
1998 - Nova Scotia Provincial Medical Board, Specialty Licence: 10866.
1996 - 1998 British Columbia Provincial Medical Board, Specialty Licence: 14776.
1995 - 1996 British Columbia Provincial Medical Board, Educational Licence: 27233.
1994 - 1995 British Columbia Provincial Medical Board, Educational Licence: 26339.
1993 Nova Scotia Provincial Medical Board, Specialty Licence: 10866.
1993 New Brunswick Provincial Medical Board, Locum Specialty Licence.
1993; 06 Fellow of Royal College of Physicians, Pediatrics, Canada. Number: 0442011.
1989 - 1993 Nova Scotia Provincial Medical Board, Educational Licence.
1986 - 1989 College of Physicians and Surgeons of Ontario, General Licence, Registration: 55331.
1986; 06 Licentiate of the Medical Council of Canada, Registration Number: 61813.
1985; 07 Medical Council of Canada Qualifying Examination.
CV – Conrad Fernandez, MD, FRCP(C)
3
ACADEMIC and WORK EXPERIENCE:
2012 (01-06) Sabbatical, Dalhousie University, Halifax, NS. (Visits to Perth, Australia and HSC,
Toronto, Canada)
2011 (09) - Head, Division of Pediatric Hematology/Oncology, Department of Pediatrics, IWK
Health Centre, Halifax, NS.
2011 (05-08) Interim Head, Division of Pediatric Hematology/Oncology, Department of Pediatrics,
IWK Health Centre, Halifax, NS.
2010 (07) - Senior Scientist, Beatrice Hunter Cancer Research Institute, Halifax, NS, Canada.
2009 - Professor, Pediatric Hematologist/Oncologist, Department of Pediatrics, IWK Health
Centre, Dalhousie University, Halifax, Nova Scotia, Canada.
2009 - Professor, Department of Bioethics, Dalhousie University, Halifax, Nova Scotia.
Canada. (Cross-appointment)
2005 - 2009 Associate Professor, Faculty of Graduate Studies, Dalhousie University, Halifax, Nova
Scotia, Canada. (Cross-appointment)
2005 - 2007 Associate Professor, Department of Medicine, QEII Hospital, Dalhousie University.
Halifax, Nova Scotia, Canada. (Cross-appointment)
2004 - 2009 Associate Professor, Department of Bioethics, Dalhousie University, Halifax, Nova
Scotia, Canada. (Cross-appointment)
2003 - 2009 Associate Professor, Pediatric Hematologist/Oncologist, Department of Pediatrics,
IWK Health Centre, Dalhousie University, Halifax, Nova Scotia, Canada.
2002 - 2005 Assistant Professor, Department of Medicine, QEII Hospital, Dalhousie University,
Halifax, Nova Scotia, Canada.
1998 - Medical Director, Maritime Provinces Pediatric Bone Marrow Transplantation
Program, IWK Health Centre, Halifax, Nova Scotia, Canada.
1998 - 2003 Assistant Professor, Pediatric Hematologist/Oncologist, Department of Pediatrics, IWK
Health Centre, Dalhousie University, Halifax, Nova Scotia, Canada.
1996 - 1998 Clinical Instructor, Pediatric Hematologist/Oncologist, British Columbia's Children's
Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
1994 - 1996 Pediatric Hematology/Oncology Subspecialty Resident, University of British
Columbia, Vancouver, British Columbia, Canada.
1994 (01-04) Pediatrician, Nazareth Mission Hospital, Nairobi, Kenya.
1993 (07-12) Emergency Room Pediatrician, Izaak Walton Killam Children's Hospital. Halifax,
Nova Scotia, Canada.
1993 (07-12) Administrative Assistant, Postgraduate Medical Education (Pediatrics), IWK Health
Centre, Halifax, Nova Scotia, Canada.
1993 (08-12) Pediatric Respirology Assistant, Cystic Fibrosis, Chest and General Respirology
Clinics, IWK Health Centre, Halifax, Nova Scotia, Canada.
1993 (08-12) Clinical Research Fellow, Endocrinology, IWK Health Centre, Halifax, Nova Scotia,
Canada.
1993 (07) Pediatric Locum, Moncton, New Brunswick, Canada.
1992 - 1993 Co-Chief Resident, Pediatrics, IWK Health Centre, Dalhousie University, Halifax,
Nova Scotia, Canada.
CV – Conrad Fernandez, MD, FRCP(C)
4
1989; 1991; Dalhousie Outpost Nurses Program, Teacher, Dalhousie University, School of Nursing
1992 Halifax, Nova Scotia, Canada.
1988 - 1989 Family Practice, The Hugh Allen Clinic, Sioux Lookout, Ontario, Canada. Including
monthly one-week fly-in visits to Native Canadian Reserve Outpost Nursing Stations.
(Fort Hope, Sandy Lake and Landsdowne House)
1987 (08) Family Practice Locum: Dr. M. Salomon, Ottawa, Ontario, Canada.
1986 - 1987 Family Practice, Ignace, Ontario, Canada.
1982 (06-08) Technical Assistant: Human WBC gene expression, Cell Science Laboratories,
University of Western Ontario, London, Ontario, Canada. Supervisor: Dr. B. G.
Atkinson.
1981 (06-08) Laboratory Assistant: Metabolic regulation, Institute for Biotechnological Research
(GBF).
1980 (06-07) Stoeckheim, West Germany. Supervisor: Dr. H.U. Schairer.
AWARDS and HONOURS:
2011 Nominated: 2011 IWK Health Centre Family Leadership Council’s Annual Award for
Excellence in Patient and Family Centred Care, Halifax, Nova Scotia, Canada.
2010 Department of Pediatrics Endowment Award, Canadian research committee strategies
assessment, Halifax, Nova Scotia, Canada.
2008 Best poster, Society of International Pediatrics Annual meeting, Other Section (Ethics),
Berlin, Germany.
2005 Distinguished Service Award, Dalhousie Health Sciences Research Ethics Board,
Dalhousie University, Halifax, Nova Scotia, Candace.
2005 Nominated: PARI-MP Excellence in Teaching Award, Canada.
2004 Pediatric Resident 2004-2005 "Silver Spoon" Teaching Award, IWK Health Centre
and Dalhousie University, Halifax, Nova Scotia, Canada.
2003 Junta General del Principado de Asturias - International Society of Bioethics (SIBI)
2002 Prize in Ethics. Assent and Dissent to Research by Children with Chronic Illness.
Gijon, Spain.
1993 Ross Award for Resident Research. A Survey of Pain Management in Canadian Level
III Neonatal Intensive Care Units. IWK Health Centre, Halifax, Nova Scotia, Canada.
1982 Natural Science Dean’s List, University of Western Ontario, London, Ontario, Canada.
1982 Offered University of Western Ontario Graduate Scholarship, London, Ontario,
Canada.
CV – Conrad Fernandez, MD, FRCP(C)
5
COMMITTEES - CURRENT SERVICE:
2018 - Responsible Conduct of Research Investigative Committee. IWK Health Center
Research Ethics. Member.
2018 - Gender Equity and FMC. Member.
2018 - Voting Body Steering Committee. Children’s Oncology Group. Member.
2017 - CIHR. College of reviewers. Member.
2017 - Return of Research Results Committee. Children’s Oncology Group. Member.
2017 - Panel on Research Ethics. Secretariat on Responsible Conduct of Research. TriCouncil
Policy of Canada. Member.
2016 - Program of Care for Cancer (Nova Scotia). Quality Improvement and Safety Council
Committee. Member.
2016- Renal Tumor Steering Committee, Children's Oncology Group, Chair.
2016- Specialty Committee in Adolescents and Young Adults Oncology (AYA). Royal
College of Physicians and Surgeons. Member.
2016 - Program of Care for Cancer. Health Services Planning – Steering Committee. Member.
2016 - Atlantic Provinces Pediatric Hematology Oncology Network (APPHON).
Board member.
2015 - Project Every Child. Pediatric MATCH. Germline results reporting committee.
Children’s Oncology Group. Member.
2015 - Panel on Research Ethics. TCPS 2 revisions. Subcommittee on Incidental Findings.
Member.
2013 - Principal Investigator. Children’s Oncology Group. Site PI.
2013 - Beatrice Hunter Cancer Research Institute. Board Member.
2013 - Beatrice Hunter Cancer Research Institute. Research Committee. Member.
2013 - National Cancer Institute (US). PDQ Editorial Advisory Board. Member.
2012 - Atlantic Regional Action Partnership, CPAC AYA Taskforce. Member.
2012 - Dalhousie University Research Ethics Appeal Board, Member.
2011 - Division Heads Council, Department of Pediatrics, IWK Health Centre, Vice Chair.
2011 - Hematology-Oncology Interdisciplinary Council (HOIC), Member.
2010 - Executive Committee, Department of Pediatrics, IWK Health Centre, Member.
2008 - COG Bioethics Committee, Children’s Oncology Group, Vice Chair.
2005 - COG Bioethics Research Steering Committee, Children’s Oncology Group, Member.
2000 - “Tip of the Toes” Outdoor Expeditions for Teen Cancer Survivors, Local coordinator.
CV – Conrad Fernandez, MD, FRCP(C)
6
COMMITTEES - COMPLETED SERVICE
2017-2018 Pediatric Hematologist-Oncologist Search Committee. Chair.
2017 COG Publications Task Force. Member.
2014 - 2017 Panel of Research Ethics. Secretariat on Responsible Conduct of Research.
Research Participant Education Subcommittee. Member.
2016-2017 POGO Pediatric Oncology Group of Ontario. Provincial Pediatric Oncology Planning
Committee (Ontario). External Member.
2016-2017 Head of the Department of Pathology search committee. Member.
2016 CIHR Project Grant Pilot Competition. Stage I Review committee. Member.
2016 - 2017 Diagnostic Imaging faculty. Search committee. Member.
2013 - 2017 Return of Results Committee. Children’s Oncology Group. Co-Chair. (now member)
2010 – 2017 Research Committee, Department of Pediatrics, IWK Health Centre, Chair.
2001 - 2016 Renal Tumor Steering Committee, Children's Oncology Group, Member.
2012 - 2016 Working Group Disclosing Genomic Incidental Findings in a Cancer Biobank: An
ELSI Experiment - NIH/NC/NHGRI grant. Member.
2016 CIHR Project Grant Pilot Competition. Stage I Review committee. Member.
2015 Search Committee. Anatomic Pathology Division Head. Member.
2014 Chair in Child and Adolescent Mental Health Outcomes. Search Committee. Member.
2014 - 2016 Canadian Partnership for Tomorrow Project – Access Oversight Committee. Member.
2013 - 2014 Beatrice Hunter Cancer Research Institute 5th Annual meeting 2014. Child, Adolescent
and Young Adult Cancer. Planning committee. Chair.
2013 - 2014 Canadian Bone Marrow Transplant Group Annual meeting 2014. Planning
Committee. Chair Pediatrics section.
2012 - 2013 CIHR Health Professional Awards – Fellowships Committee. Member.
2012 AFP Standing Committee on Innovation. Member.
2010 - 2012 AYA Committee, Canadian Partnership Against Cancer/C17, Member.
2010 - 2011 Web Site Redevelopment Committee, CureSearch, California, Member.
2011 - 2012 AYA RCPSC Fellowship Diploma, Working Committee, Member.
2011 - 2012 Haematopathologist, IWK Health Centre, Search Committee, Member.
2011 - 2015 Cancer Care Nova Scotia Site Teams (Pediatric Site Team rep), Member.
2011 Pediatric Hematologist/Oncologist Search Committee, Chair.
2011 Canada Research Chair Tier 2, Faculty of Medicine, Search Committee, Member.
CV – Conrad Fernandez, MD, FRCP(C)
7
2011 Promotion and Tenure Committee, Department of Bioethics, Member.
2010 Vaccine Epidemiologist Search Committee, IWK Health Centre, Member.
2010 Department of Pediatrics Trainee Research Day 2010, Organizing Committee,
Chairman.
2009 -2016 ELSI and Privacy Task Force, Canadian Partnership for Tomorrow, Member.
2009 - 2012 PATH - Atlantic Senior Leadership Team, Member.
2009 - 2010 AYA Steering Committee, Children’s Oncology Group, Member.
2009 - 2010 CARMS Pediatric Resident Selection Committee, Member.
2009 Joint ASCO/COG Ethics Symposium Planning Committee, Member (Past Co-Chair).
2008 - 2012 Taskforce on Returning Research Results to Participants, Bioethics Committee,
Children’s Oncology Group, Chair.
2008 -2012 NCEHR, National Advisory Board, Best Practices for Research Involving Children and
Adolescents, Member.
2008 - 2010 Nominating Committee, Faculty of Medicine, Dalhousie University, Member.
2008 - 2009 Search Committee – Faculty, Department of Bioethics, Dalhousie University, Chair.
2008 - 2009 NSHEN Meeting, Planning Committee, Member.
2008 Joint ASCO/COG Ethics Symposium Planning Committee, Member (Past Co-Chair).
2008 Annual Hematology/Medical Oncology Symposium, Planning Committee, October
2008, Halifax, NS, Member.
2007 - 2011 Appointment, Promotion & Tenure Committee, Department of Bioethics, Dalhousie
University, Member.
2007 - 2010 IWK Health Centre Research Ethics Board, Co-Chairman.
2007 Pediatric Rheumatology Search Committee, IWK Health Centre, Member.
2007 Joint ASCO/COG Ethics Symposium Planning Committee, October 2007, Denver, CO,
Co-Chairman.
2007 Annual Hematology/Medical Oncology Symposium, Planning Committee, September
2007, Halifax, NS, Member.
2006 - 2007 IWK Health Centre Research Ethics Board, Member.
2006 Annual Hematology/Medical Oncology Symposium, Planning Committee, Member.
2006 Norah Stephens Oncology Scholar Awards, Grants Committee, Member.
2005 - 2009 Pediatric Palliative Care Search Committee, IWK Health Centre, Member.
2005 - 2008 Taskforce on Ethical Issues in Correlative Biology Studies, Bioethics Committee,
Children’s Oncology Group, Chairman.
2005 - 2007 Canadian Cancer Society (NS Division) Chair in Population Cancer Research, Search
Committee, Member.
2005 - 2006 CIHR Tier II Chair: Health Economics, Search Committee, Member.
2005 Canadian Bioethics Society Annual Meeting (2005), Abstract Committee, Member.
CV – Conrad Fernandez, MD, FRCP(C)
8
2004 - 2010 Canadian Pediatrics Society, Bioethics Committee, Member.
2004 - 2005 Pediatric Hematology - Oncology Clinician Scientist Search Committee, IWK Health
Center, Chairman.
2004 - 2005 Canadian Bioethics Society Annual Meeting (2005), Organizing Committee, Member.
2004 Hematopoietic Stem Cell Transplantation Committee, Children’s Oncology Group,
Member.
2004 Intellectual Property Rights, Subcommittee, Finance Management Committee,
Department of Pediatrics, IWK Health Centre, Member.
2003 - 2005 Assent Task Force, Bioethics Committee, Children’s Oncology Group, Member.
2003 - 2004 Dalhousie University Health Sciences Research Ethics Board, Chairman.
2003 Gastroenterology Search Committee, IWK Health Centre, Member.
2002 - 2004 Patient Safety Advisory Group, Capital Health District Authority, Member.
2002 - 2004 Mortality Review Committee, IWK Health Centre, Chairman.
2002 - 2004 Patient Care Committee, IWK Health Centre, Member.
2001 - 2008 Adult Hematology Residency Training Committee, QEII, Member.
2001 - 2008 Bioethics Committee, Children’s Oncology Group, Member.
2001 - 2003 Young Investigators Committee, Children’s Oncology Group, Member.
2001 Department of Surgery, IWK Health Centre Internal Review Committee, Member.
2000 - 2001 Maritime Hereditary Cancer Program, Steering Committee, Member.
2000 - 2002 Canadian Bone Marrow Transplantation Group, Annual Meeting, Organizing
Committee, Member; Co-Chair: Pediatric Transplantation; Co-Chair: Higher Plains-
Conflicts and Dilemmas.
2000 - 2002 IWK-Grace End-of-Life Standards Committee, DNR Working Group, Member.
1999 - 2003 Candlelighters Research Steering Committee, Member.
1999 - 2002 Dalhousie University Health Sciences Research Ethics Board, Member.
1999 - 2000 Long-Term Follow Up Committee, Member, Canadian Children’s Cancer Cooperative.
1999 - 2000 Small Centers Committee, Chairman, Canadian Children’s Cancer Cooperative.
1998 - 2002 Morbidity Committee, Chairman, IWK Grace Health Centre, Halifax, Nova Scotia.
1998 - 2001 Medical Care Committee, Member, IWK Grace Health Centre, Halifax, Nova Scotia.
1998 - 2000 Long-Term Follow Up Committee, Member, Atlantic Pediatric Hematology Oncology
Network, IWK Grace Health Centre, Halifax, Nova Scotia.
1996 - 1998 Sociobehavioural Cancer Research Network Pediatric Oncology Research Interests
Group, BC Cancer Agency, Vancouver, BC.
1996 - 1997 Sedation Committee, BC's Children's Hospital, Vancouver, BC.
1996 - 1997 Fever/Neutropenia Committee, BC's Children's Hospital, Vancouver, BC.
1996 - 1997 Long-Term Follow Up Committee, Oncology, BC's Children's Hospital, Vancouver,
BC.
1995 - 1997 Pain Committee, BC's Children's Hospital, Vancouver, BC.
(For committees prior to 1996, please contact me)
CV – Conrad Fernandez, MD, FRCP(C)
9
MANUSCRIPTS SUBMITTED/PENDING:
1. Robinson CA, Orr A, Gaston D, Yorke J, Nightingale M, Matsuoka M, Jiang H, Hu P,
Macgillivray C, Corkery D, Steele S, Dellaire G, Berman J, Fernandez C, Samuels M,
Majewski J, Geldenhuys L, Hewlett T, West M, McMaster CR, Bedard K. A germline
mutation in HYOU1 predisposes individuals to nephrosclerosis and chronic kidney failure.
Submitted to JCI. Under revision.
2. Arbiv OA, Kalbfleisch M, Klaassen RJ, Fernandez CV, Yanofsky RA, Wu J, Pastore Y, Silva
M, Lipton JH, Brossard J, Michon B, Abish S, Steele M, Sinha R, Belletrutti M, Breakey V,
Jardine L, Goodyear L, Sung L, Schechter-Finkelstein T, Waespe N, Zlateska B, Cada M,
Dror. Risk factors for poor survival after hematopoietic stem cell transplantation in inherited
bone marrow failure syndromes. Submitted to Pediatr Blood Cancer.
3. Mullen EA, Gooskens SLM, Hamilton TE, van den Heuvel-Eibrink MM, Green DM,
Grundy PE, Daw NC, Dome JS, Fernandez CV. Severe Hepatopathy and Sinusoidal
Obstruction Syndrome (SOS) in National Wilms Tumor Study 3 to 5: A report of incidence,
severity, and effects on planned treatment and outcome. To be submitted to Journal of Clinical
Oncology.
4. Mullen EA, Anderson JR, Steacy KJ, Geller JI, Green DM, Norkool P, Khanna G,
Malogolowkin MH, Fernandez CV and Dome JS. Impact of surveillance imaging modality
on survival after recurrence in patients with Wilms tumor: A Report from the Children’s
Oncology Group. Submitted to J Clinical Oncology. Revision submitted.
5. Kromptic K, Finlay GA, Gregoire M-C, Forgeron PA, Fernandez CV, Price V Acute
neuropathic pain in adolescent oncology patients: Successful management using systemic
lidocaine. To be submitted to the Can J Anesthesia.
6. Ali S, Ali M, Brager R, Gassas A, Gacsadi A, Hong C, Naqvi A, Weitzman S, Fernandez CV,
Crooks B, Schechter T, Krueger J. Comparison between Myeloablative and Reduced
Intensity Preparative Regimens for Patients with Hemophagocytic Lymphohistiocytosis.
Submitted to Pediatric Blood Cancer.
7. Tutelman PR, Chambers CT, Stinson JN, Parker JA, Barwicke M, Wittemani HO, Jibb L,
Stinson H, Fernandez CV, Nathan PC, Campbell F, Irwin K. The Implementation
Effectiveness of a Freely Available Pediatric Cancer Pain Assessment Application: A Pilot
Study. Submitted to J Medical Internet Research (JMIR). In revision.
8. Lauhasurayotin S, Cuvelier J, Klaassen RJ, Fernandez CV, Pastore YD, Abish S, Wu JK,
Steele M, Jardine L, Breakey VR, Brossard J, Sinha R, Silva M, Goodyear L, Lipton JH,
Michon B, Belletrutti MJ, Sung L, Stephen SW, Shabanova I,Li H, Zlateska B, Dhanraj S,
Cada M, Dror Y. Re-analysis of next generation sequencing gene panel data by normalized
coverage values reveals previously undetected copy number variations in inherited bone
marrow failure syndromes. Submitted to Eur J Hum Genet.
9. Ma J, Siminoski K, Alos N, Halton J, Ho J, Cummings E, Shenouda N, Matzinger MA, Lentle
B, Jaremko J, Wilson B, Stephure D, Stein R, Sbrocchi AM, Rodd C, Lewis VA, Laverdière
C, Israels S, Grant R, Fernandez CV, Dix DB, Couch R, Cairney E, Barr R, Atkinson S,
Abish S, Moher D, Rauch F, Ward LM and the Canadian STOPP Consortium. Contributions
of vertebral fractures and glucocorticoid exposure to height deficits in children during
treatment for acute lymphoblastic leukemia. Submitted to Journal of Clinical Endocrinology
and Metabolism. In revision.
10. Msaouel1 P, Hong AL, Mullen EA, Atkins MB, Walker CL, Lee C, Carden MA, Genovese G,
Linehan WM, Rao P, Merino MJ, Grodman H, Dome JS, Fernandez CV, Geller JI, Apolo
AB, Daw NC, Hodges CH, Moxey-Mims M, Wei D, Bottaro DP, Staehler M, Karam JA,
CV – Conrad Fernandez, MD, FRCP(C)
10
Rathmell WK, Tannir NM. Updated recommendations on the diagnosis and clinical trial
eligibility criteria for patients with renal medullary carcinoma. Submitted to Clinical
Genitourinary Cancer.
11. Jibb LA, Nathan PC, Breakey V, Fernandez CV, Johnston DL, Lewis V, McKillop S, Patel S,
Sabapathy C, Strahlendorf C, Victor JC, Moretti M, Nguyen C, Insull H, Hamilton R, Stinson
JN. The Pain Squad+ Smartphone App to Support Real-Time Pain Management for
Adolescents with Cancer: Protocol for a Randomized Controlled Trial. To be submitted to
BMJ Open.
PUBLICATIONS (Peer Reviewed): h-index 37 (i10 index 87)
1. Iaboni DSM, Chi YY, Dome JS, Fernandez CV. Outcome of Wilms Tumor patients with
bone metastasis enrolled on National Wilms Tumor Studies 1-5: A report from the Children’s
Oncology Group. Accepted Pediatric Blood Cancer. In Press.
2. Cajaiba MM. Dyer , Geller JI, Jennings LJ, George D, Kirschmann D, Rohan SM, Cost N,
Khanna G, Mullen EA, Dome JS, Fernandez CV, Perlman EJ.The Classification of Pediatric
and Young Adult Renal Cell Carcinomas Registered on the Children’s Oncology Group
(COG) Protocol AREN03B2 Following Focused Genetic Testing. Cancer. 2018 June 15. Doi:
10.1002/cncr.31578.
3. Friedman JM, Bombard Y, Cornel M, Fernandez CV, Junker AK, Plon SE, Stark Z, and
Knoppers BM for the Paediatric Task Team of the Global Alliance for Genomics and Health
Regulatory and Ethics Works team. Genome-wide Sequencing in Acutely-Ill Infants:
Genome Medicine’s Critical Applicaiton? Genetics in Medicine. 2018 Jun 12. doi:
10.1038/s41436-018-0055-z. [Epub ahead of print] PMID:29895853.
4. Ward LM, Ma J, Lang B, Ho J, Alos N, Matzinger MA, Shenouda N, Lentle B, Jaremko JL,
Wilson B, Stephure D, Stein R, Sbrocchi AM, Rodd C, Lewis V, Laverdière C, Israels S,
Grant RM, Fernandez CV, Dix DB, Cummings EA, Couch R, Cairney E, Barr R, Abish S,
Atkinson SA, Hay J, Rauch F, Moher D, Siminoski K, Halton J and the Canadian STOPP
Consortium. Bone Morbidity and Recovery in Children with Acute Lymphoblastic Leukemia:
Results of a Six-Year Prospective Longitudinal Study. Bone Miner Res. 2018 May 22. doi:
10.1002/jbmr.3447. [Epub ahead of print] PMID:29786884.
5. Dix DB, Seibel NL, Chi YY, Khanna G, Gratias E, Anderson JR, Mullen EA, Geller JI,
Kalapurakal JA, Paulino AC, Perlman EJ, Ehrlich PF, Malogolowkin M, Gastier-Foster JM,
Grundy PE, Fernandez CV, Dome JS on behalf of the AREN0533 Study Committee.
Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report
From the Children's Oncology Group AREN0533 Study. J Clin Oncol. 2018 Jun
1;36(16):1564-1570. doi: 10.1200/JCO.2017.77.1931. Epub 2018 Apr 16.PMID:29659330.
6. Wolf SM, Scholtes E, Koenig BA, Petersen GM, Berry SA, Beskow LM, Daly MB,
Fernandez CV, Green RC, LeRoy BS, Lindor NM, O’Rourke PP, Radecki Breitkopf C,
Rothstein MA, Van Ness B, and Wilfond BS. Pragmatic Tools for Sharing Genomic Research
Results with the Relatives of Living and Deceased Research Participants. J Law Med Ethics.
2018 Mar;46(1):87-109. doi: 10.1177/1073110518766024. Epub 2018 Mar 27. PMID:
30008546
CV – Conrad Fernandez, MD, FRCP(C)
11
7. Geerlinks AV, Digout C, Bernstein M, Chan A, MacPhee S, Pambrun C, Gallant G, Lois
Wyatt L, Fernandez CV, Price VE. Improving Time To Antibiotics For Pediatric Oncology
Patients With Fever and Suspected Neutropenia By Applying Lean Principles. Accepted
Pediatric Emergency Care. In press.
8. Bettle A, Latimer M, Fernandez CV, Hughes J. Supporting Parents Acute Lymphoblastic
Leukemia (ALL) Pain Care involvement: A Qualitative Interpretive Description. J Pediatr
Oncol Nurs. 2018 Jan/Feb;35(1):43-55. doi: 10.1177/1043454217727518. Epub 2017 Aug 29.
PMID:28849687.
9. V Rahimzadeh, C Schickhardt, BM Knoppers, K Sénécal, DF Vears, CV Fernandez, S
Pfister, S Plon, EW Clayton, S Terry, J Williams, MS Williams, M Cornel, JM Friedman. Key
Implications of Data Sharing in Pediatric Genomics: Points to Consider for KIDS. JAMA
Pediatrics. 2018 May 1;172(5):476-481. doi: 10.1001/jamapediatrics.2017.5500. PMID:
29554172
10. Tutelman PR, Chambers CT, Stinson SN, Parker JA, Fernandez CV, Witteman HO, Nathan
PC, Barwick M, Jibb LA, Irwin K, Campbell F. Pain in Children with Cancer: Prevalence,
Characteristics, and Parent Management. Clinical Journal of Pain. Clin J Pain. 2018
Mar;34(3):198-206. doi: 10.1097/AJP.0000000000000531. PMID:28678061.
11. Arbiv OA, Klaassen R, Fernandez CV, Yanofsky RA, Wu J, Robitaille N, Silva M, Lipton
JH, Brossard J, Michon B, Abish S, Steele M, Sinha R, Belletrutti M, Breakey V, Jardine L,
Goodyear L, Sung L, Waespe N, Zlateska b, Cada M, and Dror Y. Molecular Analysis and
Genotype-Phenotype Correlation Among Patients with Diamond-Blackfan Anemia. Clin
Genet. 2018 Feb;93(2):320-328. doi: 10.1111/cge.13158. Epub 2017 Dec 27. PMID:
29044489.
12. Borretta L, MacDonald T, Price V, Bernstein M, Fernandez C, Kulkarni K. Management
Experience of Peripherally inserted central catheters in Pediatric Oncology Patients: A 15 year
Population-Based review from Maritimes, Canada. J Pediatr Hematol Oncol. 2018
Jan;40(1):e55-e60. doi: 10.1097/MPH.0000000000000882.PMID: 28562513
13. Fernandez CV, Mullen EA, Chi YY, Ehrlich PF, Perlman EJ, Kalapurakal JA, Khanna G,
Paulino AC, Hamilton TE, Gow KW, Tochner Z, Hoffer F, Withycombe J, Shamberger RC,
Kim Y, Geller JI, Anderson JR, Grundy PE, Dome JS. Outcome and prognostic factors in
stage III Favorable Histology Wilms Tumor (FHWT). A report from the Children’s Oncology
Group Study AREN0532. J Clin Oncol. 2018 Jan 20;36(3):254-261. doi:
10.1200/JCO.2017.73.7999. Epub 2017 Dec 6.PMID: 29211618.
14. Ehrlich PF,Chi YY, Chintagumpala M, Hoffer F, Perlman E, Kalapurakal J, Warwick A,
Shamberger RC, Khanna G, Hamilton T, Gow K, Barnhardt D, Paulino A, Gratias E, Mullen
E, Geller J, Grundy P, Fernandez CV, Ritchey M, Dome J. Results of the first Prospective
Multi-Institutional Treatment Study in Children with Bilateral Wilms Tumor (AREN0534): A
report from the Children’s Oncology Group. Annals of Surgery. 2017 Sep;266(3):470-478.
doi: 10.1097/SLA.0000000000002356. PMID: 28795993.
15. Fernandez CV, EJ Perlman, EA Mullen, YY Chi, TE Hamilton, KW Gow, FA Ferrer, D
Barnhart, PF Ehrlich, G Khanna, J Kalapurakal, T Bocking, V Huff, Q An, JI Geller, PE
Grundy JR Anderson, JS Dome, RC Shamberger for the AREN0532 committee. Clinical
outcome and biological predictors of relapse following nephrectomy only for Very Low Risk
Wilms tumor (VLR WT). A report from Children’s Oncology Group AREN0532.
CV – Conrad Fernandez, MD, FRCP(C)
12
Annals of Surgery. 2017 Apr;265(4):835-840. [Epub ahead of print 2016. Mar
16.]PMID:27811504.
16. Sandberg J, Cajaiba M, Smith E, Servaes S, Perlman E, Mullen E, Geller J, Ehrlich PF, Dome
JS, Fernandez CV, Khanna G. Distinctive imaging findings of renal medullary carcinoma
amongst pediatric renal tumors: a report from the Children’s Oncology Group. Pediatr Radiol.
2017 Nov;47(12):1615-1621 8. doi: 10.1007/s00247-017-3926-6 . PMID 28689245.
17. Waespe N, Dhanraj S, Wahala M, Tsangaris E, Enbar1 T, Zlateska B, Li H, Klaassen RJ,
Fernandez CV, Yanofsky R, Wu JK, Pastore YD, Silva M, Lipton JH, Brossard J, Michon B,
Abish S, Steele M, Sinha R, Belletrutti MJ, Breakey VR, Jardine L, Goodyear L, Kofler L,
Ghemlas IA, Cada M, Sung L, Shago M, Scherer SW, Dror Y. The clinical impact of copy
number variants in underlying inherited bone marrow failure syndromes. NPJ Genom Med.
2017 May 10;2. pii: 18. doi: 10.1038/s41525-017-0019-2. PMID:28690869
18. Geerlinks AV, Issekutz T, Sullivan K, Cowan MJ, Dvorak C, Fernandez CV. Severe,
Persistent and Fatal T-Cell Immunodeficiency Following Therapy for Infantile Leukemia.
Pediatr Blood Cancer. 2016 Nov;63(11):2046-9. doi: 10.1002/pbc.26108. Epub 2016 Jun 29.
PMID:27354010
19. Gratias EJ, Dome JS, Jennings LJ, Anderson J, Grundy P, Mullen EA, Geller JI, Fernandez
CV, Perlman EJ. Association of Chromosome 1q Gain with Inferior Survival in Favorable
Histology Wilms Tumor: A Report from the Children’s Oncology Group. J Clin Oncol. 2016
Sep 10;34(26):3189-94. doi: 10.1200/JCO.2015.66.1140. Epub 2016 Jul 11.Jul 11. pii:
JCO661140. [Epub ahead of print] PMID:2740093.
20. Elzinga KE, Khan OF, Tang AR, Fernandez CV, Elzinga C, Heng DYC, Vickers MM,
Truong T, Tang PA. Adult Patient Perspectives on Clinical Trial Result Reporting: A survey
of cancer patients. Clin Trials. 2016 Dec;13(6):574-581.Aug 23. pii: 1740774516665597.
[Epub ahead of print]. PMID: 27559022
21. Birnie KA, Chambers CT, Chorney J, Fernandez CV, McGrath PJ. A multi-informant multi-
method investigation of family functioning and parent-child coping during child pain.
J Pediatr Psychol. 2017 Jan 1;42(1):28-39. doi: 10.1093/jpepsy/jsw045. [ Epub ahead of
print:2016 Jun 13. pii: jsw045]. PMID:2729829.
22. Knoppers BM, Sénécal K, Boisjoli J, Borry P, Cornel M, Fernandez CV, Grewal J, Holm IA,
Nelson E, Pinxten W, Shabani M, Tassé AM, Zawati M, Clayton EW on behalf of the P3G
International Paediatric Research Platform. Attaining Majority in Biomedical Research: Re-
contact for Consent? IRB: Ethics & Human Research. IRB vol. 38, no. 6;1-9. November -
December 2016.
23. LeBlanc MA, Bettle A, Berman JN, Price VE, Pambrun C, Yu Z, Tiller M, McMaster CR,
Fernandez CV. Study of glycine and folic acid supplementation to ameliorate transfusion
dependence in congenital sideroblastic anemia. Pediatr Blood Cancer. 2016 Jul;63(7):1307-9.
doi: 10.1002/pbc.25981. Epub 2016 Apr 1.PMID:27038157.
24. Ghotra S, Pambrun C, Fernandez CV, Ashley S, Parkash S, Koupaei R, Jangaard K.
Congenital Methemoglobinemia due to Hb F-M-Fort Ripley in a Preterm Newborn.
BMJ Case reports. 2016. Mar 11;2016. pii: bcr2016214381. doi: 10.1136/bcr-2016-214381.
PMID: 26969357.
25. MacDonald T, Kulkarni K, Bernstein M, Fernandez CV. Allergic reactions for intravenous
peg-asparaginase as compared to intramuscular peg-asparaginase in children with high risk
acute lymphoblastic leukemia: a population based study from the Maritimes, Canada.
J Pediatr Hematol Oncol. 2016 2016 Jul;38(5):341-4. doi: 10.1097/MPH.0000000000000520.
PMID:26925715.
CV – Conrad Fernandez, MD, FRCP(C)
13
26. Unguru Y, Fernandez CV, Bernhardt B, Berg S, Pyke-Grimm K, Woodman C, Joffe S. An
Ethical Framework for Allocating Scarce Life-saving Chemotherapy and Supportive Care
Drugs for Childhood Cancer. J Natl Cancer Inst. 2016 Jan 29;108(6). pii: djv392. doi:
10.1093/jnci/djv392. Print 2016 Jun. PMID: 26825103
27. Pedro Fernández-Murray JP, Prykhozhij SV, Dufay N, Steele S, Gaston D, Nasrallah GK,
Coombs AJ, Fernandez CV, Berman JN, McMaster CR. Glycine and folate ameliorate
models of congenital sideroblastic anemia. PLOS Genetics . 2016 Jan 28;12(1):e1005783. doi:
10.1371/journal.pgen.1005783. eCollection 2016 Jan. PMID:26821380.
28. Birnie KA, Chambers CT, Chorney J, Fernandez CV, McGrath PJ. Dyadic analysis of child
and parent trait and state pain catastrophizing in children’s pain. Pain. 157 (2016) 938–948.
Epub 2015 Dec 12. [Epub ahead of print] PMID:26713422. Awarded the Brain Star Award
from CIHR Institute of Neurosciences, Mental Health and Addiction (http://www.cihr-
irsc.gc.ca/e/9600.html) and the Dr. John T. Goodman Award for Trainee Research in
Pediatric Pain (http://pediatric-pain.ca/Goodman%26PatPrize).
29. Sénécal K, Rahimzadeh V, Knoppers BM, Fernandez CV, Avard D, Sinnett D. Statement of
Principles on the Return of Research Results and Incidental Findings in Paediatric Research: A
Multi-site Consultative Process. Genome. 2015 Dec;58(12):541-8. doi: 10.1139/gen-2015-
0092. Epub 2015 Nov 10.PMID:26613133.
30. Fernandez CV, O’Connell C, Ferguson M, Orr AC, Robitaille JM, Knoppers BM, McMaster
CR. Stability of Attitudes to the Ethical Issues Raised in the Return of Incidental Genomic
Research Findings in Children – A Follow up Study. Public Health Genomics. 2015 Sept
2015;18(5):299-308. doi: 10.1159/000439244. PMID:26352440.
31. Ghemlas I, Li H, Zlateska B, Klaassen R, Fernandez CV, Yanofsky RA, Wu J, Pastore Y,
Silva M, Lipton JH, Brossard J, Bruno M, Abish S, Steele M, Sinha R, Belltrutti M, Breaky V,
Jardine L, Goodyear L, Sung L, Dhanraj S, Reble E, Wagner A, Beyene J, Ray P, Meyn S,
Cada M, Dror Y. Application of novel next generation sequencing gene panel assay to genetic
and clinical diagnosis of inherited bone marrow failure syndromes. J Med Genet. 2015
Sep;52(9):575-84. doi: 10.1136/jmedgenet-2015-103270. Epub 2015 Jul 1.PMID: 26136524.
32. Cummings EA, Ma J, Fernandez CV, Halton J, Alos N, Miettunen PM, Jaremko JL, Ho J,
Shenouda N, Matzinger MA, Lentle B, Wilson B, Taback S, Stephure D, Stein R, Sbrocchi
AM, Rodd C, Lewis VA, Laverdiere C, Israels S, Grant RM, Dix DB, Couch R, Cairney E,
Barr R, Atkinson S, Abish S, Moher D, Gaboury I, Hay J, Rauch F, Siminoski K, Ward LM
and the Canadian STOPP Consortium. Incident Vertebral Fractures in the Four Years
Following Chemotherapy Initiation in Children with Acute Lymphoblastic Leukemia: Fracture
Characteristics and Risk Factors. J Clin Endocrinol Metab. 2015 Sep;100(9):3408-17. doi:
10.1210/JC.2015-2176. Epub 2015 Jul 14. PMID: 26171800.
33. Dome JS, Graf N, Geller JI, Fernandez CV, Mullen EA, Spreafico F, Van den Heuvel-
Eibrink M, Pritchard-Jones K. Advances in Wilms Tumor Treatment and Biology: Progress
through International Collaboration. Journal of Clinical Oncology. 2015 Sep 20;33(27):2999-
3007. PMID: 26304882.
34. LeBlanc CM, Ma J, Taljaard M, Roth J, Scuccimarri R, Miettunen P, Lang B, Huber AM,
Houghton K, Jaremko JL, Ho J, Shenouda N, Matzinger MA, Lentle B, Stein R, Sbrocchi AM,
Oen K, Rodd C, Jurencak R, Cummings EA, Couch R, Cabral D, Atkinson S, Alos N, Rauch
F, Siminoski K, Ward LM; Canadian STeroid-Associated Osteoporosis in Pediatric Population
(STOPP) Consortium. Incident Vertebral Fractures and Risk Factors in the First Three Years
Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic Disorders. J
CV – Conrad Fernandez, MD, FRCP(C)
14
Bone Miner Res. 2015 Sep;30(9):1667-75. doi: 10.1002/jbmr.2511. Epub 2015 May 26.
Collaborator.
35. Wilfond BS, Fernandez CV, Green RC. Disclosing secondary findings from pediatric
sequencing to families: Considering the “benefit to families” in provider recommendations. J
Law Med Ethics. 2015. 43(3):552-558. Article first published online: 19 OCT 2015 | DOI:
10.1111/jlme.12298. PMID:26479565.
36. Fernandez CV, O’Rourke PP, Beskow LM. Canadian Research Ethics Board Leadership
attitudes to the return of genetic research results to individuals and their families. J Law,
Medicine, and Ethics. 2015. 43(3):514-522. Article first published online: 19 OCT 2015 | DOI:
10.1111/jlme.12293. PMID: 26479560.
37. Wolf SM, Branum R, Koenig BA, Petersen GM, Berry SA, Beskow LM, Daly MB,
Fernandez CV, Green RC, LeRoy BS, Lindor NM, O’Rourke PP, Radecki Breitkopf C,
Rothstein MA, Van Ness B, Wilfond BS. Returning a Research Participant’s Genomic Results
to Relatives: Analysis and Recommendations. J Law Med Ethics 2015. 43(3):440-463. Article
first published online: 19 OCT 2015 | DOI: 10.1111/jlme.12288. PMID: 26479555.
38. Cada M, Segbefia CI, Klaassen R, Fernandez CV, Yanofsky RR, Wu J, Pastore Y, Silva M,
Lipton JH, Brossard J, Michon B, Abish S, Steele M, Sinha R, Belletrutti M, Breakey V,
Jardine L, Goodyear L, Sung L, Shago M, Sharma P, Zlateska B, Dror Y. Impact of category,
cytopathology and cytogenetics on outcome of clonal and malignant myeloid transformation in
inherited bone marrow failure syndromes. Haematologica. 2015 May 100(5):633-42. E pub 14
Feb2015. pii: haematol.2014.117457. PMID: 25682607
39. Guilcher G, Fernandez CV, Joffe S. Are hybrid umbilical cord blood banks really the best of
both worlds? J Med Ethics. 2015 Mar;41(3):272-5. doi: 10.1136/medethics-2013-101673.
Epub 2014 May 13. PMID: 24825373
40. Noel M, Boerner KE, Birnie KA, Caes L, Parker JA, Chambers CT, Fernandez CV, Lee K.
The Ethical Acceptability of Deception in Research with Children. J of Developmental and
Behavioural Pediatrics 2015 Feb/Mar 36(2):75-85. PMID: 25650951.
41. Ma J, Siminoski K, Alos N, Halton J, Ho J, Lentle B, Matzinger MA, Shenouda N, Abish S,
Atkinson S, Barr R, Cabral DA, Cairney E, Clarson C, Couch R, Cummings EA, Dix DB,
Fernandez CV, Grant RM, Israels S, Laverdière C, Lewis VA, Rodd C, Sbrocchi A, Scharke
M, Stein R, Stephure D, Taback S, Wilson B, Rauch F, Ward LM and the Canadian STOPP
Consortium. The Choice of Normative Pediatric Reference Database Changes Spine Bone
Mineral Density Z-scores but Not the Relationship of Bone Mineral Density With Prevalent
Vertebral Fractures. J of Clin Endocrinol and Metabolism. 2015 Mar;100(3):1018-27. doi:
10.1210/jc.2014-3096. Epub 2014 Dec 11 2014 PMID: 25494661.
42. Samuel N, Villani A, Fernandez CV, Malkin D. Treating the Family with Cancer:
Sequencing, Surveillance and Society. Nature Rev Clin Oncol. 2014 Dec;11(12):723-731 doi:
10.1038/nrclinonc.2014.169 PMID: 25311347.
43. Gaston D, Hansford S, Oliveira C, Nightingale M, Pinheiro H, Macgillivray C, Kaurah P,
Rideout A, Steele P, Soares G, Huang W, Whitehouse S, Blowers S, LeBlanc MA, Jiang H,
Greer W, Samuels M, Orr A, Fernandez CV, Majewski J, Ludman M, Dyack S, Penney L,
McMaster CR, Huntsman D, Bedard K. Germline mutations in MAP3K6 are associated with
familial gastric cancer. PLoS Genetics. 2014 Oct 23;10(10):e1004669. doi:
10.1371/journal.pgen.1004669. eCollection 2014. PMID:25340522.
44. Cataudella D, Morley T, Nessin A, Fernandez C, Johnston D, Sung L, & Zelcer S.
Development of a New Instrument – the Pediatric Supportive Care Scale (PSCS) - to Assess
CV – Conrad Fernandez, MD, FRCP(C)
15
the Quality of Life in Children with Advanced Cancer. Pediatric Blood and Cancer. 2014 Oct
14;61(10):1840-5. doi: 10.1002/pbc.25115. [Epub 2014 Jun 19] PMID:24947134.
45. Morley T, Cataudella D, Fernandez C, Sung L, Johnston D, Nesin A, & Zelcer, S.
Development of the Pediatric Advanced Care Quality of Life Scale (PAC-QoL): Evaluating
Comprehension of Items and Response Options. Pediatric Blood and Cancer. 2014
Oct;61(10):1835-9. doi: 10.1002/pbc.25111. [Epub 2014 Jun 19] PMID:24947009.
46. Chappells H, Parker L, Fernandez CV, Conrad C, Drage J, MacDonald J, O’Toole G,
Campbell N, Dummer T. Private drinking water wells and arsenic exposure: a review of
policy and management systems for health risk awareness and reduction. J of Water and
Health.2014 Sep;12(3):372-92. doi: 10.2166/wh.2014.054. PMID:25252340.
47. Fernandez CV, Bouffet E, Malkin D, Jabado N, O’Connell C, Avard D, Knoppers BM,
Ferguson M, Boycott KM, Sorensen PH, Orr AC, Robitaille JM, McMaster CR. Attitudes of
Parents to the Return of Targeted and Incidental Genomic Research Findings in Children.
Genetics in Medicine. 2014 Aug;16(8):633-40. [E pub 16 Jan 2014] doi:
10.1038/gim.2013.201.PMID:24434691
48. Robitaille JM, Gillett RM, Leblanc M, Gaston D, Nightingale M, Mackley MP, Parkash S,
Hathaway J, Thomas A, Ells A, Traboulsi E, Héon E, Roy M, Shalev S, Fernandez CV,
MacGillivray C, Wallace K, McMaster CR, Bedard K. Phenotypic Overlap Between Familial
Exudative Vitreoretinopathy (FEVR) and Microcephaly Lymphedema Chorioretinal Dysplasia
(MLCRD) Caused by KIF11 Mutations. JAMA Ophthalmology. 2014 Dec 132 (12):1393-
1399. E pub Aug 14. doi: 10.1001/jamaophthalmol.2014.2814. PMID 25124931.
49. Birnie KA, Chambers CT, Fernandez CV, Forgeron PA, Latimer MA, McGrath PJ,
Cummings EA Finley GA. Hospitalized children continue to report undertreated and
preventable pain. Pain Research & Management 2014 Jul-Aug;19(4):198-204 [Epub May 7]
pii: 16011. PMID: 24809068.
50. Ferrer FA, Herbst KW, Fernandez CV, Khanna G, Dome JS, Mullen EA, Geller JI, Gratias E,
Shamberger R, Ritchey M, Ehrlich PF. Feasibility and Potential Impact of Using CT Volume
as a Predictor of Specimen Weight in a Subgroup of Patients with Low Risk Wilms Tumors
Registered on COG Study AREN03B2.. J Pediatr Urol. 2014 Oct;10(5):969-73. doi:
10.1016/j.jpurol.2014.02.006. Epub 2014 Mar 15. PMID:24863984
51. DeCamp M, Joffe S, Fernandez C, Faden RR, Unguru Y and the Working Group on
Chemotherapy Drug Shortages in Pediatric Oncology. Chemotherapy Drug Shortages In
Pediatric Oncology: A Consensus Statement. Pediatrics. 2014 Mar;133(3):e716-24. doi:
10.1542/ peds.2013-2946. [Epub 2014 Feb 2] PMID: 24488741.
52. Phan V1, Blydt-Hansen T, Feber J, Alos N, Arora S, Atkinson S, Bell L, Clarson C, Couch R,
Cummings EA, Filler G, Grant RM, Grimmer J, Hebert D, Lentle B, Ma J, Matzinger M,
Midgley J, Pinsk M, Rodd C, Shenouda N, Stein R, Stephure D, Taback S, Williams K, Rauch
F, Siminoski K, Ward LM; Canadian STOPP Consortium. Skeletal findings in the first 12
months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome.
Osteoporos Int. 2014 Feb;25(2):627-37. doi: 10.1007/s00198-013-2466-7. Epub 2013 Aug 16.
Collaborator. PMID 23948876.
53. Chappells H, Campbell N, Drage J, Fernandez CV, Parker L, Dummer TJB. Understanding
the translation of scientific knowledge about arsenic risk exposure among private well water
users in Nova Scotia. Science of the Total Environment (STOTEN). Epub 18 Jan 2014;
doi:10.1016/j.scitotenv.2013.12.108. PMID:24444512.
54. Kleiderman E, Knoppers BM, Fernandez CV, Boycott K, Ouellette G, Wong-Rieger D,
Adam S, Richer J, Avard D. Returning Incidental Findings from Genetic Research to Children:
CV – Conrad Fernandez, MD, FRCP(C)
16
Views of Parents of Children Affected by Rare Diseases. J Med Ethics. Epub: 2013 Dec 19;
doi:10.1136/medethics-2013-101648. PMID:24356209.
55. Ferrer FA, Rosen N, Herbst K, Fernandez CV, Khanna G, Dome JS, Mullen E, Gow KW,
Barnhart DC, Shamberger RC, Ritchey M, Ehrlich P. Image-based Feasibility of Renal
Sparing Surgery for Very Low Risk Unilateral Wilms Tumors. J Urol. 2013
Nov;190(5):1846-51 [Epub: 2013 May 30] doi: pii: S0022-5347(13)04513-
8.10.1016/j.juro.2013.05.060. PMID 23727411.
56. Fernandez CV, Strahlendorf C, Avard D, Knoppers K, O’Connell C, Malkin D, Jabado N,
Boycott K, Sorenson P. Attitudes of Researchers to the Return to Participants of Incidental and
Targeted Genomic Findings Obtained in a Research Setting. Genetics in Medicine. 2013
Jul;15(7):558-64. [On line 31 Jan 2013.
http://www.nature.com/doifinder/10.1038/gim.2012.183] PMID 23370450.
57. Dome JS, Fernandez CV, Mullen EA, Kalapurakal JA, Geller JI, Huff V, Gratias EJ, Dix
DB, Ehrlich PF, Khanna G, Anderson JR, Naranjo A, and Perlman EJ. Children’s Oncology
Group’s 2013 Blueprint for Research. Pediatric Blood Cancer 2013 Jun;60(6):994-1000. [E
pub 2012 Dec 19] PMID:23255438.
58. Siminoski K, Lee K, Abish S, Alos N, Bell L, Blydt-Hansen T, Couch R, Cummings EA,
Ellsworth J, Feber J, Fernandez CV, Halton J, Huber AM, Israels S, Jurencak R, Lang B,
Laverdière C, LeBlanc C, Lewis V, Midgley J, Miettunen PM, Oen K, Phan V, Pinsk M,
Rauch F, Rodd C, Roth J, Saint-Cyr C, Scuccimarri R, Stephure D, Taback S, Wilson B,
Ward LM, and the Canadian STOPP Consortium. The Development of Bone Mineral
Lateralization in the Arms. Osteoporosis International 2013(Mar) 24: 999-1006. [E Pub 2012
Jun 29] PMID 22109742.
59. Unguru Y, Joffe S, Fernandez CV, Yu A. Ethical issues for control arm patients after
revelation of benefits of experimental therapy for neuroblastoma. J Clinical Oncology 2013
Feb 10;31(5): 641-63 [E pub 2013 January 7] PMID 23295797.
60. Shiff NJ1, Brant R, Guzman J, Cabral DA, Huber AM, Miettunen P, Roth J, Scuccimarri R,
Alos N, Atkinson SA, Collet JP, Couch R, Cummings EA, Dent PB, Ellsworth J, Hay J,
Houghton K, Jurencak R, Lang B, Larche M, Leblanc C, Rodd C, Saint-Cyr C, Stein R,
Stephure D, Taback S, Rauch F, Ward LM; Canadian Steroid-associated Osteoporosis in the
Pediatric Population Consortium. Glucocorticoid-related changes in body mass index among
children and adolescents with rheumatic diseases. Arthritis Care Res (Hoboken). 2013
Jan;65(1):113-21. doi: 10.1002/acr.21785. Collaborator. PMID 22826190.
61. Fernandez CV, Ruccione K, Wells R, Long JB, Pelletier W, Hooke MC, Pentz RD, Noll RB,
Baker J, O’Leary M, Reaman G, Adamson PC, Joffe S. Recommendations for the return of
research results to study participants and guardians: A report from the Children’s Oncology
Group. J Clinical Oncology 2012;30:4573-4579. [E pub 2012 Oct 29] PMID 23109703
62. Alos N, Grant RM, Ramsay T, Halton J, Cummings EA, Miettunen PM, Abish S, Atkinson S,
Barr R, Cabral DA, Cairney E, Couch R, Dix DB, Fernandez CV, Hay J, Israels S, Laverdière
C, Lentle B, Lewis V, Matzinger M, Rodd C, Shenouda N, Stein R, Stephure D, Taback S,
Wilson B, Williams K, Rauch F, Siminoski K, Ward L; STOPP consortium. High Incidence
of Vertebral Fractures in Children with Acute Lymphoblastic Leukemia 12 Months After the
Initiation of Therapy. J Clin Oncology 2012 (Aug); 30(22):2760-7. [Epub 2012 Jun 25]
PMID 22734031.
63. Siminoski K, Lee KC, Jen H, Warshawski R, Matzinger MA, Shenouda N, Charron M,
Coblentz C, Dubois J, Kloiber R, Nadel H, O'Brien K, Reed M, Sparrow K, Webber C, Lentle
B, Ward LM; STOPP Consortium. Anatomical distribution of vertebral fractures: comparison
CV – Conrad Fernandez, MD, FRCP(C)
17
of pediatric and adult spines. Osteoporos Int. 2012 Jul;23(7):1999-2008. doi: 10.1007/s00198-
011-1837-1. Epub 2011 Nov 23. PMID:22109742
64. Gardiner B, Morash B, Riddell C, Wang H, Fernandez CV, Yhap M, Berman JN. The
Incidence and Prognostic Significance of 9p21 Abnormalities In Pediatric Acute
Lymphoblastic Leukemia Patients. Pediatric Blood Cancer 2012 (Jun);58(6):852-9. [Epub
ahead of print Jul 27. doi: 10.1002/pbc.23285]. PMID 21796768.
65. Angelski CL, Fernandez CV, Weijer C and Gao J. The Publication of Ethically Uncertain
Research: Attitudes and Practices of Journal Editors. BMC Medical Ethics 2012 (Apr);13:4.
PMID 22494972.
66. Shaw R, Issekutz AC, Fraser R, Schmit P, Morash B, Monaco-Shawver L, Orange JS,
Fernandez CV. Bilateral adrenal EBV-associated smooth muscle tumors in a child with a
natural killer cell deficiency. Blood 2012 (Apr);119(17):4009-401. (doi:10.1182/blood-2011-
10-385377). PMID 22427204.
67. Marjerrison S, Fernandez CV, Price VE, Njume E, Hesseling P. The use of ultrasound in
endemic Burkitt’s lymphoma in Cameroon. Pediatr Blood Cancer 2012 (Mar);58(3):352-5.
68. Kazenwadel J, Secker GA, JL Yajuan, Rosenfeld JA, Wildin RS, Dyack S, Fernandez CV,
Shimamura A, Zhang M, Walsh T, Holland SM, Hickstein DD, Horwitz MS, Hahn CN, Scott
HS, Harvey NL. Loss of function germline GATA2 mutations in patients with MDS/AML or
MonoMAC syndrome and primary lymphedema. Blood 2012 (Feb);119(5):1283-91. PMID
22147895.
69. Feber J, Gaboury I, Ni A, Alos N, Arora S, Bell L, Blydt-Hansen T, Clarson C, Filler G, Hay
J, Hebert D, Lentle B, Matzinger M, Midgley J, Moher D, Pinsk M, Rauch F, Rodd C,
Shenouda N, Siminoski K, Ward LM; Canadian STOPP Consortium. Skeletal findings in
children recently initiating glucocorticoids for the treatment of nephrotic syndrome.
Osteoporos Int. 2012 Feb;23(2):751-60. doi: 10.1007/s00198-011-1621-2. Epub 2011 Apr 15.
PMID: 21494860
70. Rodd C, Lang B, Ramsay T, Alos N, Huber AM, Cabral DA, Scuccimarri R, Miettunen PM,
Roth J, Atkinson SA, Couch R, Cummings EA, Dent PB, Ellsworth J, Hay J, Houghton K,
Jurencak R, Larché M, LeBlanc C, Oen K, Saint-Cyr C, Stein R, Stephure D, Taback S, Lentle
B, Matzinger M, Shenouda N, Moher D, Rauch F, Siminoski K, Ward LM; Canadian Steroid-
Associated Osteoporosis in the Pediatric Population (STOPP) Consortium. Incident vertebral
fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a
national observational study. Arthritis Care Res (Hoboken). 2012 Jan;64(1):122-31. doi:
10.1002/acr.20589.
71. McMurter B, Parker L, Fraser RB, Magee JF, Kozancyzn C, Fernandez CV. Parental Views
on Tissue Banking in pediatric Oncology patients. Pediatr Blood Cancer 2011
(Dec)15;57(7):1217-21 [E pub Jan 2010) PMID 21254370.
72. Birnie K, Noel M, von Baeyer CL, Chambers CT, Fernandez CV. The cold pressor task
(CPT): Is it an ethically acceptable pain research method in children? J Pediatric Psychology
2011 (Nov) 36(10):1071-81. [E pub Oct 5 2010] PMID 20926408.
73. Fernandez CV, Li N, Mullen E, Grundy P, Perlman E, Shamberger R, Ehrlich P, Dome J.
Barriers to the enrolment of children in the Children’s Oncology Group study of very low risk
Wilms’ tumor. A report from the Children’s Oncology Group. J Pediatr Hematology
Oncology 2011 Oct;33(7):521-523. PMID 21941145.
74. Cox K, Fernandez CV, Chambers CT, Bandstra NF, Parker JA. Impact on Parents of
Receiving Individualized Feedback of Psychological Testing Conducted With Children as Part
CV – Conrad Fernandez, MD, FRCP(C)
18
of a Research Study. Accountability in Research 2011 Sep-Oct;18(5):342-56. PMID
21916741.
75. Tsangaris E, Klaassen R, Fernandez CV, Yanofsky R, Scherek E, Champagne J, Silva M,
Lipton JH, Brossard J, Samson Y, Abish S, Steele M, Ali K, Dower N, Athale U, Jardine L,
Hand JP, Stephen D, Odame I, Canning P, Allen C, Beyene J, Dror Y. Genetic analysis of
inherited bone marrow failure syndromes from the CIMFR comprehensive cohort of Canadian
patients. J Med Genet 2011 Sep;48(9):618-28. [E pub 2011 Jun 9].
76. Hashmi SK, Klaassen R, Fernandez CV, Yanofsky R, Wu J, Champagne J, Silva M, Lipton
JH, Brossard J, Samson Y, Abish S, Steele M, Ali K, Dower N, Athale U, Jardine L, Hand JP,
Allen C, Beyene J, Dror Y. Comparative analysis of Shwachman-Diamond Syndrome to
Other Inherited Bone Marrow Failure Syndromes and Genotype-Phenotype Correlation.
Clinical Genetics 2011 (May) 79:5:448-458 [E pub 22 May 2010] doi: 10.1111/j.1399-
0004.2010.01468.
77. Fernandez CV, Fraser G, Freeman C, Grunfeld E, Gupta A, Mery LS. Schechter B for the
Canadian Task Force on Adolescents and Young Adults with Cancer. Principles and
Recommendations for the Provision of Health Care in Canada to AYA with Cancer and
Survivors of Cancer as AYA and Children. J Adolescent Young Adult Oncology 2011
(May);1(1):53-59.
78. Hilliard R, Fernandez CV, Tsai E and the Canadian Pediatrics Society Bioethics Committee.
Ethical participation of children and youth in medical education. Position statement. Pediatr
Child Health 2011 (Apr);16(4):223-232. PMID 22468127.
79. Fabsitz RB, McGuire A, Sharp RR, Hudson K, Pandey M, Beskow LM, Biesecker LG,
Bookman E, Burke W, Burchard EG, Church G, Wright Clayton E, Eckfeldt J, Fernandez
CV, Fisher R, Fullerton SM, Gabriel S, James C, Jarvik G, Kittles R, Leib J, O’Donnell C,
O’Rourke RP, Lyman Rodriguez L, Romero F, Schully SD, Shuldiner AR, Sze RF, Thakuria
J, Wolf SM, Burke GL. Ethical and Practical Guidelines for Reporting Genetic Research
Results to Study Participants: Updated Guidelines from an NHLBI Working Group.
Circulation: Cardiovascular Genetics 2010 (Dec);3:574-580. PMID 21156933.
80. Abbott LS, Deevska M, Fernandez CV, Dix D, Price VE, Wang H, Parker L, Yhap M,
Fitzgerald C, Barnard D, Berman JN. The Impact of Prophylactic Cryoprecipitate and Fresh
Frozen Plasma on the Incidence of CNS Thromboses in Children with Acute Lymphoblastic
Leukemia Receiving Asparaginase. Blood 2009 Dec 10;114(25):5146-51. [Pre-published
online October 12, 2009; DOI 10.1182] PMID 19822902.
81. Quackenbush KE, Luna-Fineman S, Magee JF, Gundogan M, Golobi M, Takeshi I,
Fernandez CV. Neuroblastoma involvement of the falx cerebri. Pediatr Blood Cancer 2009
Dec 15;53(7):1337-9. PMID 19821537.
82. Read K, Fernandez CV, Gao J, Strahlendorf C, Moghrabi A, Pentz R, Barfield R, Baker J,
Santor D, Kodish E, Weijer C. Decision-making by adolescents and parents of children with
cancer regarding health research participation. Pediatrics 2009 Sept 12;4(3):959-956. [Epub
2009 Aug 10] PMID 19706586.
83. Bebbington M, Langley JM, Fernandez CV. Clinical Vignette: Fever and purpuric lesions in
a preschooler. The Canadian Journal of Infectious Diseases and Medical Microbiology 2009
(Aug) 20(3): e110-111. PMID 20808451.
84. Henry H, Fernandez CV, Corsten G. Post transplant lymphoproliferative disorder in an
adolescent masquerading as a complicated primary EBV infection. BMJ Case Reports 2009;
doi:10.1136/bcr.04.2009.1758 [Published 9 June 2009] PMID 21686965.
CV – Conrad Fernandez, MD, FRCP(C)
19
85. Guernsey DL, Jiang H, Campagna DR, Evans SC, Ferguson M, Kellogg MD, Lachance M,
Matsuoka M, Nightingale M, Rideout A, St-Amant L, Schmidt PJ, Orr A, Bottomley SS,
Fleming MD, Ludman M, Dyack S, Fernandez CV, Samuels ME. Mutations in
mitochondrial carrier family member SLC25A38 cause non-syndromic autosomal recessive
congenital sideroblastic anemia. Nature Genetics 2009 Jun;41(6):651-3. [Epub 2009 May 3]
PMID 19412178.
86. Baker JM, Lewis VA, Fernandez CV, Duval M, Crooks BN, Yuille K, Freedman MH, Doyle
JJ, and Dror Y. Allogeneic Hematopoietic Stem Cell Transplantation of Patients with Fanconi
Anemia and High Risk Features Using Fludarabine without Radiation. Pediatic Blood Cancer
2009 May;52(5):683-5. PMID 19156855.
87. Halton J, Gaboury I,Grant R, Alos N, Cummings EA, Matzinger M, Shenouda N, Lentle B,
Abish S, Atkinson S, Cairney E, Dix D, Israels S, Stephure D,Wilson B, Hay J, Moher D,
Rauch F,Siminoski K, Ward LM and the Canadian STOPP Consortium. Advanced Vertebral
Fracture Among Newly Diagnosed Children With Acute Lymphoblastic Leukemia: Results of
the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) Research
Program. J Bone Mineral Research 2009 24(7):1326-1134 [Published online on February 9,
2009] doi: 10.1359/JBMR.090202.
88. Fernandez CV, Gao J, Strahlendorf, C, Moghrabi A, Pentz RD, Barfield RC, Baker JN,
Santor D, Weijer C, Kodish E. The return of research results to participants: Attitudes and
needs of adolescents and parents of children with cancer. Journal of Clinical Oncology 2009
Feb;27(6):878-83. [E pub 21 Jan 2009] Profiled: Hem/Onc Today, 2009. PMID 19164211.
89. Fernandez CV, Anderson J, Breslow NE, Dome JS, Grundy PE, Perlman EJ, Green DM, and
the National Wilms Tumor Study Group/Children’s Oncology Group. Anthropomorphic
measurements and event free survival in patients with favourable histology Wilms tumor: A
report from the Children’s Oncology Group. Pediatr Blood Cancer 2009 (Feb);52(2):254-258.
[E pub 6 Nov 2008] PMID 18989885.
90. Rowan Legge A, Weijer C, Gao J, Fernandez CV. A comparison of journal instructions
regarding institutional review board approval and conflict of interest between 1995 and 2005. J
Med Ethics 2009 (Jan);35:74-78.
91. Fernandez CV. Physician obligations to patients in clinical research. Bioethics Education
Project. Royal College of Physicians and Surgeons of Canada. 2009 (Jan). Available at:
Section VII. http://rcpsc.medical.org/bioethics/cases/index.php
92. Fernandez CV. Public expectations for return of results - time to stop being paternalistic?
AJOB 2008 (Nov);8:46-48.
93. Berman JN, Greer, WL, Loh M, Riddell C, Morash B, Dumas N, Fernandez CV, Ludman M.
JAK2 V617F Positive polycythemia vera in a child with neurofibromatosis type I. Pediatr
Blood Cancer 2008 (Nov);51(5):689-91. [E print 2008 July 11] PMID 18623221.
94. Tsai E, principal author. Fernandez CV, member of committee. Advance care planning for
pediatric patients. Position statement (B2008-02). Statement of the Canadian Pediatric
Society. Pediatr Child Health 2008 13(9):791-796. PMID 19061110.
95. Fernandez CV (lead author). Ethical Issues in Health Research in Children. Canadian
Paediatric Society Position Statement. Bioethics Committee. Pediatr Child Health 2008
(Oct);13(8):707-712. (Parent supplement:
www.caringforkids.cps.ca/healthybodies/HealthResearch.htm).
96. Finlay KA, Fernandez CV. Failure to report and provide commentary on research ethics
board approval and informed consent in medical journals. J Med Ethics
2008(Oct);34(10):761-764.
CV – Conrad Fernandez, MD, FRCP(C)
20
97. Teo TJ, Klaassen R, Fernandez CV, Yanofsky R, Wu J, Champagne J, Silva M, Lipton JH,
Brossard J, Samson Y, Abish S, Steele M, Ali K, Dower N, Athale U, Jardine L, Hand JP,
Maniatis G, Beyene J, Dror Y. Unclassifiable inherited bone marrow failure syndrome: A
report from the Canadian Inherited Marrow Failure Registry (CIMFR). Pediatrics 2008
(July);122:e139-148. PMID 18595958.
98. Simpson CD, Gao J, Fernandez CV, Yhap M, Price VE, Berman JN. Routine Bone Marrow
Examination in the Initial Evaluation of Pediatric Hodgkin’s Disease: The Canadian
Perspective. Br J Hematology 2008 (June);141(6):820-826. [E pub 18 April 2008] PMID
18422997.
99. Wang C, Camfield CS, Fernandez CV, Hurley T, Campbell K. Successful Neurological
Outcome of a Child with Classical Phenylketonuria and Acute Lymphoblastic Leukemia: A
Seven Year Follow Up. American Journal of Medical Genetics 2007 Dec 15;143A(24):3324-
7. [E pub 4 May 2007] PMID 17480007.
100. Benedict J, Simpson C, Fernandez CV. Validity and consequence of informed consent in
pediatric bone marrow transplantation: The parental experience. Pediatr Blood & Cancer
2007 (Nov);49:846-851. [E pub 6 Oct 2006] PMID 17029247.
101. Kozanczyn C, Collins K and Fernandez CV. Providing Research Results to Study
Participants: US Institutional Review Board Guidance. Accountability in Research 2007
(Oct);14(4):255-267. PMID 18246944.
102. MacNeil SD, Fernandez CV. Attitudes of Research Ethics Board Chairs toward disclosure of
research results to research participants. Results of national survey. J Med Ethics 2007
(Sept);33:549-553. PMID 17761827.
103. J Brown, E Cooper, L Frankton, M Steeves-Wall, J Gillis-Ring, W Barter, A McCabe, CV
Fernandez. Complementary and alternative therapies: Survey of knowledge and attitudes of
health professionals at a tertiary pediatric/women’s care facility. Complementary therapiesin
Clinical Practice 2007 (Aug);13(3):194-200. PMID 17631262.
104. Rigby H, Fernandez CV, Langley J, Mailman T, Crooks BNA, Higgins A. Routine
surveillance for bloodstream infections in a pediatric hematopoietic stem cell transplant
cohort: do patients benefit? Can J Infect Dis & Med Microbiol 2007 (July/Aug);18:253-256.
PMID 18923737.
105. Fernandez CV. Abnormal volunteer results. AHRQ WebM&M [serial online] June 2007.
Available at: http://www.webmm.ahrq.gov/case.aspx?caseID=153. Accessed June 11, 2007.
106. Lefaivre MJ, Chambers CT, Fernandez CV. Providing parents with individualized feedback
on the results of psychological testing conducted for research purposes with children: Ethical
issues and Guidelines. J Clin Child Adoles Psychiatr 2007 (Jun);36(2)242-252. Awarded:
Michael Enzle Memorial Award for best graduate student peer-reviewed publication in the
area of research ethics and human participant protection in research. Co-sponsored by the
National Council on Ethics in Human Research, Canadian Institutes of Health Research and
the Interagency Panel on Research Ethics. Ottawa, Canada. 2008. PMID 17484696.
107. Fernandez CV. The return of research results to participants: an ongoing debate modeled in
cancer research. Harvard Health Policy Review 2007 (Spring);8(1):16-28.
108. Fernandez CV, Santor D, Weijer C, Strahlendorf C, Moghrabi A, Pentz R, Gao J, Kodish E.
The return of research results to participants: Pilot questionnaire of adolescents and parents of
children with cancer. Pediatr Blood & Cancer 2007 (Apr); 48(4):441-6. [E pub 19 Jan 2006].
109. Fernandez CV. Our moral obligations in caring for patients with orphan cancers. CMAJ
2007 (Jan) 176(3):297-9. PMID 17261816.
CV – Conrad Fernandez, MD, FRCP(C)
21
110. Joffe S, Fernandez CV, Pentz RD, Ungar DR, Matthew NA, Alessandri AJ, Woodman CL,
Singer DA, Kodish E. Guidelines for involving children in decision-making about research
participants. J Pediatr 2006 (Dec);149(6):862-868. PMID 17137908.
111. Steele JM, Sung L, Klaassan R, Fernandez CV, Yanofsky R, Wu J, Odame I, Silva M, Ali K,
Brossard J, Samson Y, Champagne J, Abish S, Le D, Jardine L, Hand JP, Dower N, Lipton J,
Charpentier K, Freedman M, Morgovsky L, Stephens D, Dror Y. Disease progression in
recently diagnosed patients with inherited marrow failure syndromes: A report from the
Canadian Inherited Marrow Failure Registry. Pediatr Blood & Cancer 2006 (Dec);47(7):918-
925. [E pub 4 May 2006].
112. Fernandez CV, Weijer C. Obligations in offering to disclose genetic research results.
American Journal of Bioethics 2006 (Nov-Dec);6(6):44-46. PMID 17085409.
113. Baruchel S, Diezi M, Hargrave D, Stempak D, Gammon J, Moghrabi A , Coppes M,
Fernandez CV, and Bouffet E. Safety and pharmacokinetics of Temozolomide using a
dose-escalation, metronomic schedule in recurrent pediatric brain tumors. Eur J Cancer 2006
(Sept);42(14):2335-42. [E pub 7 Aug 2006].
114. Fernandez CV. Ethical Issues Arising in the Return of Research Results to Research
Participants. Bioethics Education Project. Royal College of Physicians and Surgeons of
Canada. April 2006. http://rcpsc.medical.org/bioethics/cases/case_7_3_5_e.php
115. Satyanarayana S, Cummings EA, Fernandez CV, Barnard D. Hyperphagia following Acute
Lymphoblastic Leukemia - A symptom worth heeding. Clin Pediatr (Phil) 2006 (Apr);
45(3):271-273.
116. Fernandez CV, Barr R. Adolescents and young adults with cancer: an orphaned population.
Pediatr & Child Health 2006 (Feb);11(2):103-106. PMID 19030262.
117. MacNeil SD, Fernandez CV. Informing research participants of research results: analysis of
Canadian university-based research ethics board policies. J Med Ethics 2006 (Jan);32(1):49-
54.
118. Yu W, Fraser RB, Gaskin DA, Fernandez CV, Wright JR. C-kit positive metastatic
pigmented clear cell epithelioid tumor (Malignant PEComa) arising from the kidney in a child
without tuberous sclerosis. Ann Diagnost Path 2005 (Dec);9(6):330-334.
119. Fernandez CV, Fraser RB, Magee F. The crucial role tumor specimen handling plays in
childhood cancer outcomes. Pediatr & Child Health 2005 (Oct);10(8):471-472.
120. Rigby H, Fernandez CV. Providing research results to study participants: support versus
practice of researchers presenting at the American Society of Hematology annual meeting.
Blood 2005 (Aug);106(4):1199-1201 [E pub 5 May 2005].
121. Steele M, Hitzler J, Doyle JJ, Yuille K, Fernandez CV, Dror Y. Low-intensity hematopoietic
stem-cell transplantation across human leukocyte antigen barriers in a patient with congenital
amegakaryocytic thrombocytopenia and monosomy 7. Pediatr Blood & Cancer 2005
Aug;45(2);212-6. [E pub 21 Mar 2005].
122. Losier A, Taylor B, Fernandez CV. Use of alternative therapies in patients presenting to a
pediatric emergency department. J Emerg Med 2005;28(3):267-271. Reprinted in: Yearbook
of Emergency Medicine 2006, Quintana E ed. 2006.
123. Rigby H, Schmidt M, Yu W, Fernandez CV. Lack of response of a metastatic renal PEComa
to successive courses of DTIC based therapy and imatinib mesylate. Pediatr Blood & Cancer
2005 Aug;45(2):202-6. [E pub 9 Feb 2005].
CV – Conrad Fernandez, MD, FRCP(C)
22
124. Fernandez CV, Taweel S, Kodish ED, Weijer C. Disclosure of research result to research
participants: Needs and attitudes of adolescents and parents. Pediatr Child Health
2005;10(6):332-334.
125. Conway J, Dyack S, Crooks BNA, Fernandez CV. Mixed donor chimerism and low level
iduronidase expression may be adequate for neurodevelopmental protection in Hurler’s
syndrome. J Pediatr 2005 (Jul);147(1):106-8.
126. Anglesio MS, Evdokimova V, Melnyk N, Zhang L, Fernandez CV, Grundy PE, Leach S,
Marra MA, Brooks-Wilson AR, Penninger J, Sorensen PH. Differential expression of a novel
ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumour versus
normal kidney. Hum Mol Genet 2004;13(18): 2061-2074.
127. Macfarlane RJ, McCully BJ and Fernandez CV. Induction therapy without tumor lysis
syndrome for pediatric leukemia patients with marked hyperleukocytosis treated with
rasburicase. Pediatr Neophrol 2004;19(8):924-927.
128. Fernandez CV, Skedgel C, Weijer C. Consideration and costs of disclosing study findings to
research participants. CMAJ 2004;170(9):1417-1419.
129. Fernandez CV. Context in shaping the ability of a child to assent to research. Amer J
Bioethics 2003;3(4):29-30.
130. Fernandez CV, Gillis-Ring J. Strategies for the Prevention of Medical Error in Pediatrics. J
Pediatr 2003;143(2):155-162.
131. Fernandez CV, Kodish ED, Shurin SB, Weijer C. Disclosure of the right of research
participants to receive research results: Attitudes and needs of principal investigators in the
Children’s Oncology Group. J Pediatr Hemat Oncol 2003;25(9):704-708.
132. Shouldice E, Fernandez CV, McCully B, Schmidt M, Fraser R, Cook C. Successful
treatment of disseminated osteomyelitic and hepatosplenic aspergillosis in a patient with acute
undifferentiated leukemia. J Pediatr Hemat Oncol 2003;25(9):732-734.
133. Fernandez CV, Kodish ED, Taweel S, Shurin SB, Weijer C. Disclosure of the right of
research participants to receive research results: An analysis of consent forms in the
Children’s Oncology Group. Cancer 2003;97(11):2904-2909.
134. Fernandez CV, Kodish E, Weijer C. Returning research results to subjects. An ethical
imperative. IRB: Ethics & Human Research 2003;25(3):12-19.
135. Beresford L, Fernandez CV, Cummings E, Sanderson S, Ming-Yu W, Giacomantonio M.
Mediastinal polyembryoma associated with Klinefelter’s syndrome. J Pediatr Hemat Oncol
2003;25(4): 321-323.
136. McMulkin HM, Yanchar NL, Fernandez CV, Giacomantonio C. Sentinel lymph node
mapping and biopsy: a potentially valuable tool in the management of childhood extremity
rhabdomyo-sarcoma. Pediatr Surg Int 2003 Aug;19(6):453-6. [E pub May 10 2003].
137. Fernandez CV, Gordon K, Van Den Hof M, Baylis F. Knowledge and attitudes of pregnant
women with regard to collection, testing and banking of cord blood stem cells. CMAJ 2003
(Mar);168:695-698.
138. Ljungman G, McGrath PJ, Cooper E, Widger K, Ceccolini J, Fernandez CV, Frager G,
Wilkins K. Psychosocial needs of families with a child with cancer. J Pediatr Hemat Oncol
2003;25: 223-231.
139. Fernandez CV, Lestou V, Wildish J, Lee CLY Sorensen P. Detection of a novel t(6;15)
(q21;q21) translocation in a pediatric Wilms tumor. Cancer Genetics and Cytogenetics
2001;129(2):165- 167.
CV – Conrad Fernandez, MD, FRCP(C)
23
140. Kim A, Fernandez CV , Greer WL, Hogg D, Lassam N, Resch L. Concurrent acute lympho-
blastic leukemia and juvenile pilocytic astrocytoma in a pediatric patient. Am J Ped Hem
Oncology 2000;2:451-453.
141. Fernandez CV. Can we prevent cytotoxic disasters? Br J Hematology 2000;108:464-469.
142. Fernandez CV, Esau R, Hamilton D, Fitzsimmons B, Pritchard S. Intrathecal vincristine: an
analysis of reasons for a recurrent fatal chemotherapeutic error with recommendations for
prevention. J Pediatr Hemat/Oncol 1998;20:587-590.
143. Fernandez CV, Stutzer C, MacWilliam L, Fryer C. Alternative and complementary therapy
use in pediatric oncology patients in British Columbia. Prevalence of and reasons for use or
non-use. J Clin Oncol 1998;16:1279-1286.
144. Schultz KR, Fernandez CV, Israel DM, Magee F, Wensley D, Sargent MA, Abella E,
Karanes C. Association of gastroesophageal reflux with obstructive lung disease in children
after allogeneic bone marrow transplantation. Blood 1995;85:3763-3765.
145. CV Fernandez. Pediatric Bone Marrow Transplantation: Ethical Considerations. Annals
RCPSC 1994;27:291-295.
146. CV Fernandez and EP Rees. Pain Management in Canadian Level III Neonatal Intensive
Care Units. Can Med Assoc J 1994;150:499-504.
147. Finley GA, MacManus B, Sampson SE, Fernandez CV and Retallick R. Delayed Seizures
following sedation with propofol: Report of two pediatric cases. Can J Anes 1993;40:863-865.
148. CV Fernandez, R Bortolussi, KE Gordon, JG Gatien, SHS Lee, MS Shadrabadi.
Mycoplasma pneumoniae infection associated with central nervous system complications. A
report of two cases and review of the literature. J Child Neuro 1993;8:27-31.
149. CV Fernandez. Hallucinations induced by an antihistamine-decongestant mixture. Can Fam
Phys 1992;38:2184-2186.
CV – Conrad Fernandez, MD, FRCP(C)
24
ABSTRACTS SUBMITTED:
1. Kalapurakal JA, Paulino AC, Chi YY, Kim Y, Ji L, Ehrlich PF, Perlman EJ, Mullen EA,
Geller JI, Khanna G, Fitzgerald TJ, Laurie F, Tochner Z, Hamilton TE, Gow KW,
Shamberger RC, Grundy PE, Dome JS, Fernandez CV. Impact of radiation therapy on
patterns of relapse and survival in children with stage III favorable histology Wilms tumor.
Submitted to ASTRO. San Antonio, TX. Oct 2018
2. Tutelman, P.R., Chambers, C.T., Stinson, J.N., Parker, J.A., Irwin, K., Witteman, H., Barwick,
M., Fernandez, C., Jibb, L., Campbell, F., & Nathan, P. Evaluating the Engagement of
Patients and Parents as Research Partners in a Knowledge Translation Intervention to Improve
Children’s Cancer Pain Management. Poster submitted for presentation at the IASP 17th
World Congress on Pain, Boston, MA. Sept 2018.
3. M-E Robinson, J Ma, N Alos, S Atkinson, D Cabral, R Couch, E A Cummings, J Feber R M
Grant, J Ho, J L Jaremko, B Lentle, M Matzinger, H Nadel, C Rodd, A Sbrocchi, N Shenouda,
R Stein, D Stephure, F Rauch, K Siminoski, L M Ward, and the Canadian STOPP
Consortium. The Incidence of Vertebral Fractures in Pediatric Nephrotic Syndrome in the Six
Years Following Glucocorticoid Initiation. Submitted to the American Society for Bone and
Mineral Research Conference. September 2018. Montreal, PQ.
4. Geller JI, Cost NG, Chi YY, Perlman E, Cajaiba M, Khanna G, Mullen E, Kalapurakal J,
Tracy E, Ehrlich PF, Dome J and Fernandez CV. Trial in Progress – Children’s Oncology
Group (COG) Study AREN 1721: A Randomized Phase 2 Trial of Axitinib/Nivolumab
combination therapy vs single agent Axitinib or Nivolumab for Translocation Renal Cell
Carcinoma (tRCC) across all age groups. Submitted to the Kidney Cancer Association annual
meeting. November 2018. Miami, Fl.
5. James I. Geller, Nicholas G. Cost, Mariana Cajaiba, Yueh-Yun Chi, Elizabeth J. Perlman,
Yeonil Kim, , Elizabeth A. Mullen, Richard D. Glick, Geetika Khanna, Najat C. Daw, Peter F.
Ehrlich, Conrad V. Fernandez, Jeffrey S. Dome. A Prospective Study of Pediatric Renal
Cell Carcinoma: A Report From the Children’s Oncology Group (COG) Study AREN0321.
Submitted to the Kidney Cancer Association annual meeting. November 2018. Miami, Fl.
6. Sharon E. Plon, Sarah Scollon, Steve Joffe, Jaclyn Biegel, Shashikant Kulkarni, George Miles
Conrad V Fernandez Pediatric MATCH Germline Reporting Committee, D. Williams
Parsons. Germline reporting in the NCI-COG Pediatric MATCH National Precision Oncology
Trial. Submitted to the American Society of Human Genetics. October 2018. San Diego, Ca.
ABSTRACTS:
1. Murali Chintagumpala, Elizabeth Perlman, Yeonil Kim, Fred Hoffer, John Kalapurakal, Ann
Warwick, Robert Shamberger, Geetika Khanna, Tom Hamilton, Ken Gow, Arnold Paulino,
Eric Gratias, Elizabeth Mullen, James Geller, Paul Grundy, Conrad Fernandez, Michael L
Ritchey, James Dome, and Peter Ehrlich. Outcomes based on histopathologic response to pre-
operative chemotherapy in children with bilateral wilms tumor-a prospective study (COG
AREN0534). Accepted to SIOP annual meeting. Kyota, Japan. November 2018. Oral
presentation.
CV – Conrad Fernandez, MD, FRCP(C)
25
2. Peter F Ehrlich, Murali M Chintagumpala, Yueh-Yun Chi, Frederic A Hoffer, Elizabeth J
Perlman, John A Kalapurakal, Ann Warwick, Robert C Shamberger, G Khanna, Tom E
Hamilton, Ken W Gow, Richard Glick, Arnold C Paulino, Eric J Gratias, Elizabeth A Mullen,
James I Geller, Paul E Grundy, Conrad V Fernandez , Michael L Ritchey, and James S
Dome. Nephron Sparing Surgery and Outcomes of Bilaterally-Predisposed Unilateral Wilms
Tumors. A report from the Children’s Oncology Group Study ARENO534. Accepted Plenary.
American Pediatric Surgery Association meeting. Palm Desert, CA. May 2018.
3. Geller J, Cost N, Chi YY, Perlman E, Kim Y, Cajaiba M, Mullen E, Glick R, Khanna G, Daw
N, Ehrlich P, Fernandez CV, Dome JS. A prospective study of pediatric renal cell carcinoma:
A report from the Children’s Oncology Group. Accepted for oral presentatation at the Annual
meeting of ASCO. Chicago, Ill. June 2018.
4. Parker, J.A., Chambers, C.T., Stinson, J.N., Tutelman, P.R., Drake, E.K., Barwick, M.,
Campbell, F., Fernandez, C.V., Irwin, K., Jibb, L., Nathan, P., Witteman, H. (2017, May).
The reach of the #KidsCancerPain Campaign: A partnership to improve parent awareness and
use of evidence-based pain management in children with cancer. Poster accepted for
presentation at the 39th Annual Canadian Pain Society Scientific Meeting, May 2018.
Montreal, QC.
5. Tutelman, P.R., Chambers, C.T., Stinson, J.N., Parker, J.A., Drake, E.K., Barwick, M.,
Campbell, F., Fernandez, C. V., Irwin, K., Jibb, L.., Nathan, P.C., & Witteman, H. (2018,
April). Making Cancer Less Painful for Kids: Partnering with an Online Cancer Education
Resource to Reach Parents with Evidence-Based Cancer Pain Information. In A. Kzazk,
Innovative interventions for children with cancer and their families. Workshop accepted for
presentation at the 2018 Society of Pediatric Psychology Annual Conference (SPPAC),
Orlando, Florida.
6. Iaboni DSM, Chi YY, Dome JS, Fernandez CV. Outcome of Wilms Tumor patients with
bone metastasis enrolled on National Wilms Tumor Studies 1-5: A report from the Children’s
Oncology Group. Accepted for oral presentation at the Department of Pediatrics Annual
Research Trainee Day. April 2018. Halifax, NS.
7. Parsons L, Mullen EA, Geller J, Chi YY, Khanna G, Glick R, Vallance K, Kim Y, Cajaiba
MM, Fernandez CV, Dome JS, Perlman EJ. Outcome Analysis of Stage 1 Epithelial
Favorable Histology Wilms tumors. Annual meeting Society for Pediatric Pathology.
Vancouver, BC. March 2018
8. Goldstein JA, Jennings LJ, Chi YY, Mullen EA, Geller J, Vallance K, Fernandez CV, Dome
JS, Perlman EJ, Cajaiba MM. BRAF exon 15 mutations in the evaluation of well-
differentiated epithelial nephroblastic neoplasms in children. Annual meeting Society for
Pediatric Pathology., Vancouver, BC. March 2018.
9. Lauhasurayotin S, Shabanova I, Li H, Dhanraj S, Zlateska B, Klaassen RJ, Fernandez C,
Cuvelier GDE, Wu JK, Pastore YD, Silva M, Lipton JH, Brossard J, Michon B, Abish S,
Steele M, Sinha R, Belletrutti MJ, Breakey VR, Jardine L, Goodyear L, Sung L, Shago M,
Cada M, Stephen SW and DrorY. Re-analysis of next generation sequencing gene panel data
by normalized coverage values reveals previously undetected copy number variations in
inherited bone marrow failure syndrome. Presented at the American Society of Hematology
annual meeting. Abstract 2460. Dec 2017.
CV – Conrad Fernandez, MD, FRCP(C)
26
10. JA Parker, CT Chambers, JN Stinson, PR Tutelman, E Drake, M Barwick, F Campbell, CV
Fernandez, K Irwin, L Jibb, P Nathan, & H Witteman. The Reach of the #KidsCancerPain
Campaign: A Partnership to Improve Parent Awareness and Use of Evidence-Based Pain
Management in Children with Cancer. Presented at the International Forum on Pediatric Pain
(IFPP). White Point, NS. October 2017.
11. Tutelman, P, Chambers, C., Stinson, J., Parker, J., Stinson, H., Barwick, M., Campbell, F.,
Fernandez, C., Irwin, K., Jibb, L., Nathan, P., & Witteman, H. The Implementation of a
Freely Available Smartphone App to Assess Pain and Its Impact in Children with Cancer.
Poster presented at the 2017 Society of Pediatric Psychology Annual Conference. March
2017.Portland, OR.
12. Sandberg J, Smith E, Cajaiba M, Servaes S, Mullen E, Ehrlich P, Geller J, Dome J, Fernandez
C, Khanna G. Pediatric renal medullary carcinoma - distinctive imaging findings: a report
from the Children's Oncology Group. SPR. Vancouver, BC. May 2017. Pediatr Radiol 2017;
47 (Suppl 1):S162.
13. MacLellan, Dawn L., Karakach, Tobias K., Romao, Rodrigo L.P., Fernandez Conrad V.
Urinary Metabolite alterations in Wilms’ Tumor. Oral presentation Society of Pediatric
Urology annual meeting, Montreal, PQ September 2017.
14. LS Penney, E. Aberg, K. Harrison, J. Brock, C. Fernandez, J. Frazer. Beckwith-Wiedemann
Syndrome Caused by Non-Mosaic uniparental Disomy of the Complete Chromosome 11.
European Society of Human Genetics. 27-30 May, 2017. Copenhagen, Denmark.
15. Perri R. Tutelman, Christine T. Chambers, Jennifer N. Stinson, Jennifer A. Parker, Barwick,
M., Campbell, F., Fernandez, C., Irwin, K., Jibb, L., Nathan, P. & Witteman, H. Using
Thunderclap To Raise Awareness About #Kidscancerpain Over Social Media. Oral
presentation. SIOP annual meeting. October 2017. Washington, DC. Pediatr Blood Cancer
2017;64:226772.S80.
16. Najat C. Daw, Yueh-Yun Chi, Yeonil Kim, John A. Kalapurakal, Fredric A. Hoffer, James I.
Geller, Elizabeth J. Perlman, Peter F. Ehrlich, Elizabeth A. Mullen, Anne Warwick, Paul E.
Grundy, Eric Gratias, Deborah Ward, James R. Anderson, Rajkumar Venkatramani, Conrad
Fernandez and Jeffrey S. Dome on behalf of the AREN0321 Study Committee. Effect of
chemotherapy dosage on outcome in the treatment of stage II – IV diffuse anaplastic Wilms
tumor: results from the Children’s Oncology Group AREN0321 study. Oral presentation.
SIOP annual meeting. October 2017. Washington, DC. Pediatr Blood Cancer
2017;64:226772.S44.
17. Elizabeth Mullen, Elizabeth Perlman, Yueh-Yun Chi, David Dix, Eric Gratias, Julie Gastier-
Foster, Geetika Khanna, Peter Ehrlich, James Geller, John Kalapurakal, Conrad Fernandez,
Jeff Dome, COG Renal Tumors Committee. Impact of 1q status on outcomes of Stage IV
Favorable Histology Wilms Tumor (FHWT) patients treated on Children’s Oncology Group
(COG) Study AREN0533: on behalf of the Renal Tumor Committee. Oral presentation. SIOP
annual meeting. October 2017. Washington, DC. Pediatr Blood Cancer 2017;64:226772.S43.
18. E Smith , P Ehrlich, G Khanna, K Gow, T Hamilton, S Servaes, D Barnhart, R Glick, R
Dasgupta, F Ferrer, E Mullen, J Geller, C Fernandez, J Kalapurakal,E Gratias, J Dome, D
Dix. Feasibility of Complete Resection of Residual Lung Nodules after Chemotherapy in
Patients with Stage IV Favorable Histology Wilms Tumor (WT). A report from the COG
CV – Conrad Fernandez, MD, FRCP(C)
27
AREN0533 study. Oral presentation. SIOP annual meeting. October 2017. Washington, DC.
Pediatr Blood Cancer 2017;64:226772.S84.
19. James I. Geller, Yueh-Yun Chi, John A. Kalapurakal, Najat Daw, Yeonil Kim, John A.
Kalapurakal, Fredric A. Hoffer, Elizabeth J. Perlman, Peter F. Ehrlich, Elizabeth A. Mullen,
Anne Warwick, Arnold Paulino, Zelig Tochner, Kenneth Gow, Paul E. Grundy, Eric Gratias,
Deborah Ward, James R. Anderson, Conrad Fernandez and Jeffrey S. Dome on behalf of the
AREN0321 Study Committee. Rhabdoid Tumor: Results From The Children’s Oncology
Group Aren0321 Study. Oral presentation. SIOP annual meeting. October 2017. Washington,
DC. Pediatr Blood Cancer 2017;64:226772.S245.
20. Tutelman, P., Chambers, C., Stinson, J., Parker, J., Stinson, H., Barwick, M., Campbell, F.,
Fernandez, C., Irwin, K., Jibb, L., Nathan, P., & Witteman, H. (2017, May). Physical and
psychological interventions for pediatric cancer pain management. Poster presented at the
Canadian Pain Society 2017 Annual Scientific Meeting, Halifax, NS.
21. Tutelman, P, Chambers, C., Stinson, J., Parker, J., Irwin K, Barwick, M., Campbell, F.,
Fernandez, C., Irwin, K., Jibb, L., Nathan, P., & Witteman, H. Home-based management of
pediatric cancer pain. Poster presentation to the International Symposium on Pediatric Pain
(ISPP). July 2017. Kuala Lumpur, Malaysia.
22. Iaboni DSM, Chi YY, Dome JS, Fernandez CV. Outcome of Wilms Tumor patients with
bone metastasis enrolled on National Wilms Tumor Studies 1-5: A report from the Children’s
Oncology Group. Poster presented at the annual meeting of ASPHO. Apr 26-29, 2017.
Montreal, PQ.
23. Tutelman, P, Chambers, C., Stinson, J., Parker, J., Stinson, H., Barwick, M., Campbell, F.,
Fernandez, C., Irwin, K., Jibb, L., Nathan, P., & Witteman, H. The Implementation of a
Freely Available Smartphone App to Assess Pain and Its Impact in Children with Cancer.
Poster presented at the 2017 Society of Pediatric Psychology Annual Conference. March
2017.Portland, OR.
24. V.N. Rahimzadeh , C. Schickhardt , J. Friedman , M.C. Cornel , S. Pfister , D. Avard , D.F.
Vears , K. Sénécal , W. Pinxten , C. Fernandez , S. Plon , A. Thorogood , B.M. Knoppers , E.
Winkler. The sharing of genomics and health-related data from children: a case of big data and
little ethics? Presented at the 66th Annual Meeting of The American Society of Human
Genetics, Program number 3059. October 2016, Vancouver, Canada.
25. Ketan Kulkarni, Zeina Asyyed, Tamara MacDonald, Victoria Price, Conrad Fernandez,
Mark Bernstein. Body Mass Index is independently associated with symptomatic venous
thrombotic events in pediatric oncology patients: A study from Maritimes, Canada. ISTH.
Montpellier, France. May 2016.
26. Ketan Kulkarni, Tamara MacDonald, Carol Digout, Krista Rigby, Vicky Price, Conrad
Fernandez, Mark Bernstein. Age, type of cancer and use of asparaginase are independently
associated with requirement of tissue plasminogen activator for episodes of central venous
catheter dysfunction in pediatric oncology patients. E poster presented at SIOP, Dublin,
Ireland. October 2016.
27. Forbrigger Z, Digout C, Fernandez CV, Bernstein M, Kulkarni K. Significantly Inferior year
Overall and Event Free Survival In Pediatric Oncology Patients with Symptomatic Venous
CV – Conrad Fernandez, MD, FRCP(C)
28
Thrombotic events (sVTE) As Compared To Those Without sVTE: A Population Based Study
From Maritimes, Canada. Accepted to ASH San Diego Dec 2016. Oral presentation.
28. Halton J, Ma J, Babyn P, Kaste S, Matzinger, MA, Abish S, Barr R, Cairney E, Dix DB,
Fernandez CV, Grant, RM, Israels S, Laverdière C, Lewis, V, Wilson B, Ward LM and the
Canadian STOPP Consortium. The prevalence of osteonecrosis is high after treatment for
acute lymphoblastic leukemia. E poster presented at SIOP, Dublin, Ireland. October 2016.
29. Ashley Geerlinks, Carol Digout, Mark Bernstein, Andrew Chan, Shannon MacPhee, Chantale
Pambrun, Gloria Gallant, Lois Wyatt, Elizabeth Irving, Conrad Fernandez, Victoria Price.
Improving time to antibiotics for pediatric oncology patients with febrile neutropenia by
applying Lean process improvement methodology. E poster presented at SIOP, Dublin,
Ireland. October 2016.
30. Najat C. Daw, Yueh-Yun Chi, Elizabeth A. Mullen, John A. Kalapurakal, Jing Tian, Geetika
Khanna, James I. Geller, Elizabeth J. Perlman, Peter F. Ehrlich, Anne Warwick, Conrad V.
Fernandez, Paul E. Grundy, and Jeffrey S. Dome on behalf of the AREN0321 Study
Committee. Treatment of stage I focal or diffuse anaplastic Wilms Tumor: A report from the
Children’s Oncology Group. Oral platform presented at SIOP Dublin Ireland October 2016.
31. Fernandez CV, Hebb AO, Bouchard M, Walling SA. Return of genomic results relevant to
personalized decision-making in brain tumor patients. Pilot questionnaire results. E poster.
Presented at SIOP Dublin Ireland October 2016.
32. Kathryn A. Birnie KA, Chambers CT, Chorney J, Fernandez CV, McGrath PJ. Family
Functioning and Parent-Child Coping During Children’s Acute Pain. The Canadian Pain
Society Annual meeting. Vancouver. BC. May 2016.
33. Marissa A. LeBlanc, Amanda Bettle, Jason Berman, Victoria Price, Chantale Pambrun, Zhijie
Yu, Marilyn Tiller, Christopher R. McMaster, Conrad V. Fernandez. Glycine and folic acid
supplementation does not ameliorate transfusion dependence in congenital sideroblastic
anemia. Canadian Statistical and Human Genetics meeting. Halifax, NS April 2016. Poster
presentation.
34. Arbiv OA. Zlateska B, Klaassen RJ, Fernandez C, Yanofsky R, Wu J, Silva M, Lipton JH,
Brossard J, Michon B, Abish S, Steele M, Sinha S, Belletrutti MJ, Breakey VR, Jardine L,
Goodyear L, Sung L, Wahala M, Ghemlas IA, Li H, Cada M, Dror Y. Molecular analysis of
Diamond Blackfan anemia and genotype-phenotype correlation: Experience from the
Canadian Inherited Marrow Failure Registry. Diamond Blackfan Anemia International
Consensus Conference, Atlanta, GA, March 5-7, 2016 SRA
35. Zlateska B, Klaassen R, Fernandez CV, Yanofsky R, Wu J, Silva M, Lipton JH, Brossard J,
Abish S, Steele M, Jardine L, Sinha R, Breakey V, Michon B, Pastore Y, Goodyear L,
Beletrutti M, Waespe N, Dhanraj S, Li H, Cada M, Sung L, Dror Y. Bone Marrow
Characteristics In Shwachman-Diamond Syndrome And Hematological Complications. 8th
International Congress on Shwachman-Diamond Syndrome, Verona, Italy, April 17-20, 2016.
SRA
36. Crooks B, Doyle J, Fernandez C, Spicer C, Shea S. Defending the Donor: When at-Risk
Siblings Cannot Consent. Tandem Bone Marrow Transplant meetings. Hawaii. Feb 2016.
Poster presentation.
CV – Conrad Fernandez, MD, FRCP(C)
29
37. Spicer C, MacLellan D, Fraser R, Crooks BNA, Fernandez CV. Isolated penile meatal
chronic GVHD in a boy following allogeneic transplant for JMML. Tandem Bone Marrow
Transplant meetings. Hawaii. Feb 2016. Poster presentation.
38. Ma J. Hay, B. Martin, B. Wilson, P.M. Miettunen, J. L. Jaremko, A. M. Huber, K Houghton, J.
Ho, R. Grant, D.B. Dix, M. Charron, R. Barr, T. Blydt-Hansen, L.M Ward and the Canadian
STOPP Consortium. Contrasting bone fragility at diagnosis between active and inactive
children with Acute Lymphoblastic Leukemia. Pediatric Work Physiology (PWP) Conference.
Utrecht, Netherlands. September 2015. Published in: Pediatric Exercise Science Volume 28
issue 4 Suppl 1 2016 [doi 10.1123]
39. Nicolas Waespe, Santhosh Dhanraj, Manju Wahala, Tom Enbar, Bozana Zlateska, Hongbing
Li, Robert Klaassen, Conrad V Fernandez, Rochelle A Yanofsky, John Wu, Yves Pastore,
Mariana Silva, Jeff H Lipton, Josee Brossard, Bruno Michon, Sharon Abish, MacGregor
Steele, Roona Sinha, Mark Belletrutti, Vicky R. Breakey, Lawrence Jardine, Lisa Goodyear,
Liat Kofler, Michaela Cada, Lillian Sung, Mary Shago, Stephen Scherer, Yigal Dror. Copy
number variants underlying inherited bone marrow failure syndromes. Blood 2015; 126 (23):
2416 ASH annual meeting. Orlando, FLD. Dec 2015.
40. Omri A Arbiv, Bozana Zlateska, Robert Klaassen, Conrad V Fernandez, Rochelle Yanofsky,
John Wu, Nancy Robitaille, Mariana Silva, Jeff H Lipton, Jossee Brossard, Bruno Michon,
Sharon Abish, MacGregor Steele, Roona Sinha, Mark Belletrutti, Vicky Breakey, Lawrence
Jardine, Lisa Goodyear, Lillian Sung, Manju Wahala, Ibrahim Ghemlas, Hongbing Li,
Michaela Cada, Yigal Dror. Molecular analysis of Diamond Blackfan anemia and genotype-
phenotype correlation; experience from the Canadian Inherited Marrow Failure Registry.
Blood 2015; 126 (23): 3621. ASH annual meeting. Orlando, FLD. Dec 2015.
41. Zeina Asyyed, MacDonald T, Price V, Fernandez C, Bernstein M, Kulkarni K. Assessing
Incidence of and Risk Predictors Ascertained at Diagnosis for Symptomatic Venous
Thrombotic Events in Pediatric Cancer Patients: a 20-Year Population Based Study from the
Maritimes, Canada. Accepted to ASH annual meeting. Orlando, FLD. Dec 2015. Selected for
ASH Abstract Achievement Award and 2016 Highlights of ASH.
42. Lisa Borretta, Tamara MacDonald, Vicky Price, Conrad Fernandez, Mark Bernstein, Ketan
Kulkarni. Management Experience of Peripherally inserted central catheters in Pediatric
Oncology Patients: A 15 year Population-Based Study from Maritimes, Canada. Accepted to
ASH annual meeting. Orlando, FLD. Dec 2015.
43. Ketan Kulkarni, Tamara MacDonald, Vicky Price, Conrad Fernandez, Jason Berman,
Pamala Cox, Mark Bernstein, Bruce Crooks, Samina Afzal, Margaret Yhap. Peripherally
inserted central catheters are significantly associated with symptomatic venous thrombotic
events in pediatric oncology patients: a population based study form Maritimes, Canada.
Submitted to SIOP. Cape Town, S Africa Oct 2015. Pediatr Blood Cancer.2015;62:S293.
44. Ketan Kulkarni, Tamara MacDonald, Carol Digout, Victoria Price, Pamala Cox, Conrad
Fernandez, Mark Bernstein, Margaret Yhap. Symptomatic venous thrombotic events are
associated with significantly increased requirement of central venous catheters in pediatric
cancer patients: a population-based study from Maritimes, Canada. Submitted to SIOP. Cape
Town, S Africa Oct 2015. Pediatr Blood Cancer.2015;62:S168
45. Birnie KA, Chambers CT, Chorney J, Fernandez CV, McGrath P. Predicting child pain
outcomes from child and parent pain catastophizing. Accepted to the International Forum of
Pediatric Pain (IFPP) in White Point, NS October 2015.
CV – Conrad Fernandez, MD, FRCP(C)
30
46. Bozana Zlateska, Robert Klaassen, Conrad V Fernandez, Rochelle Yanofsky, John Wu,
Yves Pastore, Mariana Silva, Jeff H Lipton, Jossee Brossard, Bruno Michon, Sharon Abish,
McGregor Steele, Roona Sinha, Mark Belletrutti, Vicky Breakey, Lawrence Jardine, Lisa
Goodyear, Michaela Cada, Ibrahim Ghemlas, Hongbing Li, Yigal Dror. Genotyping strategies
in Fanconi Anemia patients in Canada. The 27th Annual Fanconi Anemia Research Fund
Scientific Symposium, Toronto, Ontario, September 17-20, 2015.
47. Fernandez CV, EJ Perlman, EA Mullen, YY Chi, TE Hamilton, KW Gow, FA Ferrer, D
Barnhart, PF Ehrlich, G Khanna, J Kalapurakal, T Bocking, V Huff, Q An, JI Geller, PE
Grundy JR Anderson, JS Dome, RC Shamberger for the AREN0532 committee. Clinical
outcome and biological predictors of relapse following nephrectomy only for Very Low Risk
Wilms tumor. A report from Children’s Oncology Group AREN0532. Accepted for poster
with discussion. American Society of Clinical Oncology Annual meeting. Chicago, Ill. June
2015. J Clin Oncology 2015;33(supp;abstract 10023).
48. Ketan Kulkarni, Tamara MacDonald, Vicky Price, Pamala Cox, Conrad Fernandez, Mark
Bernstein, Peggy Yhap. Blood group, Age and Type of cancer are independently associated
with symptomatic venous thrombotic events in pediatric cancer patients: A population based
study from Maritimes, Canada. Accepted ISTH 2015. Toronto, ON, June 2015.
49. Dix D, Fernandez CV, Chi Y-Y, Anderson J, Mullen E, Geller J, Gratias E, Khanna G,
Kalapurakal J, Perlman EJ, Seibel N, Ehrlich P, Malogolowkin M, Grundy P, Dome J on
behalf of the AREN0533 Study Committee. Treatment of favorable histology Wilms Tumor
with combined loss of heterozygosity of chromosome 1p and 16q: A report from the
Children’s Oncology Group studies AREN0532 and AREN0533. American Society of Clinical
Oncology Annual meeting. Chicago, Ill. June 2015. J Clin Oncol 2015; 33(suppl;abstract
10009). ASCO Post Evening News Spotlight
https://urldefense.proofpoint.com/v2/url?u=http-3A__cl.s4.exct.net_-3Fqs-
3Df2fc978d4a95ab7b16caae7b167f165d2e4cff40e71ad628f5a0aa127819f287&d=BQMCAg&
c=Zoipt4Nmcnjorr_6TBHi1A&r=3bVQWgTcgONyQpCBLpHmUw&m=GMCR7mapD6m6d
jyy_QBi5DM8eBQAtc2EcO0WSGIML_Y&s=tUKqM6N1Y6Q4-
fh4SRM6A_gqO4zYm1iip5AuPmPp6Gs&e=
50. CV Fernandez, EA Mullen, PF Ehrlich, J Kalapurakal, G Khanna, YY Chi, E Perlman, A
Paulino, TE Hamilton, KW Gow, FA Ferrer, Z Tochner, FA Hoffer, J Withycombe, R
Shamberger, JI Geller, JR Anderson, PE Grundy, J Dome for the AREN0532 study committee.
Outcome and prognostic factors in COG stage III Favorable Histology Wilms Tumor treated
with doxorubicin, actinomycin , vincristine and radiotherapy. A report from the Children’s
Oncology Group study AREN0532. American Society of Clinical Oncology Annual meeting.
Chicago, Ill. June 2015. J Clin Oncology 2015;33(suppl;abstract 10010).
51. Ashley Geerlinks, Carol Digout, Mark Bernstein, Andrew Chan, Shannon MacPhee, Chantale
Pambrun, Gloria Gallant, Amy Long, Lois Wyatt, Elizabeth Irving, Conrad Fernandez,
Victoria Price. Improving time to antibiotics for pediatric oncology patients with febrile
neutropenia by applying lean process improvement methodology. Platform presentation A
Geerlinks. Department of Pediatrics Research Day. April 2015. Winner best presentation.
52. Ashley Geerlinks, Thomas Issekutz, Mark Bernstein, Victoria Price, Samina Afzal, Bruce
Crooks, Jason N Berman, Robert Fraser, Conrad V Fernandez. Severe, Persistent and Fatal
T-cell Immunodeficiency Post Infantile Leukemia Therapy. Poster presentation Department of
Pediatrics Research Day. April 2015.
CV – Conrad Fernandez, MD, FRCP(C)
31
53. M.A. LeBlanc, A. Brown, D. Gaston, M. Nightingale, N. Hamel, J. Zhang, E. Lalonde, J.
Majewski, W. Foulkes, A. Orr, C.V. Fernandez, CR. McMaster, K. Bedard. Identification of
the genomic mutation causing a rare inherited form of kidney cancer. Poster presentation.
American Society of Pediatric Hematology Oncology Annual Meeting. Phoenix, AZ. May
2015.
54. Geerlinks A, Issekutz T, Bernstein M, Price V, Berman JN, Crooks B, Afzal S, Fraser R,
Fernandez CV. Persistent and Fatal T cell Immunodeficiency Post Infantile Leukemia
Therapy American Society of Pediatric Hematology Oncology Annual meeting. Phoenix, AZ.
May 2015.
55. Ghotra SK, Pambrun C, Fernandez CV, Parkash S, Koupaei R, Jangaard K. Congenital
Methaemoglobinemia due to Hb F-M-Fort Ripley in a Preterm Newborn. Poster presentation
Department of Pediatrics Trainee Research Day. Halifax, NS. April 2015.
56. Birnie KA, Chambers CT, Chorney J, Fernandez CV, McGrath P. Predicting child pain
outcomes from child and parent pain catastophizing, anxiety and distress. Poster presentation
Department of Pediatrics Trainee Research Day. Halifax, NS. April 2015.
57. Birnie KA, Chambers CT, Chorney J, Fernandez CV, McGrath PJ.. Predicting child pain
outcomes from child and parent pain catastrophizing, anxiety, and distress. Canadian Pain
Society annual meeting. Charlottetown, PEI. May 2015.
58. Noel M, Boerner KE, Birnie KA, Caes L, Parker JA, Chambers CT, Fernandez CV, Lee K.
The Ethical Acceptability of Deception in Pediatric Psychology Research. Society of Pediatric
Psychology Annual Conference. San Diego. Apr 2015.
59. Ghotra SK, Pambrun C, Fernandez CV, Parkash S, Koupaei R, Jangaard K. Congenital
Methaemoglobinemia due to Hb F-M-Fort Ripley in a Preterm Newborn. Presented at
Canadian National Perinatal Meeting February 2015.
60. Ghemlas I, Li H, Zlateska B, Klaassen R, Fernandez CV, Yanofsky RA, Wu J, Pastore Y,
Silva M, Lipton JH, Brossard J, Bruno M, Abish S, Steele M, Sinha R, Belltrutti M, Breaky V,
Jardine L, Goodyear L, Sung L, Dhanraj S, Reble E, Wagner A, Beyene J, Ray P, Meyn S,
Cada M, Dror Y. Application of novel next generation sequencing gene panel assay to genetic
and clinical diagnosis of inherited bone marrow failure syndromes. Oral presentation.
American Society of Hematology. San Francisco. Blood 2014 (Dec);124:257; published ahead
of print Dec 5, 2014.
61. Kalbfleisch M, Cada M, Klaassen R, Fernandez CV, Yanofsky RA, Wu J, Pastore Y, Silva
M, Lipton JH, Brossard J, Michon B, Abish S, Steele M, Sinha R, Belletrutti M, Breakey V,
Jardine L, Goodyear L, Sung L, Bayene K, Finkelstein Shechter T, Zlateska B, Dror Y. Risk
factors for poor survival after hematopoietic stem cell transplantation in inherited bone marrow
failure syndromes. Poster presentation. American Society of Hematology. San Francisco. Blood
2014 (Dec);124:2592; published ahead of print Dec 5, 2014.
62. M.A. LeBlanc, A. Brown, D. Gaston, M. Nightingale, N. Hamel, J. Zhang, E. Lalonde, J.
Majewski, W. Foulkes, A. Orr, C.V. Fernandez, CR. McMaster, K. Bedard. Identification of
the genomic mutation causing a rare inherited form of kidney cancer. Oral presentation. The
BHCRI Biannual Research Meeting. Halifax, NS. 4 Nov 2014.
CV – Conrad Fernandez, MD, FRCP(C)
32
63. Birnie, K.A., Chambers, C.T., Chorney, J., Fernandez, C.V., & McGrath, P.J.Relationships
between anxiety, the parent-child dyad, and parenting during a conflict discussion task. Poster
presentation. Department of Psychiatry Research Day. Halifax, NS. 24 Oct 2014.
64. Romao R, Pierce J, Afzal S, Davies D, Fernandez CV, Bernstein M, Lorenzo A. Surgical
resection and buccal mucosa vaginoplasty for local control in botryoid rhabdomyosarcoma.
Poster presentation. Canadian Association of Pediatric Surgery Annual Meeting. Toronto,
ON. Oct 2014.
65. R Romao, J Pierce, S Afzal, D Davies, CV Fernandez, M Bernstein, A Lorenzo. Surgical
resection and buccal mucosa vaginoplasty for local control in botryoid rhabdomyosarcoma.
Poster presentation. SIOP Annual Meeting. Toronto, ON. Oct 2014. Pediatric Blood &
Cancer 2014:61(S2):1455.
66. MacDonald T, Kulkarni K, Berstein M, Fernandez C, Yhap M. Significantly higher incidence
of allergic reactions for intravenous peg-asparaginase as compared to intramuscular peg-
asparaginase in children with high risk acute lymphoblastic leukemia. Poster presentations.
SIOP Annual Meeting. Toronto, ON. Oct 2014. Pediatric Blood & Cancer 2014:61(S2):664.
67. Kulkarni K, MacDonald T, Price V, Fernandez C, Berman J, Bernstein M, Crooks B, Afzal
S, Yhap M. Establishing incidence and characteristics of symptomatic venous thrombotic
events in pediatric cancer patients in the Maritimes, Canada: a population based study. Poster
presentation. SIOP Annual Meeting. Toronto, ON. Oct 2014. Pediatric Blood & Cancer
2014:61(S2):745.
68. Mullen E, Geller J, Gratias E, Perlman E, Ehrlich P, Khanna G, Najaro A, He Y, Hamilton T,
Ferrer F, Glick R, Gow K, Barnhardt D, Kandel J, Dasqupta R, Hill A, Hoffer F, Serveas S,
Gastier-Foster J, Huff V, Fernandez C, Grundy P, Dome J. First 4000 patients on Children’s
Oncology Group (COG) Renal Tumor (RT) Risk Stratification and Biology Protocol
AREN03B2. Oral presentation. SIOP Annual Meeting. Toronto, ON. Oct 2014. Pediatric
Blood & Cancer 2014:61(S2):364.
69. Howard AF, Hasan H, Fernandez C, Lo A, Pritchard S, Nelson M, Bobinski MA, Goddard K.
Canadian initiatives to recall childhood cancer survivors lost to medical follow up. Oral
Presentation. European Symposium on Late Complications after Childhood Cancer.
Edinburgh, UK. Sept 2014.
70. Paulino AC, Gratias EJ, Fernandez CV, Ehrlich PF, Gow KW, Naranjo A, Perlman EJ, Dome
JS, Kalapurakal JA Outcomes and Patterns of Failure after Preoperative Chemotherapy for
Favorable Histology Wilms Tumor on National Wilms Tumor Study (NWTS) – 5. Oral
presentation. ASTRO (American Society for Radiation Oncology). San Francisco, CA. Sept
2014.
71. Spicer C, MacLellan D, Fraser R, Crooks BNA, Fernandez CV. Isolated penile meatal
chronic GVHD in a boy following allogeneic transplant for JMML. Poster presentation.
Canadian Bone Marrow Transplant Group Annual Meeting. Halifax, NS. June 2014.
72. Bettle A, Latimer M, Hughes J, Fernandez C. Parental involvement to reduce pain in children
with acute lymphoblastic leukemia. Poster presentation. Integrated Health Research Training
Partnership Graduate Student Research Day. Halifax, NS. May 2014.
73. Brown A, LeBlanc MA, Gaston D, Majewski J, Foulkes W, Fernandez CV, McMaster CR,
Bedard K. Epigenetic mechanisms potentially influencing gene expression in a rare form of
CV – Conrad Fernandez, MD, FRCP(C)
33
familial Wilms Tumour. Poster discussion. European Human Genetics Conference. Milan,
Italy. May 2014. Eur J Hum Genetics2014;22(suppl 1):320 ( P16.77.S).
74. Gillett RM, Gaston D, Nightingale M, MacGillivray C, Fernandez CV, Hayne O, Couban S,
McMaster CR, Greer W, Bedard K. Elucidation of genetic changes associated with a rare form
of familial myelodysplastic syndrome. European Human Genetics Conference. Milan, Italy.
May 2014. Eur J Hum Genetics2014;22(suppl 1):472 ( J12.086).
75. Brown A, LeBlanc MA, Gaston D, Majewski J, Foulkes W, Fernandez CV, McMaster CR,
Bedard K. Epigenetic mechanisms potentially influencing gene expression in a rare form of
familial Wilms Tumour. Poster presentation. Department of Pathology Research Day.
Halifax, NS. May 2014.
76. Gaston D, Whitehouse S, Nightingale M, MacGillivary C, Orr A, Steele P, Rideout AL, Huang
WY, Greer W, Majewski J, Dyack S, Ludman M, Penney LS, Fernandez CV, McMaster CR,
Bedard K. Mutations in MAP3K6 are associated with familial gastric cancer. Oral
presentation. Department of Pathology Research Day. Halifax, NS. May 2014.
77. Gillett RM, Gaston D, Nightingale M, MacGillivray C, Fernandez CV, Hayne O, Couban S,
McMaster CR, Greer W, Bedard K. Elucidation of genetic changes associated with a rare form
of familial myelodysplastic syndrome. Poster presentation. Department of Pathology Research
Day. Halifax, NS. May 2014.
78. MacLellan D, Karakach T, Naranjo A, Fernandez CV. Urinary metabolite profiling by
nuclear magnetic resonance spectroscopy distinguishes control patients from wilms tumor
(WT) and WT tumor by stage. Print publication. American Society of Clinical Oncology
Annual Meeting. Chicago. May 2014.
79. Mullen E, Geller J, Gratias E, Perlman E, Ehrlich P, Khanna G, Najaro A, He Y, Hamilton T,
Ferrer F, Glick R, Gow K, Barnhardt D, Kandel J, Dasqupta R, Hoffer F, Serveas S,
Fernandez C, Grundy P, Dome J. Real Time Central Review: A report of the first 3000
patients enrolled on the Children’s Oncology Group Renal Tumor Biology and Risk
Stratification Protocol AREN03B2. Platform presentation. American Society of Clinical
Oncology Annual Meeting. Chicago. May 2014.
80. Gaston D, Hansford S, Oliveira C, Nightingale M, Pinheiro H, Macgillivray C, Kaurah P,
Rideout A, Steele P, Soares G, Huang W, Whitehouse S, Blowers S, LeBlanc MA, Jiang H,
Greer W, Samuels M, Orr A, Fernandez CV, Majewski J, Ludman M, Dyack S, Penney L,
McMaster CR, Huntsman D, Bedard K. Germline mutations in MAP3K6 predispose to familial
gastric cancer. Platform presentation. European Human Genetics Conference. Milan, Italy.
May 2014. Eur J Hum Genetics2014;22(suppl 1):29 (C08.3).
81. Geerlinks A, Digout C, Bernstein M, Chan A, MacPhee S, Pambrun C, Irving E, Wyatt L,
Gallant G, Long A, Wilson K, Fernandez C, Price V Improving time to antibiotics for
pediatric oncology patients with febrile neutropenia by applying lean process improvement
methodology. Poster presentation. American Society of Pediatric Hematology Oncology
Annual Meeting. Chicago. May 2014.
82. Higgins KS, Chambers CT, Birnie K, Fernandez CV. Offering Parents Individualized
Feedback from Psychological Testing Conducted with Children for Research Purposes:
Perspectives of Canadian Researchers and REB Members. Poster presentation. Department of
Pediatrics Research Trainee Day 2014. Halifax, NS. April 2014
CV – Conrad Fernandez, MD, FRCP(C)
34
83. Zlateska B, Li H, Ghemlas I, Klaassen R, Fernandez CV, Yanofsky R, Wu J, Pastore Y, Silva
M, Lipton J, Brossard J, Michon B, Abish S, Steele M, Sinha R, Belletrutti M, Breakey V,
Jardine L, Goodyear L, Wagner A, Cada M, Dror Y. Genotyping strategies for Diamond
Blackfan Anemia patients in Canada. DBA meeting. Atlanta GA. March 2014.
Haematologica [0390-6078] Zlateska B. yr:2014 vol:99 pg:385 -385
84. Cataudella D, Morley T, Fernandez C, Johnston D, Sung L, and Zelcer S. Development of the
pediatric supportive care scale (PSCS): preliminary content validation. POGO Annual
Meeting. Toronto, ON. Nov 2013.
85. Sénécal K, Knoppers BM, Rahimzadeh V, Fernandez CV, Sinnett D, Boycott KM. Statement
of Principles on the Return of Research Results and Incidental Findings in Paediatric
Research: A Multi-site Consultative Process. POGO Annual meeting. Toronto, ON. Nov
2013.
86. Birnie K, Chambers C, Chorney J, Fernandez CV, McGrath P. Influence of child and parent
pain catastrophizing and anxiety on child experimental pain outcomes. Department of
Psychiatry Annual Research Day. Halifax, NS. Nov 2013.
87. Yorke J, Fernandez C, Morash B, Dyack S. How individuals with a chromosome deletion
can reveal candidate genes for congenital anomalies. Annual Department of Pediatrics
Trainee Research Day. Halifax, NS. April 2013.
88. Fernandez CV, Bouffet E, Malkin D, Jabado N, O’Connell C, Avard D, Knoppers K,
Boycott K, Sorensen P, Orr AC, McMaster C. Attitudes to the Return of Incidental and
Targeted Genomic Findings Obtained in a High Risk Pediatric Cancer versus an Inherited
Genetic Condition Research Setting. J Clin Oncol 2013;31 (suppl; abstr 10066).
89. Senecal K, Knoppers BM, Avard D, Fernandez C. Returning research results and incidental
findings: challenges for the health care system. Canadian Association Health Services Policy
Research. Vancouver, BC. May 2013.
90. Kleiderman E, Avard D, Knoppers B, Fernandez C and Boycott K. Parental Views on
Returning Incidental Findings from Genetic Research to Children: Is it in the Child’s Best
Interest? Canadian Bioethics Society Annual Meeting. Banff, ALTA. May 2013.
http://www.cbs-scb2013.ca/posters.php
91. Senecal K, Levesque E, Fernandez C, Tasse AM, Zawati M, Knoppers BM, Avard D.
Statement of principles on the return of research results and incidental findings. Canadian
Bioethics Society Annual meeting. Banff, ALTA. May 2013. http://www.cbs-
scb2013.ca/posters.php
92. Senecal K, Levesque E, Fernandez C, Tasse AM, Zawati M, Knoppers BM, Avard D.
Statement of principles on the return of research results and incidental findings. Canadian
Association of Research Ethics Board. Annual Meeting. Calgary, ALTA. April 2013.
93. Knoppers BM, Avard D, Fernandez C, Longo C, Boycott K. Comparison of Parental and
Researcher Perceptions on the Return of Incidental Findings from Genetic Research to
Children. International Cancer Genome Consortium Meeting. Heidelberg, Germany.
December 2012.
94. Berman JN, Fernandez-Murray JP, Nasrallah GK, Fernandez CV, Jarrar AB, Coombs AJ, and
McMaster CR. Glycine supplementation – a novel therapeutic strategy for congenital
sideroblastic anemia. Proceedings of the Annual meeting of the American Society of
CV – Conrad Fernandez, MD, FRCP(C)
35
Hematology. Atlanta, GA USA. Dec 2012. https://ash.confex.com/ash/2012/webprogram/
Paper49165.html
95. Fernandez CV, Strahlendorf C, Avard D, Knoppers K, O’Connell C, Malkin D, Jabado N,
Boycott K, Sorenson P. Attitudes of Researchers to the Return to Participants of Incidental and
Targeted Genomic Findings Obtained in a Research Setting. Proceedings of the Annual
meeting of the American Society of Hematology. Atlanta, GA USA. Dec 2012.
(https://ash.confex.com/ash/2012/webprogram/Paper46954.html).
96. Cada M, Segbefia CI, Klaassen R, Fernandez CV, Yanofsky R, Wu J, Champagne J, Silva M,
Lipton JH, Brossard J, Samson Y, Abish S, Steele M, Ali K, Dower N, Athale U, Jardine L,
Hand JP, Odame I, Canning P, Allen C, Sung L, Beyene J, Dror Y. Outcome and Clinical
Characteristics of Clonal and Malignant Myeloid Transformation in Inherited Bone Marrow
Failure Syndromes. Proceedings of the Annual Meeting of the American Society of
Hematology. Atlanta, GA USA. Dec 2012.
https://ash.confex.com/ash/2012/webprogram/Paper51339.html
97. Bartlett G, Avard D, MacGibbon B, Page M, Fernandez CV, Palmour R, Secko D, Knoppers
B. Direct-to-Consumer Genomic Testing in Children: Pilot Survey to Assess Health
Professionals’ Experiences. 40th North American Primary Care Research Group Annual
Meeting. New Orleans, Louisiana USA. Dec 2012.
98. Leblanc MA, Nightingale M, Gaston D, Majewski J, Orr A, Fernandez CV, McMaster CR,
Bedard K. Identification of the genomic mutation causing a rare inherited form of childhood
kidney cancer. Gairdner Foundation meeting. Ottawa, ON. November 2012.
99. Birnie KA, Chambers CT, Cummings EA, Fernandez CV, Finley GA, Forgeron PA, Latimer
MA, McGrath PJ. Agreement between hospitalized children and parents’ ratings of pain
intensity and pain treatment threshold. IWK Interdisciplinary Research Conference. Halifax,
NS. November 2012.
100. Cada M, Segbefia CI, Klaassen R, Fernandez CV, Yanofsky R, Wu J, Champagne J, Silva
M, Lipton JH, Brossard J, Samson Y, Abish S, Steele M, Ali K, Dower N, Athale U, Jardine
L, Goodyear L, Odame I, Canning P, Zlateska B, Sung L, Beyene J, Dror Y. Clonal and
malignant myeloid transformation in inherited bone marrow failure syndromes. Poster
presentation. European Working Group of MDS and JMML in Childhood – 6th International
Symposium on MDS and Bone Marrow Failure Syndromes in Childhood. Prague, Czech
Republic, Nov 2012.
101. Mullen EA, Gooskens SLM, Hamilton TE, vanden Heuvel-Eibrink MM, Green DM, Grundy
PE, Daw NC, Dome JS, Fernandez CV, Children’s Oncology Group. Sinusoidal obstruction
syndrome during treatment for renal tumors on NWTS3, 4 and 5: Treatment and Outcome.
SIOP 2012 Annual Meeting. London, UK. Oct 2012. Pediatric Blood and Cancer 2012;59
(6):1010-1011.
102. Ferrer F, Herbst KW, Fernandez CV, Khanna G, Mullen EA, Dome JS, Shamberger RC,
Ritchey ML, Ehrlich P. Image-based Feasibility of Renal Sparing Surgery for Low Volume
Unilateral Wilms Tumors. American Academy of Pediatrics Annual Meeting. New Orleans,
LA. Oct 2012.
103. Leblanc MA, Nightingale M, Gaston D, Majewski J, Orr A, Fernandez CV, McMaster CR,
Bedard K. Identification of the genomic mutation causing a rare inherited form of childhood
kidney cancer. Department of Pathology Research Day. Halifax, NS. May 2012.
CV – Conrad Fernandez, MD, FRCP(C)
36
104. Chen PL, Greer W, Fernandez C, McMaster CR, Bedard K. Development of a cell culture
model for Charcot-Marie Tooth Disease – a functional study of the LRSAM1 protein.
Department of Pathology Research Day. Halifax, NS. May 2012.
105. Gaston D, Orr A, Fernandez CV, McMaster C, Bedard K. Next-Gen Sequencing, Systems
Biology, and the Data Deluge: Identifying Causative Genes of Rare Diseases in the Post-
Genomics Era. Department of Pathology Research Day. Halifax, NS. May 2012.
106. Birnie KA, Chambers CT, McGrath PJ, Fernandez CV, Chorney J. The influence of parent-
child factors on communication during painful experiences: A dissertation proposal. Poster
presentation. Canadian Pain Society Annual meeting. May 2012, Whistler BC.
107. Ferrer F, Ehrlich P, Shamberger R, Fernandez CV. Image-based Feasibility of Renal Sparing
Surgery for Low Volume Unilateral Wilms Tumors. American Urological Association Annual
Meeting. Atlanta, GA. May 2012.
108. Birnie KA, Chambers CT, Cummings EA, Fernandez CV, Finley GA, Forgeron PA, Latimer
MA, McGrath PJ. Agreement between hospitalized children and parents’ ratings of pain
intensity and pain treatment threshold. Poster presentation. Canadian Pain Society Annual
meeting. Whistler BC. May 2012.
109. Birnie KA, Chambers CT, Cummings EA, Fernandez CV, Finley GA, Forgeron PA, Latimer
MA, McGrath PJ. Agreement between hospitalized children and parents’ ratings of pain
intensity and pain treatment threshold. Poster presentation. Department of Pediatrics
Research Day. Halifax, NS. April 2012.
110. Morley T, Cataudella D, Nesin A, Johnston D, Fernandez C, Sung L, Zelcer S. The pediatric
supportive care scale (PSCS): an instrument to assess quality of life in children with terminal
malignancy. Poster presentation. POGO Annual Meeting. Toronto, ON. Nov 2011. Winner
– best poster in psychosocial category.
111. Kathryn A. Birnie, Christine T. Chambers, Elizabeth A. Cummings, Conrad V. Fernandez,
G. Allen Finley, Paula A. Forgeron, Margot A. Latimer, & Patrick J. McGrath. Patient and
parent-reported pain prevalence and management in a Canadian pediatric hospital. Poster
presentation. International Forum on Pediatric Pain. Whitepoint, NS . Oct 2011.
112. Mullen EA, Anderson JR, Steacy KJ, Geller JI, Green DM, Norkool P, Fernandez CV,
Khanna G, Malogolowkin MH, and Dome JS. The impact of surveillance imaging on overall
survival in patients with recurrent Wilms Tumor: A Report from the Children’s Oncology
Group. ASCO Annual Meeting. Chicago, Ill. June 2011. JCO 2011;29:15s:593s.a9536.
113. Elzinga K, Fernandez CV, Heng DYC, Tang PA. Returning research results to clinical trial
participants: a survey of cancer patients. ASCO Annual Meeting. Chicago, Ill. June 2011.
JCO 2011;29:15s:192s.a2611.
114. Zlateska B, Hashmi SK, Klaassen R, Fernandez CV, Yanofsky R, Shereck, E, Champagne J,
Silva M, Lipton JH, Brossard J, Samson Y, Abish S, Steele M, Ali K, Dower N, Athale U,
Jardine L, Hand JP, Beyene J, Dror Y. Comparative analysis of Shwachman-Diamond
Syndrome to Other Inherited Bone Marrow Failure Syndromes and Genotype-Phenotype
Correlation. Proceedings of the 6th International Congress on Shwachman-Diamond
syndrome. New York, June 2011.
115. Birnie KA, Chambers CT, Cummings EA, Fernandez CV, Finley GA, Forgeron PA, Latimer
MA, & McGrath PJ. Patient and parent-reported pain prevalence and management in a
Canadian pediatric hospital. Poster Presentation. British Pain Society and Canadian Pain
Society Joint Scientific Meeting. Edinburgh, Scotland. June 2011.
CV – Conrad Fernandez, MD, FRCP(C)
37
116. Fabsitz RB, McGuire A, Sharp RR, Hudson K, Pandey M, Beskow LM, Biesecker LG,
Bookman E, Burke W, Burchard EG, Church G, Wright Clayton E, Eckfeldt J, Fernandez
CV, Fisher R, Fullerton SM, Gabriel S, James C, Jarvik G, Kittles R, Leib J, O’Donnell C,
O’Rourke RP, Lyman Rodriguez L, Romero F, Schully SD, Shuldiner AR, Sze RF, Thakuria
J, Wolf SM, Burke GL. Ethical and Practical Guidelines for Reporting Genetic Research
Results to Study Participants: Updated Guidelines from an NHLBI Working Group. ELSI
2011. Chapel Hill, NC. May 2011.
117. Birnie KA, Chambers CT, Cummings EA, Fernandez CV, Finley GA, Forgeron PA, Latimer
MA & Patrick J. McGrath. Patient and parent-reported pain prevalence and management in a
Canadian pediatric hospital. Department of Pediatrics Research Day, IWK Health
Centre/Dalhousie University. Halifax, NS. April 2011.
118. Finkelstein-Schechter T, Doyle JJ, Gassas A, Chong D, Stetsco N, Ashraf K, Fernandez CV.
Hypertension in pediatric allogeneic hematopoietic stem cell transplant patients. ABMT
Annual Meeting. Honolulu, Hawaii. February 2011.
119. Berman J, Greer W, Fernandez CV, Bernstein M, Couban S. Higher peripheral blood
compared to bone marrow BCR; ABL transcript levels in chronic phase chronic myeloid
leukemia (CML) suggests a need to revise surveillance approaches and questions the anatomic
niche of the CML stem cell. Accepted for publication. ASH 2010. Orlando, FL. December
2010.
120. Gardiner B, Morash B, Riddell C, Wang H, Fernandez CV, Yhap M, Berman J. The
incidence and prognostic significance of 9p21 abnormalities in pediatric acute lymphoblastic
leukemia patients – the IWK Health Centre experience. Poster presentation. ASH 2010.
Orlando, FL. December 2010.
121. Fernandez CV, Couban S, Liwski R, Matsuoka MP, Morash B, Berman J, Greer W, Orr AC,
Guernsey. Do the SLC25A38 or ALAS2 Genes play a Role in the Phenotypic Express Ringed
Sideroblasts in Acquired Myelodysplastic Syndrome? Accepted for publication. ASH 2010.
Orlando, FL. December 2010.
122. Craig TJ, Chambers CT, Kay-Raining Bird ER, Cummings E, Deacon SH and Fernandez CV.
Expressive and Receptive Pain Language in Typically-Developing Children. BHCRI Annual
Symposium. November 2010.
123. Craig TJ, Chambers CT, Kay-Raining Bird ER, Cummings E, Deacon SH, and Fernandez
CV. Expressive and Receptive Pain Language in Typically-Developing Children. IWK
Interdisciplinary Annual Meeting. Halifax, NS. November 2010.
124. Birnie KA, Noel M, Chambers CT, von Baeyer CL, Fernandez CV. A Survey of
Researchers’ Use of the Cold Pressor Task with Children: Methods, Ethics, and Experiences.
IWK Interdisciplinary Conference. Halifax, NS. November 2010. Winner: Best poster
award.
125. Cataudella, D., Zelcer, S., Morley, T., Johnston, D., Fernandez, C., D., Sung, L.
Development of the P-SCS: The Pediatric Supportive Care Scale, an instrument for quality of
life in children with terminal malignancy. POGO Annual Conference. Toronto, ON.
November 2010.
126. Fernandez CV, Li N, Mullen EA. Attitudes and practice towards the management of very
low risk Wilms’ tumor in the Children’s Oncology Group. SIOP 2010 Annual Meeting.
Boston, MA. October 2010.
127. Fernandez CV, Davies S, Radloff G, Hauser J, Grundy P, Breslow N, Anderson J. A case-
control study assessing the relationship of GST polymorphisms and the risk of development of
hepatopathy on NWTS-5. SIOP 2010 Annual meeting. Boston, MA. October 2010.
CV – Conrad Fernandez, MD, FRCP(C)
38
128. Marjerrison SL, Fernandez CV, Price VE, Njume E, Hesseling P. Use of Ultrasound in
Diagnosis in endemic Burkitt Lympoma in Cameroon. SIOP 2010 Annual Meeting. Boston,
MA. October 2010.
129. Kathryn A Birnie, Melanie Noel, Christine T Chambers, Carl L von Baeyer, Conrad V
Fernandez. A Survey of Researchers’ Use of the Cold Pressor Task with Children: Methods,
Ethics, and Experiences. World Congress of Pain. Montreal, QC. August 2010.
130. Fernandez CV, Li N, Mullen EA. Attitudes and practice towards the management of very
low risk Wilms’ tumor in the Children’s Oncology Group. 7th International Symposium on the
Biology of Renal Tumors. Banff, Alta. March 2010.
131. Fernandez CV, Davies S, Radloff G, Hauser J, Grundy P, Breslow N, Anderson J. A case-
control study assessing the relationship of GST polymorphisms and the risk of development of
hepatopathy on NWTS-5. 7th International Symposium on the Biology of Renal Tumors.
Banff, Alta. March 2010.
132. Craig TJ, Chambers CT, Kay-Raining Bird ER, Cummings E, Deacon SH, and Fernandez
CV. Expressive and Receptive Pain Language in Typically-Developing Children. Presenter,
C. Chambers. International Symposium on Pediatric Pain. Acapulco. March 2010.
133. Berman JN, Couban S, Ebbin A, Frangoul H, Quisumbing MEB, Riddell, C, Ferguson M,
Ludman M, Fernandez CV, Cantor AB. Familial platelet disorder and predisposition to
myeloid leukemia (FDP/AML) in the absence of RUNX1 mutations. Publication only. ASH.
Annual meeting. New Orleans. December 2009. Abstract 4689.
http://abstracts.hematologylibrary.org/cgi/content/abstract/ashmtg;114/22/4689
134. Berman JN, Couban S, Ebbin A, Frangoul H, Quisumbing MEB, Riddell, C, Ferguson M,
Ludman M, Fernandez CV, Cantor AB. Familial platelet disorder and predisposition to
myeloid leukemia (FDP/AML) in the absence of RUNX1 mutations. Blood 2009
(Nov);114(22):abstract 4689.
135. J. A. Kalapurakal, M. Gopalakrishnan, R. Shore, Y. Zhang, C. Fernandez, Z. Tochner, A.
Paulino, J. Dome, V. Sathiaseelan, A. Kepka. Feasibility And Potential Utility Of Cardiac-
sparing Lung IMRT In Children With Wilms Tumor: A dosimetry study. ASTRO meeting.
Chicago, Ill. November 2009.
136. Britney McMurter, Louise Parker, Robert B Fraser, Fergall Magee, Christa Kozancyzn,
Conrad V Fernandez. Parental Views on Tissue Banking. Platform presentation. BHCRI
2009 Cancer Research Symposium. Halifax, NS. November 2009.
137. Britney McMurter, Louise Parker, Robert B Fraser, Fergall Magee, Christa Kozancyzn,
Conrad V Fernandez. Parental Views on Consent, Tissue Taking and Tissue Banking in
Pediatric Oncology Patients. Blood 2009 (Nov);114(22):34a.
138. Burrell S, Johnson S, Fernandez CV, Colwell B. Nuclear Medicine Assessment of Non-
target Organ Response to Cancer Therapy. Poster presentation. BHCRI 2009 Cancer
Research Symposium. Halifax, NS. November 2009.
139. Berman JN, Couban S, Ebbin A, Frangoul H, Quisumbing MEB, Akie TE, Ridell C, Ferguson
M, Ludman MD, Fernandez CV, Cantor AB. Familial platelet disorder and predisposition to
myeloid leukemia (FDP/AML) in the absence or RUNX1 mutations - a report of three
families. Poster presentation. BHCRI 2009 Cancer Research Symposium. Halifax, NS.
November 2009.
140. Gardiner RB, Berman JN, Riddell C, Gaudet M, Fernandez CV, Yhap M, Morash B. The
incidence and prognostic significance of 9p21 abnormalities in pediatric ALL patients - the
CV – Conrad Fernandez, MD, FRCP(C)
39
IWK experience. Poster presentation. BHCRI 2009 Cancer Research Symposium. Halifax,
NS. November 2009.
141. Burrell S, Colwell B, Johnson S, Fernandez CV. Nuclear Medicine Assessment of Non-
target Organ Response to Oncology Therapy. Annual meeting RSNA (Radiological Society of
Nuclear Medicine. Chicago. November 2009.
142. Lesleigh S. Abbott, Mariana Deevska, Victoria E. Price, Dorothy R. Barnard, Conrad V.
Fernandez, Margaret Yhap, Colleen Fitzgerald, David Dix, and Jason N. Berman. The
Impact of Prophylactic Cryoprecipitate and Fresh Frozen Plasma on the Incidence of CNS
Thromboses in Children with Acute Lymphoblastic Leukemia Receiving Asparaginase. Poster
presentation, S. Abbot. ISTH Annual Meeting. Boston, MA. July 2009.
143. Karine Bédard, Bartha Maria Knoppers, Cathy Anne Pachnowski, Saminda Pathmasiri, Paula
Robson on behalf of the CPT Project Investigator Group and ELSI/Privacy Task Force.
Accessing Population Database Biobanks: Challenges and Considerations in the Canadian
Partnership for Tomorrow (CPT) Project. The Age of Personalized Genomics Conference.
Banff, Alta. June 2009.
144. Magee JF, Cavanaugh J, Rudolph K, Fernandez CV. System delays in childhood cancer
diagnosis. Poster presentation, F Magee. PAS annual meeting. Baltimore, MD. June 2009.
145. Tsangaris E, Klaassen R, Fernandez CV, Yanofsky R, Scherek E, Champagne J, Silva M,
Lipton JH, Brossard J, Samson Y, Abish S, Steele M, Ali K, Dower N, Athale U, Jardine L,
Hand JP, Stephen D, Odame I, Canning P, Allen C, Beyene J & Dror Y. Genetic Analysis of
Inherited Bone Marrow Failure Syndromes from one comprehensive cohort of patients.
Proceedings of the 5th International Congress on Pediatric MDS and Bone Marrow Failure
Syndromes. June 2009: pp 2.
146. Hashmi SK, Allen C, Klaassen R, Fernandez CV, Yanofsky R, Wu J, Champagne J, Silva M,
Lipton JH, Brossard J, Samson Y, Abish S, Steele M, Ali K, Dower N, Athale U, Jardine L,
Hand JP, Beyene J, Dror Y. Comparative analysis of Shwachman-Diamond Syndrome to
other Inherited Marrow Failure Syndromes. Proceedings of the 5th International Congress on
Pediatric MDS and Bone Marrow Failure Syndromes. Page 3. June 2009.
147. Segbefia C, Klaassen R, Fernandez CV, Yanofsky R, Shereck E, Champagne J, Silva M,
Lipton JH, Brossard J, Samson Y, Abish S, Steele M, Ali K, Dower N, Athale U, Jardine L,
Hand JP, Allen C, Beyene J, Dror Y. Malignant myeloid transformation is high in patients
with inherited marrow failure syndromes (poster). Proceedings of the 5th International
Congress on Pediatric MDS and Bone Marrow Failure Syndromes. Page 3. June 2009.
148. Cox K, Bandstra N, Fernandez C, Chambers C, Craig T. Impact on parents of receiving
individualized feedback on results of language and development testing conducted as part of a
research study. Poster presentation, K. Cox. Canadian Bioethics Society Conference.
Hamilton. May 2009.
149. Fernandez CV, Strahlendorf C, Santor D, Pentz R, Barfield R, Gao J, Baker J, Kodish E,
Moghrabi A, Weijer C. Adolescent decision-making in clinical trial participation. Annual
meeting of SIOP, Berlin, Germany. Oct 2008.
http://www3.interscience.wiley.com/homepages/106561790/SIOP-2008-Online-Abstracts.pdf
150. Fernandez CV, Gao J, Strahlendorf C, Pentz R, Barfield R, Baker J, Moghrabi A, Kodish E,
Santor D, Weijer C. Parental decision-making in clinical trial participation. Annual meeting
of SIOP. Berlin, Germany. Oct 2008.
http://www3.interscience.wiley.com/homepages/106561790/SIOP-2008-Online-Abstracts.pdf
151. Andrew C. Issekutz, Thomas B. Issekutz, Derek Rowter, Conrad V. Fernandez, Robert
Fraser, Bruce Mazer and David Mitchell. Two New Cases of ZAP70 Deficient Severe
CV – Conrad Fernandez, MD, FRCP(C)
40
Combined Immune Deficiency with Unusual Presentations, Novel Gene Mutations and
Successful Immune Reconstitution with Cord Blood Stem Cell Transplantation. European
Society Immunodeficiency Meeting. October 2008.
152. Angelski C, Fernandez CV, Weijer C, Gao J. The Publication of Ethically Uncertain
Research: Attitudes and Practices of Journal Editors. Poster presentation, C Angelski.
Canadian Bioethics Society Annual Meeting. John’s, Nfld. June 2008.
153. Hashmi SK, Klaassen R, Fernandez CV, Yanofsky R, Wu J, Champagne J, Silva M, Lipton
JH, Brossard J, Samson Y, Abish S, Steele M, Ali K, Dower N, Athale U, Jardine L, Hand JP,
Allen C, Beyene J, Dror Y. Shwachman-Diamond syndrome among other inherited marrow
failure syndromes. A report from the Canadian Inherited Marrow Failure Registry (CIMFR).
Pediatr Blood Cancer 2008;10 (May):8a.
154. R.Grant, J. Halton, S.Abish, R. Barr, E. Cairney, D. B. Dix, C. Fernandez, S. Israels, V.
Lewis, A. Moghrabi, B. Wilson, N. Shenouda, M. Matzinger, L. M. Ward and the Canadian
STOPP Consortium. Osteoporosis Screening in Childhood Acute Lymphoblastic Leukemia:
A First Step in Understanding the Natural History of Vertebral Compression. Pediatr Blood
Cancer. 2008.
155. J. Halton, S.Abish, R. Barr, E. Cairney, D. B. Dix, C. Fernandez, R. Grant, S. Israels, V.
Lewis, A. Moghrabi, B. Wilson, S. Atkinson, M.A. Matzinger, N. Shenouda, L. M. Ward and
the Canadian STOPP Consortium. The Relationship Between Lumbar Spine Bone Mineral
Density and Vertebral Compression at Leukemia Diagnosis. Pediatr Blood Cancer. 2008.
156. Simpson DC, Gao J, Fernandez CV, Yhap M, Price VE, Berman JN. The role of Bone
Marrow Examination in the Initial Evaluation of Pediatric Hodgkin’ Disease: The Canadian
Perspective. Blood 2007 (Dec);110 (11):688a.
157. Berman JN, Greer WL, Loh M, Riddell C, Morash B, Dumas N, Fernandez CV, Ludman M.
Rare Case Of Jak2 V617f Positive Polycythemia Vera In A Child With Neurofibromatosis
Type 1. Blood 2007 (Dec);110 (11): 239b.
158. Fernandez CV, Anderson J, Breslow N, Dome J, Grundy P, Perlman E, Green D for the
NWTSG/COG. Patient weight and event free survival for children under 2 years of age at
diagnosis with favorable histology Wilms' tumor. American Society of Clinical Oncology
Annual Meeting. Chicago. May 2007. JCO 2007;25(18S): 723s.
159. Fernandez CV, Santor D, Weijer C, Strahlendorf C, Moghrabi A, Pentz R, Kodish E, Gao J,
Barfield R. The return of research results to participants: a multicenter study. Pediatr Blood&
Cancer 2007;49(4):543.
160. Craig TJ, Chambers CT, Cummings E, Deacon H, Fernandez CV, Gillespie J, Kay-
Rainingbird E. Expressive and receptive pain language and its relationship to general
language development among children with and without medical conditions: A work in
Progress. CRTP Halifax. May 2007. No published abstract.
161. Skidmore DL, Hunter A, Morash B, Beis J, Fernandez CV. A Case of ATR-16 in
conjunction with a duplication of 4pterm: The importance of haematological manifestations in
pointing to the diagnosis. American College of Medical Genetics Annual Meeting. March
2007. No published abstract.
162. Fernandez CV, Rigby H, Langley J, Mailman T, Crooks BNA, Higgins A. Routine
surveillance for bloodstream infections in a pediatric hematopoietic stem cell transplant
cohort: do patients benefit? Blood 2006(Dec);108(11):409b.
163. Rowan-Legg A, Weijer C, Gao J, Fernandez CV. A 10-year follow-up study on the
requirement for institutional review board approval prior to publication of human research
CV – Conrad Fernandez, MD, FRCP(C)
41
results. Public Responsibility in Medicine and Research. Annual meeting. Washington.
November 2006. No published abstract.
164. Lefaivre M-J, Chambers CT, Fernandez CV. Offering parents individualized results of
psychological testing conducted for research purposes with children: Ethical issues and
guidelines. Canadian Psychology 2006;47(2a):200-201a.
165. MacDonald T, Payne L, Dyack S, Schmidt M, Gordon K, Fernandez CV, Barnard D, Yhap
M, Crooks B, Price V. Hypermanganesemia, polycythemia, iron deficiency and neurological
deterioration in a young girl. Pediatr Blood & Cancer 2006;46(6):701a.
166. Pentz R, Barfield R, Joffe S, Fernandez C, Kodish E. A research ethics case: sibling donors.
Pediatr Blood & Cancer 2006;46(6):706a.
167. Maniatis G, Klaassen R, Fernandez CV, Yanofsky R, Wu J, Champagne J, Odame I, Silva M,
Lipton JH, Ali K, Brossard J, Samson Y, Abish S, Le D, Dower N, Jardine L, Hand JP, Sung
L, Freedman M, Stephens D, Dror Y. Diamond Blackfan Anemia (DBA) among other
inherited marrow failure syndromes. A report from the Canadian Inherited Marrow Failure
Registry (CIMFR). 7th Annual International Diamond Blackfan Anemia Consensus
Conference 2006. (Presenter, G Maniatis). No published abstract.
168. Fernandez CV, Santor D, Weijer C, Strahlendorf C, Mohgrabi A, Pentz R, Kodish E. The
return of research results to potential research participants. Pilot study of adolescents and
parent of children with cancer. Pediatr Blood & Cancer 2005;45(4):583a.
169. Gaudet M, Lee CLY, Fernandez CV. Clinical significance of i(7)(q10) as the sole acquired
abnormality in the bone marrow of an infant with Shwachman-Diamond syndrome.
Association of Genetics Technologists Annual Meeting. June 2005. (Presenter, M. Gaudet).
No published abstract.
170. MacNeil SD, Fernandez CV. Informing research participants of research results: An analysis
of the attitudes of Canadian University-based Research Ethics Board Chairs. Pediatric Child
Health 2005;10 suppl B:40B.
171. JM Steele, L Sung, R Klaassen, C Fernandez, R Yanofsky, J Wu, I Odame, M Silva, A
Kaiser, J Brossard, Y Samson, J Champagne, S Abish, D Le, L Jardine, JP Hand, N Dower, J
Lipton, M Freedman, K Charpentier, L Morgovsky, D Stephens, Y Dror, and Canadian
Inherited Marrow Failure Registry. Disease progression in recently diagnosed patients with
inherited marrow failure syndromes: A report from the Canadian Inherited Marrow Failure
Registry. Pediatric Blood Cancer 2005; 44(6): 538.
172. Crooks BNA, Dror Y, Fernandez CV, Dooley J. Demylelinating encephalopathy following
second BMT for Fanconi anemia. Stem cell transplantation in children: current results and
controversies. Meeting #8. Scottsdale, Az. Jan 2005. (Presenter, B Crooks). No published
abstract.
173. Conway J, Dyack S, Fernandez CV. Mixed donor chimerism and low level
alpha-1-iduronidase expression may be adequate for neurodevelopmental protection in
Hurler’s syndrome. Stem cell transplantation in children: current results and controversies.
Meeting #8. Scottsdale, Az. Jan 2005. (Presenter, J Conway). No published abstract.
174. Fernandez CV, Jurgens T, Brown J, Cooper E, Otley A, Frankton L, McLellan A,
Mykhaloviskiy E, Milroy P. The scope of practice of complementary and alternative health
care practitioners caring for children and youth in Canada. Building your research team.
Accepted for presentation at demystifying the research process: practical advice for health
professionals. IWK Health Centre. Nov 2004. (Presenter, J Brown). No published abstract.
CV – Conrad Fernandez, MD, FRCP(C)
42
175. Jennifer Conway, David Dix, Conrad Fernandez. Comparison of the incidence of sinus
venous thrombosis between two pediatric centers that differ in their practice of replacing
fibrinogen and antithrombin III during induction chemotherapy for ALL. Canadian Child
Health Clinician Scientist Program 2nd Annual National Symposium. Nov 2004. (Presenter, J
Conway). No published abstract.
176. Conway J, Dyack S, Crooks BNA, Schmidt M, Fernandez CV. Mixed donor chimerism and
low level alpha-L-iduronidase expression may be adequate for neurodevelopmental protection
in Hurler’s syndrome. Blood 2004;104(11):5149a.
177. Rigby HB, Fernandez CV. A survey of researchers’ practice in returning research results to
research participants. Oral abstracts presented at ASH Annual meeting 2003. Blood
2004;104(11):3130a.
178. Benedict J, Simpson C, Fernandez CV. Informed consent in pediatric bone marrow
transplan-tation: the parental experience. Blood 2004;104(11):3150a.
179. C Fernandez, T Jurgens, J Brown, E Cooper, L Frankton, A MacLellan, A Otley. Pilot study
of a national survey of the scope of practice of complementary and alternative health care
practitioners in caring for children and youth. The International Pediatric Nursing Research
Symposium Proceedings. Montreal PQ. Nov 2004. (Presenter J Brown). No published
abstract.
180. Ravitsky V, Geller G, Chen DT, Fernandez CV. Disclosing research results to participants in
genetic research: Clarifying the debate. American Society of Bioethics and Humanities Annual
Meeting. Oct 2004. No published abstract.
181. J Benedict, C Simpson, CV Fernandez. Parental perceptions of the informed consent process
in pediatric bone marrow transplantation (BMT). Proc ASCO 2004;23:547a.
182. Fernandez CV, Taweel S, Kodish ED, Weijer C. Disclosure of research results to research
participants. Focus group and questionnaire development examining attitudes of participants.
Blood 2003;102(11):202a.
183. MacNeil SD, Kodish ED, Fernandez CV. Informing research participants of research results:
An analysis of pediatric informed consent conferences in randomized controlled trials. Blood
2003;102(11):202a.
184. Arif Manji, Conrad Fernandez, Rochelle Yanofsky, Robert Klaassen, John Wu, Isaac
Odame, Mariana Silva, Josette Champagne, Sharon Abish, Johan Lategan, Nancy Dower,
Kaiser Ali, John Hand, Jossee Brossard, Yvan Samson, Lawrence Jardine, Melvin Freedman,
Derek Stephen, Sunita Vohra, Karen Charpentier and Yigal Dror. Characterization Of
Hematological Phenotype Of The Inherited Marrow Failure Syndromes. Report from The
Canadian Inherited Marrow Failure Registry (CIMFR). Blood 2003;102(11):500a.
185. Arif Manji, Conrad Fernandez, Rochelle Yanofsky, Robert Klaassen, John Wu, Isaac
Odame, Mariana Silva, Josette Champagne, Sharon Abish, Johan Lategan, Nancy Dower,
Kaiser Ali, John Hand, Jossee Brossard, Yvan Samson, Lawrence Jardine, Melvin Freedman,
Derek Stephen, Sunita Vohra, Karen Charpentier and Yigal Dror. Clonal marrow cytogenetic
abnormalities in patients with Shwachman-Diamond syndrome (SDS). Report from the
Canadian Inherited Marrow Failure Registry (CIMFR). Blood 2003;102(11):427a.
186. Crooks BNA, Fraser RB, Crocker J, Acott P, Fernandez CV, Yhap ME. Evolution of
aggressive PTLD through cytotoxic therapies following renal transplantation. J Pediatr
Hemat Oncol 2003;25(4):S14.
187. Steele M, Doda W, Freedman M, Yanofsky R, Silva M, Wu J, Woodman R, Dower N, Kaiser,
Klaassan R, Odame I, Jardine L, Bernstein M, Brossard J, Fernandez C, Hand JP, Vohra S;
CV – Conrad Fernandez, MD, FRCP(C)
43
Stephens D, Dror Y. Hematological phenotype in Shwachman-Diamond syndrome. A report
from Canadian Inherited Marrow Failure Registry (CIMFR). Proceedings of the Second
International Congress on Shwachman-Diamond Syndrome June 16 - 17, 2003. P 98.
188. Doda W, Freedman M, Yanofsky R, Silva M, Wu J, Woodman R, Dower N, Kaiser A, Halton
J, Odame I, Jardine L, Bernstein M, Brossard J, Fernandez C, Hand JP, Stephens D, Dror Y.
The inherited marrow failure syndromes: epidemiology and hematological abnormalities at
presentation. A report from Canadian Inherited Marrow Failure Registry (CIMFR).
Proceedings of the Second International Congress on Shwachman-Diamond Syndrome June
16 - 17, 2003 p 90.
189. Yigal Dror for the Canadian Inherited Marrow Failure Registry (CIMFR). Clonal marrow
cytogenetic abnormalities in patients with Shwachman-Diamond syndrome. Report from the
Canadian Inherited Marrow Failure Registry (CIMFR). Second International Congress on
Shwachman-Diamond Syndrome June 16 - 17, 2003. No published abstract.
190. Fernandez CV, Kodish ED, Taweel S, Shurin SB, Weijer C. Disclosure of the right of
research participants to receive research results: An analysis of consent forms in the
Children’s Oncology Group. Blood 2002;110(11):221a.
191. Fernandez CV, Kodish ED, Shurin SB, Weijer C. Disclosure of the right of research
participants to receive research results: Attitudes and needs of principal investigators in the
Children’s Oncology Group. Blood 2002;110(11):870a.
192. Doda W, Freedman M, Yanofsky R, Silva M, Wu J, Woodman R, Dower N, Kaiser A, Halton
J, Odame I, Jardine L, Bernstein M, Brossard J, Fernandez CV, Hand JP, Vohra S, Stephens
D, Dror Y. The Canadian Inherited Marrow Failure Registry (CIMFR). Blood
2002;110(11):874a.
193. McGibbon A, Beresford L, Sanderson S, Ming-Yu WM, Giacomantonio M, Fernandez C,
Cummings E. Precocious puberty in a 4-year-old boy with a mediastinal polyembryoma and
Klinefelter syndrome. Can J Diab 2002;23(3):287.
194. Fernandez CV, Gordon K, Van Den Hof M, Baylis F. Attitudes of pregnant women to cord
blood donation, storage and testing. Med Ped Onc 2002; 39:262a.
195. Yue Li, Grace Ma, Zhigui Ma, Conrad V Fernandez, Catherine Lee, E. Fred Saunders,
Jeremy Squire, Steve W. Scherer, Stephan W. Morris, Johann K. Hitzler. Variant
RBM15-MKL1 and MKL1-RBM15 fusion transcripts in an infant with recurrent acute
megakaryoblastic leukemia and t(1;22) after allogeneic bone marrow transplantation. Blood
2001;98:563a-564a.
196. Fernandez CV, Gordon KE, Van den Hof MC, Taweel S, Baylis F. Attitudes of pregnant
women to cord blood stem cell collection, testing and donation. Proc ASCO 2001;20:18a.
197. Fernandez CV, Wildish J, Lee CLY. A unique 6q21;15q21 translocation identified in a
Wilms’ tumor. Proc ASCO 2000;19:618a.
198. Fernandez CV, Anderson RA, Massing B. Bone marrow reticulin fibrosis in a patient with
Kostmann's syndrome treated with recombinant human granulocyte-colony stimulating factor.
Proc ASPH/O 1996;5:30.
199. Fernandez CV, Stutzer C, MacWilliam L, Fryer C. Prevalence of and reasons for use or
non-use of alternative/complementary therapies in pediatric oncology patients. A survey of
patients at BC's Children's Hospital. Proc ASPH/O 1996;5:16a.
200. Stutzer C, Esau R, Fernandez CV, Lange B, Rosen-Harris B. Pediatric Oncology Pain
Management Guidelines. International Association for the Study of Pain, 8th World Congress,
1996. No published abstract.
CV – Conrad Fernandez, MD, FRCP(C)
44
201. Anderson RA, Corr TR, Lockitch G, Fernandez CV and Rogers P. Beta-2 microglobulin
(B2M) and N-acetyl-glucosaminidase (NAG) excretion are elevated post nephrotoxic
chemotherapy. Proc ASCO 1995;14:A1461.
202. C Fernandez, S Walling, M Riding, H Bawden, L Resch, W Howes and S Salisbury. Long-
term outcome of childhood craniopharyngioma. Clin Inv Med 1994;17(S):B30.
203. CV Fernandez, EP Rees. Pain management in Canadian level III neonatal intensive care
units. Clin Inv Med 1993;16(S):A39.
204. CV Fernandez and EP Rees. A survey of pain management in Canadian level III neonatal
intensive care units. Clin Res 1992;40(3):660A.
205. CV Fernandez, R Bortolussi, KE Gordon, JG Gatien, SHS Lee, MS Shadrabadi.
Mycoplasma pneumoniae infection associated with central nervous system complications. A
report of two cases and a review of the literature. Abstract. Clin Inv Med 1990;13(S):B107.
BOOK CHAPTERS:
1. Brandelli Y, Chamber CT, Fernandez CV. Ethical Considerations in Paediatric Pain Research
and Clinical Practice. In volume 1. Pain Neuroethics of the serial: Developments in
Neuroethics and Bioethics. Elsevier. 2018. In press.
2. Fernandez CV. Treatment of Wilms’ Tumor in the Children’s Oncology Group. In Renal
Tumors in Childhood. Ed. K Pritchard-Jones, J Dome. 2015.
3. Fernandez CV, Geller JI, Ehrlich PF, Hill DA, Kalapurakal JA, Grundy PE, Dome JS. Renal
tumors. In Poplack and Pizzo Principles and Practices of Pediatric Oncology. 7th Ed.
Lipincott Raven. 2014.
4. Herder M, Fernandez CV. Cancer Genomics and Bio-banking: Exploring Key Ethical and
Legal Issues. In Cancer Genomics, 1st Edition. Ed. Dellaire G, Arceci R, Berman J.
Elselvier/Academic. C 2014.
5. Senegal K, Knoppers BM, Avard D, Fernandez CV, Sinnett D, Rahimzadeh V. Ethical
Issues in Childhood Cancer Susceptibility. In The Genetic Basis of Childhood Cancer. Ed. D
Malkin. Springer. 2013. C 2014.
6. Fernandez CV, Geller JI, Ehrlich PF, Hill DA, Kalapurakal JA, Grundy PE, Dome JS. Renal
tumors. In Poplack and Pizzo Principles and Practices of Pediatric Oncology. 6th Ed.
Lipincott Raven. 2010.
7. Kenny N and Fernandez CV. Basics in Research Ethics. History of Research Ethics and the
Concept of Risk. In: Handbook for Clinician Scientists. Tools for a successful academic
career. R Bortolussi editor. Canadian Child Health Clinician Scientist Program. 2008.
BOOK (Peer-Reviewed):
1. Fernandez CV. "Convention on Human Rights and Biomedicine of the Council of Europe,
Article 6 - Protection of Persons Not Able to Consent: Assent and Dissent to Research by
Children with Chronic Illness." International Society of Bioethics. Gijon, Asturias. Spain.
2003.
CV – Conrad Fernandez, MD, FRCP(C)
45
EDITORIALS (Invited):
1. Fernandez CV. Orphan cancers and our moral obligations. CMAJ 2007 Jan
30;176(3):297,299.
2. MacNeil SD, Fernandez CV. Offering results to research participants: Is ethically right but
not yet fully explored. BMJ 2006;332(7535):188-189.
3. Fernandez CV. Publication of ethically suspect research: Should it occur? Int J Qual Health
Care 2005;17(5):377-378. (E pub 12 Aug 2005).
LETTERS TO THE EDITOR:
1. Dix DB, Seibel NL, Chi YY, Khanna G, Gratias E, Anderson JR, Mullen EA, Geller JI,
Kalapurakal JA, Paulino AC, Perlman EJ, Ehrlich PF, Malogolowkin M, Grundy PE,
Fernandez CV, Dome JS. Reply to D Green. JCO 2018. In press.
2. Fernandez CV, Dome JS, Perlman EJ, Gastier-Foster J, Ehlich PF, Mullen EA. Reply to B
Zhang. J Clin Oncol. 2018 May 10;36(14):1454-1455. doi: 10.1200/JCO.2018.78.0445.
3. Fernandez CV, Whitlock JA, Strahlendorf C, Dix D, Leaker MT, Strother D, Hull P,
Eisenstat D, Mpofu C, Sinha R, Doyle JJ, Jardine L, Chan A, Silva MP, Johnston D, Pastore
Y, Mitchell D, Brossard J, Bowes. Protecting the welfare of all Canadian children. CMAJ
2015 Jan 29. Published online:
http://www.cmaj.ca/content/187/3/162.full/reply#cmaj_el_727824
4. Fernandez CV, Shurin S, Kodish E. Offering to provide research results to participants is an
obligation. Cancer 2006:107(6):1419-1420. (E pub July 21, 2006).
5. Fernandez CV and Frager G. Not Hurting - Not Harming. CMAJ 2006 (Jan);174(2):206.
6. Fernandez CV, Kodish E, Weijer C. The importance of informed consent in offering to
return research results to research participants. Med Pediatr Oncol 2003;41:592-593.
7. Fernandez CV, Pyesmany A, Stutzer C. Alternative therapies for the treatment of childhood
cancer. N Engl J Med 1999;340:569-570.
8. JM Connor and CV Fernandez. Genetic aspects of hemifacial microsomia. Hum Gen 1984;
68:349.
CV – Conrad Fernandez, MD, FRCP(C)
46
PUBLICATIONS (Non-Peer Reviewed):
1. Fernandez CV. CAR T cells. A careful drive to the future. Impact Ethics. September 2017. https://impactethics.ca/2017/08/31/car-t-cells-a-drive-to-the-future-of-cancer-treatment/amp/
2. Senecal K, Levesque E, Fernandez C, Tasse AM, Zawati M, Knoppers BM, Avard D.
Statement of Principles on the Return of Research Results and Incidental Findings. Network of
Applied Genetic Medicine. Montreal, PQ.
http://www.rmga.qc.ca/en/documents/RMGAStatement_Principles_English_May272013_000.
3. Fernandez CV. Case 7.3.5. Informing study participants of research results. Royal College of
Canada. Bioethics Curriculum. Chapter 7. 2016. Extensively revised.
http://www.royalcollege.ca/portal/page/portal/rc/resources/bioethics/cases/section7
4. Fernandez CV. Case 7.3.5. Informing study participants of research results. Royal College of
Canada. Bioethics Curriculum. Chapter 7. 2012.
5. Guidelines for genetic testing of healthy children - addendum. Position statement (B2003-01).
Joint statement of the Canadian Pediatric Society and the Canadian College of Medical
Geneticists. Fernandez CV, principal author for addendum. L Arbour, principal author
statement. Pediatr Child Health 2008 13(4):1.
6. Fernandez CV et al. Guidelines for the Ethical Conduct of Collection of Tissue for Research
Purposes. White paper for the Bioethics Committee. Children’s Oncology Group. (Project
coordinator and principle author). 2007. COG website.
7. Joffe S, Fernandez CV, Pentz RD, Ungar DR, Matthew NA, Alessandri AJ, Woodman CL,
Singer DA, Kodish E. Guidelines for involving children in decision making about research
participants. White paper for the Bioethics Committee. Children’s Oncology Group,
(contributing author). 2006. COG website.
8. Fernandez CV. Web Module. Consideration of 'Risk' in Research Involving Children.
Canadian Child Health Clinician Scientist Program. 2005.
http://cchcsp.ca/index.php?PHXSESSID=6173ef58e88693cdb828a35ed1d20c4c
Reprinted in: Handbook for clinician scientists: Tools for a successful academic career. R
Bortolussi, ed. Canadian Child Health Clinician Scientist Program. 2008.
9. Fernandez CV. Ethical challenges in pediatric translational research. Taking “the bench to
the bedside.” SIOP 2005 Education Book.
10. Fernandez CV. Informing Study participants of research results. Children’s Oncology News
2001;2:10.
11. Handbook for Parents and Families of Children with Cancer. Contributor to sections on
Palliative Care and on Ethics, 1985. McMaster University Medical Centre, Hamilton, Ontario.
Coordinator: Dr. R. Barr.
CV – Conrad Fernandez, MD, FRCP(C)
47
PRESENTATIONS (Provincial, National and International):
(Unless indicated, all presentations made by C Fernandez)
1. Fernandez CV. PROFYLE and how it may apply to the Marathon of Hope Network. TFRI
Atlantic Workshop. Halifax, NS. 11 June 2018.
2. Fernandez CV. PROFYLE – update of current Node status and plans. C17 Annual meeting.
Halifax, NS. 23 May 2018.
3. Fernandez CV. Oncologic Emergencies. APPHON Regional Education Rounds. Halifax, NS.
3 May 2018.
4. Fernandez CV. Oncologic Emergencies. APPHON annual meeting. Halifax, NS. 18 Nov
2017.
5. Fernandez CV. Update on COG renal trials and PROFYLE. APPHON. Halifax, NS.
17 Nov 2017.
6. Fernandez CV. Consent and Assent in Phase I trials. Workshop: Developing the next
generation of early phase trials:moving the bar in paediatric oncology. Panel discussion.
Vancouver, BC. 4 November 2017.
7. Fernandez CV. Children’s Oncology Group Renal Tumor Concepts. Renal Tumour Study
Group – SIOP Annual meeting. Mallorca, Spain. 12 June 2017
8. Fernandez CV. Renal tumors concept plans update. Montreal Children’s Hospital. Montreal,
PQ. March 1, 2107.
9. Fernandez CV. Offering research results to pediatric participants: an ethical responsibility and
challenge. Vineberg invited lecture. Montreal Children’s Hospital. Montreal, PQ. March 1,
2017
10. Fernandez CV. Childhood Cancer Foundation. Fund raiser. Halifax, NS. Sept 25. 2016.
11. Fernandez CV. Shortages of drugs, surpluses of ethical challenges: an allocation framework
for childhood cancer. C17 annual meeting. CHU Ste. Justine. Montreal, PQ. 2 June 2016
12. Fernandez CV. A moral obligation to offer research results to participants. Pediatic Grand
Rounds. CHU Ste. Justine. Montreal, PQ. 27 January 2016.
13. Fernandez CV. Small group discussion (return of results, TRICEPs study, CGH in global
developmental delay) x 3 hrs. CHU Ste. Justine. Montreal, PQ. 27 January 2016.
14. Fernandez CV. Research ethics. 6th Halifax symposium of ethics in ophthalmology.
Workshops x 3. Halifax, NS. 20November 2015.
15. Geerlinks A, Digout C, Bernstein M, Chan A, MacPhee S, Pambrun C, Irving E, Wyatt L,
Gallant G, Long A, Wilson K, Fernandez C, Price V. Improving time to antibiotics for
pediatric oncology patients with febrile neutropenia by applying lean process improvement
methodology. Nova Scotia Health Quality Summit. Platform presentation by A Geerlinks.
Halifax, NS. 19 November 2015.
16. CV Fernandez. COG Research and Regional Centers. APPHON annual conference. Platform
presentation. Halifax, NS. 14 November 2015.
17. CV Fernandez. COG Wilms tumor and Neuroblastoma Research Update. APPHON annual
conference. Platform presentation. Halifax, NS. 14 November 2015.
18. CV Fernandez. Planning to offer target and incidental genomic results in the pediatric setting.
International Society for Genetic Eye Diseases and Retinoblastoma. Platform presentation:
Halifax, NS. 6 August 2015.
CV – Conrad Fernandez, MD, FRCP(C)
48
19. CV Fernandez on behalf of the renal tumor study committee. Results of AREN0532 clinical
trial for pediatric very low and standard risk Wilms tumor. Renal Tumors Study Group- SIOP.
Platform presentation: Stockholm, Sweden. 25 June 2015.
20. CV Fernandez, EA Mullen, PF Ehrlich, J Kalapurakal, G Khanna, YY Chi, E Perlman, A
Paulino, TE Hamilton, KW Gow, FA Ferrer, Z Tochner, FA Hoffer, J Withycombe, R
Shamberger, JI Geller, JR Anderson, PE Grundy, J Dome for the AREN0532 study committee.
Outcome and prognostic factors in COG stage III Favorable Histology Wilms Tumor treated
with doxorubicin, actinomycin , vincristine and radiotherapy. A report from the Children’s
Oncology Group study AREN0532. Platform presentation. American Society of Clinical
Oncology Annual meeting. Chicago, Ill. 1 June 2015.
21. Dix D, Fernandez CV, Chi Y-Y, Anderson J, Mullen E, Geller J, Gratias E, Khanna G,
Kalapurakal J, Perlman EJ, Seibel N, Ehrlich P, Malogolowkin M, Grundy P, Dome J on
behalf of the AREN0533 Study Committee. Treatment of favorable histology Wilms Tumor
with combined loss of heterozygosity of chromosome 1p and 16q: A report from the
Children’s Oncology Group studies AREN0532 and AREN0533. Platform presentation.
American Society of Clinical Oncology Annual meeting. Chicago, Ill. June 2015. David Dix
presenter.
22. Fernandez CV. Recontact in Biomedical Research. Implications of attaining age of majority.
Clinical trial perspectives. P3G International Pediatric Research Platform. Think Tank
meeting. 11 May 2015. Montreal, PQ. Platform presentation.
23. Fernandez CV. The Children's Oncology Group: An example of the power of a cooperative
clinical trials network to answer therapeutic questions in rare conditions. Pediatric Grand
Rounds. 8 April 2015. Halifax, NS, Platform presentation.
24. Fernandez CV. Challenges of consent in the child research context. CAURA East. CAREB
Atlantic 2014. 14 November 2014. Halifax, NS. Platform presentation.
25. Fernandez CV. IBMFS: A clinical approach and recent updates. Atlantic Hematology
Workshop. 13 November 2014. Halifax, NS. Platform presentation.
26. O’Rourke PP, Beskow L, Berry S, Fernandez CV. What is the IRB’s role in the return of
results? Annual Conference: Should we offer genomic research results to a participant’s
family, including after death? Consortium on Law and Values in Health, Environment & the
Life Sciences. 6 Nov 2014. Minneapolis, MN. Platform presentation by O’Rourke (Fernandez
contributor to presentation).
27. Wilfond B, Fernandez CV, Green R. Returning secondary findings from pediatric sequencing
to families. Annual Conference: Should we offer genomic research results to a participant’s
family, including after death? Consortium on Law and Values in Health, Environment & the
Life Sciences. 6 Nov 2014. Minneapolis, MN. (Fernandez contributor to presentation and
participant in panel).
28. Fernandez CV. Genomics and paediatric cancer: New ethical challenges. SIOP Meet the
Expert lectures. Society of International Pediatric Oncology. 23 and 24 October 2014.
Toronto, Ontario Platform presentations.
29. Fernandez C. Leukemia in children – where we have been and where we are going? Leukemia
and Lymphoma Society of Canada. 13 May 2014. Halifax, NS. Platform presentation
CV – Conrad Fernandez, MD, FRCP(C)
49
30. Fernandez CV. Ethics research platform. Young People's Cancer Research Program
Workshop. Toronto, ON. 30 March2014. Workshop platform presentation
31. Fernandez CV, Friedman J, Zawat M. The ethical and legal dilemma of reporting incidental
findings. POGO. Innovation in Pediatric Oncology. Nov 22 and 23, 2013.
Toronto, ON. Workshop platform presentations.
32. Fernandez CV. Providing research results to participants. POGO. Innovation in Pediatric
Oncology Nursing. Nov 21, 2013. Toronto, Ont. Platform presentation.
33. Fernandez CV. Attitudes of participants and researchers to the return of genomic research
results. Genetics & Genomics Lunch Seminar Series. Genome Atlantic. 19 June 2013. Halifax,
NS. Platform presentation.
34. Fernandez CV, Bouffet E, Malkin D, Jabado N, O’Connell C, Avard D, Knoppers K, Boycott
K, Sorensen P, Orr AC, McMaster C. Attitudes to the Return of Incidental and Targeted
Genomic Findings Obtained in a High Risk Pediatric Cancer versus an Inherited Genetic
Condition Research Setting. The American Society of Clinical Oncology. 1 June 2013.
Chicago, USA.Poster presentation.
35. Fernandez CV, Brandow C, McNeil S, Burgess W. Challenges of Informed Consent in
Research Protocols: Does TCPS2 provide further practical guidance? Canadian Bar
Association 2013 National Health Law Summit: Critical Issues in Health Law. Halifax NS.
May 2013. Platform presentation
36. Dome J, Graf N, Pritchard-Jones K, Mullen E, Perlman E, Geller J, Fernandez CV. Expert
panel in renal tumors. Questions from families. 8th International Conference on Pediatric
Renal Tumors Biology. Bethesda Md. May 2013. Platform presenter.
37. Fernandez CV. Canadian Pediatric Cancer Genomics Consortium. GELS progress. Return of
research results. CPCGC Face to Face. March 2013. Montreal PQ. Platform presentation.
38. Fernandez CV, Strahlendorf C, Avard D, Knoppers K, O’Connell C, Malkin D, Jabado N,
Boycott K, Sorenson P. Attitudes of Researchers to the Return to Participants of Incidental and
Targeted Genomic Findings Obtained in a Research Setting. Annual meeting of the American
Society of Hematology. Atlanta, GA USA. Dec 2012. Poster presentation.
39. Mullen E, Gooskens S, Hamilton TE, van den Heuverl-Eibrink MM, Green DM, Grundy PE,
Daw NC, Dome JS, Fernandez CV. Sinusoidal obstruction syndrome during treatment for
Wilms tumors in NWTS 3, 4 and 5: Incidence, severity and effect on planned treatment and
outcome. International Society of Pediatric Oncology. London, UK. October 2012. Platform
presentation.
40. Fernandez CV. On return of results in in pediatric cancer genetic research. SIOP Pediatric
Psycho-oncology program. International Society of Pediatric Oncology. London, UK.
October 2012. Platform presentation.
41. Fernandez CV and Sheikh F. Complexities of Clinical Trial Design. Workshop x 2. 5th Annual
Pediatric Chemotherapy Update Conference. Toronto. October 2012. Platform presentation.
42. Fernandez CV, Hinds P, Gammon J, Fung K. Phase I Decision making panel. 5th Annual
Pediatric Chemotherapy Update Conference. Toronto. October 2012. Platform presentation.
43. Fernandez CV. Evidenced based policy to address ethical issues that arise in genomics
research. Late Effects of Childhood Cancer Treatments – networking meeting. CIHR Institute
of Cancer Research. Toronto. September 2012. Platform presentation.
CV – Conrad Fernandez, MD, FRCP(C)
50
44. Fernandez CV. IGNITE scientific advisory board GELS update. Halifax NS. June 2012.
Platform presentation.
45. Fernandez CV, McMaster C. The IGNITE project. Update. The IGNITE research symposium
and annual general meeting. Exploring strategies to bridge the gap between bench and
bedside. June 2012. Halifax, NS. Joint Platform presentation.
46. Fernandez CV. Return of incidental findings and research results to guardians or parents of
pediatric probands. Disclosing Genomic Incidental Findings in a Cancer Biobank: An ELSI
Experiment Working Group Workshop. May 2012. Minneapolis. MN. Platform presentation.
47. Fernandez CV. Return of research results to clinical trial participants. Presidential Symposium
(Ethical Dilemmas in Pediatric Hematology/Oncology). American Society of Pediatric
Hematology Oncology annual meeting. May 2012. New Orleans, LA. Platform presentation.
48. Fernandez CV. Canadian Pediatric Cancer Genomics Consortium scientific advisory board
GELS update. April 2012. Vancouver, BC. Platform presentation.
49. Fernandez CV, Herder M, West M. Orphan Diseases: Policy and Other Societal Implications.
Genome Atlantic Rare Disease Day. February 2012. Halifax, NS. Panel platform
presentation.
50. Fernandez CV, Joffe S, Revera G. Decision making and ethics in a transplant context. POGO
Symposium. Unravelling the mysteries of transplantation. November 2011. Toronto, ON.
Panel platform presentation.
51. Fernandez CV. Research ethics: Challenges and considerations in children. Fourth Halifax
Symposium of ethics in Ophthalmology. October 2011. Halifax, NS. Workshops for national
residents (x 3).
52. Fernandez CV, Orr A. IGNITE. Identifying genes and novel therapeutics to enhance treatment.
Pediatric Grand Rounds. November 2011. Halifax NS. Platform presentation.
53. Fernandez CV. Adolescents and Young Adults with Cancer. Progress 2011. Capital
Health/QEII HSC Cancer Care Program Oncology Grand Rounds. Halifax NS. Provincial
videoconference. March 2011. Platform presentation.
54. Fernandez CV, Li N, Mullen EA. Attitudes and practice towards the management of very low
risk Wilms tumor in the Children’s Oncology Group. SIOP 2010 Annual Meeting. Boston,
MA. October 2010. Platform presentation.
55. Fernandez CV, Davies S, Radloff G, Hauser J, Grundy P, Breslow N, Anderson J. A case-
control study assessing the relationship of GST polymorphisms and the risk of development of
hepatopathy on NWTS-5. SIOP 2010 Annual Meeting. Boston, MA. October 2010. Platform
presentation.
56. Fernandez CV. Informed consent for the treatment of AYA patients with cancer. Texas
Adolescents and Young Adults Symposium. San Antonio, Texas. October 2010. Platform
presentation.
57. Fernandez CV. Beatrice Hunter Cancer Research Institute. Integrated Learning Session.
Long-term consequences of treatment. When is the cost too high? June 2010. Halifax, NS,
with videoconference to Newfoundland. Platform presentation.
58. Fernandez CV, Davies S, Radloff G, Hauser J, Grundy P, Breslow N, Anderson J. A case-
control study assessing the relationship of GST polymorphisms and the risk of development of
CV – Conrad Fernandez, MD, FRCP(C)
51
hepatopathy on NWTS-5. 7th International Symposium on the Biology of Renal Tumors.
March 2010. Banff, Alta. Platform presentation.
59. Fernandez CV, Li N, Mullen EA. Attitudes and practice towards the management of very low
risk Wilms’ tumor in the Children’s Oncology Group. 7th International Symposium on the
Biology of Renal Tumors. March 2010. Banff, Alta. Platform presentation.
60. Britney McMurter, Louise Parker, Robert B Fraser, Fergall Magee, Christa Kozancyzn, Conrad
V Fernandez. Parental Views on Consent, Tissue Taking and Tissue Banking in Pediatric
Oncology Patients. American Society of Hematology Annual Meeting. New Orleans.
December 2009. Platform presentation by B McMurter.
61. Fernandez CV. The Children’s Oncology Group approach to Low and Standard Risk Wilms’
tumor. The Chemotherapy Foundation Annual Symposium XXVII. NY, NY. November 2009.
Platform presentation.
62. Fernandez CV. Pediatric perspectives on childhood marrow failure. Aplastic Anemia &
Myelodysplasia Association of Canada. Education Day. Halifax, NS. October 2009.
Platform presentation.
63. Fernandez CV. Wilms tumor update. CRA Education Day. Children’s Oncology Group.
Dallas, Texas. October 2009. Platform presentation.
64. Fernandez CV. Returning results to participants: Researcher, participant and IRB
perspectives. Society of Clinical Research Associates. Annual Meeting. Nashville, TN. Sept
2009. Platform presentation.
65. Fernandez CV. Issues of Assent, Consent and Re-consent in pediatric research. Resident
Academic Rounds. Children’s Hospital of Eastern Ontario. Ottawa. May 2009. Platform
presentation.
66. Fernandez CV. Disclosing study results to research participants. Grand Rounds. Children’s
Hospital of Eastern Ontario. Ottawa. May 2009. Platform presentation.
67. Fernandez CV. Congenital Sideroblastic Anemia. Atlantic Medical Genetics and Genomics
Initiative Annual meeting. Halifax. May 2009. Platform presentation.
68. Fernandez CV. Complications and surveillance: Importance and methods for early detection.
Marrow Failure and Myelodysplasia Conference 2009. Hospital for Sick Children. Toronto.
March 2009. Platform presentation.
69. Fernandez CV. Disclosing research results to participants. C17 National Educational
Videoconference. Montreal, Canada. November 2008.
70. Read K, Fernandez CV, Gao J, Strahlendorf C, Pentz R, Barfield R, Baker J, Moghrabi A,
Kodish E, Santor D, Weijer C. Parental decision-making in health research participation.
Cancer Training Research Program. 2008 Cancer Research Symposium. Halifax, NS.
November 2008. Poster presentation. (Presenter, K. Read).
71. Read K, Fernandez CV, Strahlendorf C, Pentz R, Barfield R, Gao J, Baker J, Moghrabi A,
Kodish E, Santor D, Weijer C. Adolescent decision-making in health research participation.
Cancer Training Research Program. 2008 Cancer Research Symposium. Halifax, NS.
November 2008. Poster presentation. (Presenter, K. Read).
72. Fernandez CV, Strahlendorf C, Santor D, Pentz R, Barfield R, Gao J, Baker J, Kodish E,
Moghrabi A, Weijer C. Adolescent decision-making in clinical trial participation. Annual
Meeting of SIOP. Berlin, Germany. October 2008. Poster presentation.
CV – Conrad Fernandez, MD, FRCP(C)
52
73. Fernandez CV, Gao J, Strahlendorf C, Pentz R, Barfield R, Baker J, Moghrabi A, Kodish E,
Santor D, Weijer C. Parental decision-making in clinical trial participation. Annual meeting
of SIOP. Berlin, Germany. October 2008. Poster and platform presentation (best poster).
74. Fernandez CV. Disclosing research results to participants. C17 National Educational
Videoconference. Canadian pediatric oncology sites. June 2008.
75. Fernandez CV. Return of research results to participants: considerations in research involving
children. Development of best practices for research involving children and adolescents:
Filling the knowledge gap. NCEHR. St. John’s, Nfld. June 2008. Platform presentation.
76. Angelski C, Fernandez CV, Weijer C, Gao J. The publication of ethically uncertain research:
attitudes and practices of journal editors. 19th Annual Canadian Bioethics Society Conference.
St. John’s, Nfld. June 2008. Platform presentation. (Presenter, C. Angelski).
77. Angelski C, Fernandez CV, Weijer C, Gao J. The publication of ethically uncertain research:
attitudes and practices of journal editors. 20th Annual National Pediatric and Fellow Research
competition. Winnipeg, Manitoba. May 2008. Platform presentation. Presenter, C. Angelski).
78. Fernandez CV. Returning research results to participants. Are we? Should we?
Interdisciplinary Medical Oncology Grand Rounds. Telemedicine province. Halifax, Nova
Scotia. February 2008. Platform presentations.
79. Fernandez CV. Returning results to research participants. Areas of black, white and grey.
Health Law Institute Seminar Series 2007-2008. Dalhousie University. Halifax, Nova Scotia.
January 2008. Platform presentation.
80. Fernandez CV, Santor D, Weijer C, Strahlendorf C, Moghrabi A, Pentz R, Kodish E, Gao J,
Barfield R. The return of research results to participants: a multicenter study. 2007 SIOP
Annual Meeting. Mumbai, India. November 2007. Poster presentation.
81. Fernandez CV. Disclosure of research results to research participants. Normative and
philosophical considerations. 2007 ASCO/COG Symposium. Considerations in disclosing
study results to research participants. Denver, Colorado. October 2007. Platform
presentation.
82. Fernandez CV. “Ethical Challenges of Funding for Orphan Diseases Research and Treatment”.
Halifax Symposium on Ethics for Residents in Ophthalmology. Three sequential workshops.
Halifax, Nova Scotia. October 2007. Platform presentation.
83. Fernandez CV. Disclosure of research results to participants. What do participants want?
Atlantic Pediatric Hematology Oncology Network Annual Meeting. Halifax, Nova Scotia.
April 2007. Platform presentation.
84. Fernandez CV. Pediatric transfusion - indications and consequences. 2007 Anesthesia
Refresher & Blood Management Meeting. Halifax, Nova Scotia. February 2007. Platform
presentation.
85. Fernandez CV. Error in Pediatric Care (and what we might do about it). Quality and Safety
Symposium. Halifax, Nova Scotia. February 2007. Platform presentation.
86. Fernandez CV, Friedman M, Volpe J. Informed consent for complex protocols? Workshops.
Pediatric Oncology Group of Ontario 2006 Multidisciplinary Symposium on Childhood
Cancer. Childhood leukemia and its broader implications. Toronto, Canada. November 2006.
Platform presentations.
87. Rowan-Legg A, Weijer C, Gao J, Fernandez CV. A 10-year follow-up study on the
requirement for institutional review board approval prior to publication of human research
results. Public Responsibility in Medicine and Research. Annual meeting. (Presenter, A
Rowan-Legg). Washington, USA. November 2006.
CV – Conrad Fernandez, MD, FRCP(C)
53
88. Lefaivre MJ, Chambers C, Fernandez CV. Offering parents individualized results of psycho-
logical testing conducted for research purposes with children: ethical issues and guidelines.
(Presenter MJ Lefaivre). Ethics Update 2006. Canadian Psychology Association Annual
Meeting. Calgary, Canada. June 2006. Platform presentation.
89. Jillian Baker, Victor Lewis, Conrad Fernandez, Michel Duval, Kim Yuille, Melvin Freedman,
John Doyle, and Yigal Dror. Allogeneic hematopoietic stem cell transplantation of patients
with Fanconi anemia and high-risk features using fludarabine without radiation. 17th Annual
Fanconi Anemia Scientific Symposium. Geneva, Switzerland. September 2005. Poster
presentation. (Presenter, J. Baker.)
90. Fernandez CV. Ethical and philosophical challenges of taking the bench to the bedside.
Education course: Trends in the diagnosis, surveillance and treatment of children with
malignancies - the role of biology and biologicals. International Society of Pediatric Oncology
37th Annual Conference. Vancouver, Canada. September 2005. Platform presentation.
91. Fernandez CV, Santor D, Weijer C, Strahlendorf C, Mohgrabi A, Pentz R, Kodish E. The
Return of research result to potential research participants. Pilot study of adolescents and
parent of children with cancer. International Society of Pediatric Oncology 37th Annual
conference. Vancouver, Canada. September 2005. Poster presentation.
92. Fernandez CV. Low risk Wilms tumor. Fifth International Conference on Childhood Renal
Tumors. Vancouver, Canada. September 2005. Platform presentation.
93. Gaudet M, Lee CLY, Fernandez CV. Clinical significance of i(7)(q10) as the sole acquired
abnormality in the bone marrow of an infant with Schwachman-Diamond syndrome.
Association of Genetics Technologists Annual Meeting. June 2005. Poster presentation.
(Presenter, M Gaudet).
94. MacNeil SD, Fernandez CV. Informing research participants of research results: analysis of
Canadian university-based Research Ethics Board policies. Canadian Pediatric Society
Annual Meeting. Vancouver, Canada. June 2005. Poster presentation.
95. MacNeil SD, Fernandez CV. Informing research participants of research results: analysis of
Canadian university-based Research Ethics Board policies. “Ethics of Bioethics” Conference.
Albany, NY. April 2005. Platform presentation. (Presenter D MacNeil).
96. Crooks BNA, Dror Y, Fernandez CV, Dooley J. Demyelinating encephalopathy following
second BMT for Fanconi Anemia. Pediatric Bone Marrow Transplantation Update.
Scottsdale, Arizona. January 2005. (Presenter, B Crooks).
97. Conway J, Dyack S, Fernandez CV. Mixed donor chimerism and low level
alpha-1-iduronidase expression may be adequate for neurodevelopmental protection in Hurler’s
syndrome. Pediatric Bone Marrow Transplantation Update. Scottsdale, Arizona. January
2005. (Presenter J Conway).
98. Rigby HB, Fernandez CV. A survey of researchers’ practice in returning research results to
research participants. Oral abstracts presented at ASH Annual meeting 2003. ASH Annual
Meeting 2004. San Diego, CA. December 2004. Poster presentation. (Presenter, H Rigby).
99. Benedict J, Simpson C, Fernandez CV. Informed consent in pediatric bone marrow
transplantation: the parental experience. ASH Annual meeting 2004. San Diego, CA.
December 2004. Poster presentation. (Presenter J Benedict).
100. Fernandez CV. Medication errors in pediatrics. The 7th Pediatric & Women’s Health
Continuing Education Day. Halifax, Nova Scotia. November 2004. Platform presentation.
CV – Conrad Fernandez, MD, FRCP(C)
54
101. Shalowitz D, Ravitsky V, Kahn J, Fernandez CV. Disclosing research results to participants in
genetic research: clarifying the debate. American Society of Bioethics and Humanities Annual
Meeting. Philadelphia, PA. October 2004. Platform presentation.
102. Fernandez CV. Issues of assent, consent and re-consent in the adolescent. Atlantic Provinces
Pediatric Hematology Oncology Network Annual meeting. Halifax, Nova Scotia. October
2004. Platform presentation.
103. Fernandez CV. Adolescent/young adults with cancer - an orphaned group. Atlantic Provinces
Pediatric Hematology Oncology Network Annual Meeting. Halifax, Nova Scotia. October
2004. Platform presentation.
104. Fernandez CV, Taweel S, Kodish ED, Weijer C. Disclosure of research results to research
participants. Focus group and questionnaire development examining attitudes of participants.
American Society of Hematology Annual Meeting. San Diego, CA. December 2003. Platform
presentation.
105. MacNeil SD, Kodish ED, Fernandez CV. Informing research participants of research results:
An analysis of pediatric informed consent conferences in randomized controlled trials.
American Society of Hematology Annual Meeting. San Diego, CA. December 2003. Platform
presentation. (Presenter, D MacNeil).
106. Fernandez CV. The Third Halifax Symposium on Health Care Safety. From Theory to
Reality. Pediatric Issues Seminar. Halifax, NS. October 2003. Platform presentation.
107. Fernandez CV, Kodish ED, Taweel S, Shurin SB, Weijer C. Disclosure of the right of research
participants to receive research results: An analysis of consent forms in the Children’s
Oncology Group. American Society of Hematology Annual Meeting. Philadelphia, PA.
December 2002. Platform presentation.
108. Fernandez CV, Kodish ED, Shurin SB, Weijer C. Disclosure of the right of research participants
to receive research results: Attitudes and needs of principal investigators in the Children’s
Oncology Group. American Society of Hematology Annual Meeting. Philadelphia, PA.
December 2002. Poster presentation.
109. Fernandez CV. Disclosure of the right of research participants to receive research results.
Atlantic Provinces Pediatric Hematology Oncology Network Annual Meeting. Halifax, Nova
Scotia. November 2002. Platform presentation.
110. McGibbon A, Beresford L, Sanderson S, Ming-Yu W, Giacomantonio M, Fernandez C,
Cummings E. Precocious puberty in a 4-year-old boy with a mediastinal polyembryoma and
Klinefelter syndrome. Canadian Diabetes Association/Canadian Society of Endocrinology and
Metabolism. Vancouver. October 2002. Poster presentation. (Presenter, A McGibbon).
111. Fernandez CV. Cord Blood Banking. SIOP (International Society of Pediatric Oncology)
Annual meeting. Porto, Portugal. September 2002. Platform presentation.
112. Fernandez CV. Error in Pediatric Medicine. Nova Scotia Branch Canadian Society of
Hospital Pharmacists. Continuing Education Day. Halifax, Nova Scotia. May 2002.
Platform presentation.
113. Fernandez CV. Returning research results to research participants. Children’s Oncology
Group Semi-Annual Meeting. Symposium: You Just don’t understand: Investigators and
subjects in conversation. Jacksonville, Florida. April 2002. Platform presentation.
114. Fernandez CV. Cord Blood Transplantation. Canadian College of Medical Genetics and
Canadian Association of Genetic Counsellors. Annual Meeting. Symposium: Pushing the
Edge of the Envelope. Halifax, Nova Scotia. December 2001. Platform presentation.
CV – Conrad Fernandez, MD, FRCP(C)
55
115. Fernandez CV. Cord Blood Stem Cell Transplantation. Atlantic Provinces Pediatric
Hematology Oncology Network. Annual meeting. Halifax, Nova Scotia. November 2001.
Platform presentation.
116. Fernandez CV. Cord Blood Stem Cell Transplantation. Atlantic Provinces Pediatric Meeting.
Halifax, Nova Scotia. September 2001. Platform presentation.
117. Fernandez CV. Pediatric Medical Error. Medical Error Symposium: Frontline Approaches to
Clinical Practice. Halifax, Nova Scotia. August 2001. Platform presentation.
118. Fernandez CV. Attitudes of pregnant women to cord blood stem cell collection, testing and
donation. American Society of Clinical Oncology. Annual Meeting. San Francisco, USA.
May 2001. Poster presentation.
119. Fernandez CV. Attitudes of pregnant women to cord blood stem cell collection, testing and
donation. American Society of Clinical Oncology. Virtual Meeting (www.asco.org). San
Francisco, USA. May 2001.
120. Chan HSL, Calderwood S, Heon E, Fernandez CV, Blaser S, Budning A, Saunders EF, Doyle
J, Gallie BL. Combined intensive multimodality therapy successfully treats extraocular
extension of retinoblastoma. 13th International Symposium for Genetic Eye Diseases and the
10th International Symposium on Retinoblastoma. Florida, USA. May 2001. Poster
presentation. (Presenter, HSL Chan).
121. Fernandez CV. Can we prevent Cytotoxic Disasters? St. John Regional Hospital, Grand
Rounds. Saint John, New Brunswick. January 2001. Platform presentation.
122. Fernandez CV. Alternative and Complementary Therapies: A conventional medicine
perspective. Candlelighter’s 4th International Conference on Childhood Cancer. Toronto,
Canada. August 2000. Platform presentation.
123. H. McMulkin, N. L. Yanchar, C. V. Fernandez. Sentinel lymph node mapping and dissection -
a valuable modern management of childhood extremity rhabdomyosarcoma. Canadian
Association of Pediatric Surgeons. Ottawa, Canada. August 2000. Poster presentation.
(Presenter, H McMulkin)
124. Fernandez CV. A unique 6q21;15q21 translocation identified in a Wilms’ tumor. American
Society of Clinical Oncology. Annual Meeting. New Orleans, USA. May 2000. Poster
presentation.
125. Fernandez CV. Wilson’s disease - Hematological Manifestations. Atlantic Provinces
Pediatric Meeting. Halifax, Nova Scotia. October 1998. Platform presentation.
126. Fernandez CV. Alternative and Complementary Therapies. Atlantic Provinces Pediatric
Meeting. Halifax, Nova Scotia. October 1998. Platform presentation.
127. Fernandez CV. Assent and dissent to research in children with chronic, life-threatening illness.
Workshop on Assent and Dissent in Research involving Children. Halifax, Nova Scotia. March
1998. Platform presentation.
128. Fernandez CV, Freyer C, Stutzer C. Prevalence of and reasons for use or non-use of
alternative/complementary therapies in pediatric oncology patients. A survey of patients at
BC’s Children’s Hospital. Canadian Bone Marrow Transplant Group Annual Meeting.
Vancouver, British Columbia. March 1998. Platform presentation.
129. Fernandez CV. Prevalence of and reasons for use or non-use of alternative/complementary
therapies in pediatric oncology patients. A survey of patients at BC’s Children’s Hospital.
Association of Pediatric Oncology Nurses, British Columbia Chapter. Vancouver, British
Columbia. February 1997. Platform Presentation.
CV – Conrad Fernandez, MD, FRCP(C)
56
130. Stutzer C, Esau R, Fernandez CV, Lange B, Rosen-Harris B. Pediatric Oncology Pain
Management Guidelines. International Association for the Study of Pain, 8th World Congress.
Vancouver, BC. 1996.
131. Fernandez CV, Freyer C, Stutzer C. Prevalence of and reasons for use or non-use of
alternative/complementary therapies in pediatric oncology patients. A survey of patients at
BC’s Children’s Hospital. American Society of Pediatric Hematology/Oncology Annual
Meeting. Chicago, Illinois. October 1996. Platform presentation.
132. Fernandez CV. Childhood Cancer and the Family: Forward to the Future. Alternative/
complementary therapies in pediatric oncology. Candlelighter’s Childhood Cancer
Foundation. Calgary, Canada. August 1996. Platform presentation.
133. Fernandez CV, Salisbury S. Long-term outcome of childhood craniopharyngioma. Royal
College of Physicians and Surgeons of Canada, Annual Meeting. Canadian Society of
Endocrinology and Metabolism, Scientific Program. Toronto, Canada. September 1994.
Platform presentation.
134. Fernandez CV, Rees E. Survey of Pain Management in Canadian Level III Neonatal Intensive
Care Units. Canadian Pediatric Society, Scientific Program, Vancouver, Canada. Vancouver,
Canada. June 1993. Platform presentation.
135. Fernandez CV, Rees E. Survey of Pain Management in Canadian Level III Neonatal Intensive
Care Units. Eastern Society for Pediatric Research, American Federation for Clinical
Research, Joint Meeting. New York, USA. October 1992. Platform presentation.
136. Fernandez CV, Bortolussi R, Gordon KE, Gatien GJ, Lee SHS, Shadrabadi MS. Mycoplasma
pneumoniae infection associated with central nervous system complications. A report of two
cases and a review of the literature. Third Annual Pediatric Residents and Fellows Research
Symposium, University of Manitoba. Winnipeg, Manitoba. May 1991. Platform presentation.
137. Fernandez CV, Bortolussi R, Gordon KE, Gatien JG, Lee SHS, Shadrabadi MS. Mycoplasma
pneumoniae infection associated with central nervous system infection. A report of two cases
and a review of the literature. Royal College of Physicians and Surgeons of Canada, Annual
Meeting. Canadian Pediatric Society, Scientific Program. Toronto, Ontario. September 1990.
Platform presentation.
CV – Conrad Fernandez, MD, FRCP(C)
57
PRESENTATIONS (Local):
(All presentations by Fernandez unless noted)
1. Fernandez CV. Oncology emergencies. Pediatric Resident Orientation Seminars. IWK Health
Centre. Halifax, NS. 17 July 2018. (1 hour)
2. Fernandez CV. Renal tumors and Neuroblastoma. Pediatric Surgery Academic Rounds. IWK
Health Centre. Halifax, NS. 28 May 2018 (2 hours)
3. Fernandez CV. Pediatric Oncology perspectives. Physiotherapy lecture series (Year 2).
Dalhouise University. Halifax, NS. 18 April 2018. (1 hour)
4. Fernandez CV. Oncology Emergencies for the ER physician with a focus on solid tumors. ER
subspecialty fellow Rounds. (1.5 hours). Halifax NS. 17 Jan 2018.
5. Fernandez CV and Gallant G. Thalassemia and Bone Marrow Transplantation. ISANS.
Parent information session (3 hours). Halifax NS. 11 May 2017
6. Fernandez CV. Pediatric Oncology Perspectives. Physiotherapy Lecture Series (Year 2).
Dalhousie University. Halifax, NS. 10 May 2017.
7. Fernandez CV and Berman JN. PROFYLE. Clinical site initiation. Pediatric Hematology
Oncology Academic rounds lecture series. Halifax NS. 13 March 2017.
8. Fernandez CV. Renal tumors and the Genome. Human Genetics Research Seminar Series.
LSRI. Halifax, NS. 15 February 2017.
9. Fernandez CV. COG renal tumors: Update and plans. Pediatric Hematology Oncology
Academic rounds lecture series. Halifax NS. 10 February 2017.
10. Steve Jones, Chris McMaster, Conrad Fernandez, Andrew Burke, Johan Van Limbergen,
James Cowan. Research and the Future of Health Care: Using genetics to find new treatments
of disease. Panel presentation. Piccione lecture series. Halifax Central Library. Halifax, NS.
17 January 2017.
11. Fernandez CV. Pediatric Oncology Perspectives. Physiotherapy Lecture Series (Year 2).
Dalhousie University. Halifax, NS. 31 March 2016.
12. Fernandez CV. Oncology solid tumor presentations in Emergency Department. Pediatric
Emergency Resident Rounds. Dalhousie University. 23 September 2015.
13. Fernandez CV. Pediatric Oncology Perspectives. Physiotherapy Lecture Series (Year 2).
Dalhousie University. Halifax, NS. 31 March 2015.
14. Fernandez CV. Genomics and incidental findings – using paediatric cancer as a model to
explore new ethical challenges. Works in Progress series. Department of Bioethics. 9
February 2015.
15. Fernandez CV. Pediatric Oncology Chemotherapy Perspectives. Pediatric Residents Academic
Half Day rounds.2 December 2014.
16. Fernandez CV. IBMFS: A clinical approach and recent updates. Pediatric Residents Academic
Half Day rounds.2 December 2014.
CV – Conrad Fernandez, MD, FRCP(C)
58
17. Fernandez CV. Pediatric Oncology Perspectives. Physiotherapy Lecture Series (Year 2).
Dalhousie University. Halifax, NS. 9 April 2014.
18. Fernandez CV. Advances in the care of children with Wilms tumor. BHCRI Seminar Series
Session. 7 April 2014.
19. Fernandez CV. An embarrassment of riches: returning results in the age of genomics. Dr.
Tom Marrie Lecture Series. 28 February 2014.
20. Fernandez CV. Challenges and opportunities in AYA cancer Care in the Maritimes. Children’s
Health Program. 3 February 2014.
21. Fernandez CV. The return of research results in the genomic age. IWK Health Centre
Laboratory Genetics Journal Club lecture. 18 November 2013.
22. Fernandez CV. Oncology Emergencies. Pediatric Residents Academic Half Day rounds. May
2013.
23. Fernandez CV. Challenges and opportunities in pediatric oncology care in the Maritimes.
Cancer Care Nova Scotia Advisory Board. Halifax, NS. April 2013.
24. Fernandez CV. Pediatric Oncology Perspectives. Physiotherapy Lecture Series (Year 2).
Dalhousie University. Halifax, NS. March 2013.
25. Fernandez CV. Disclosing a summary of study results to participants. COG return of results
taskforce. Pediatric Hematology/Oncology Academic Half Day. Halifax, NS. March 2013.
26. Fernandez CV. Adolescent and Young Adults with Cancer: Progress 2012 and Beyond.
Pediatric Residents Academic Half Day rounds. December 2012.
27. McMaster C and Fernandez CV. Orphan diseases: Identifying genes and novel therapeutics to
enhance treatment. Department of Medicine Grand Rounds. Halifax, NS. September 2012.
28. Fernandez CV. Return of results – aggregate and individual. Hematology/Hematopathology
Fellow Ethics Series. Halifax, NS. June 2012.
29. Fernandez CV, McMaster C, Grant D. IGNITE – science, GE3LS and IP. Medical Genetics
Rounds. Halifax, NS. February 2012.
30. Fernandez CV. Pediatric Oncology. Late effects. Pediatric Residents Seminar Series. Halifax.
NS. November. 2011.
31. Fernandez CV. Research Ethics. Adult Hematopathology Ethics Series. Halifax. NS. June
2011.
32. Fernandez CV. Pediatric Oncology Perspectives. Physiotherapy Lecture Series (Year 2).
Dalhousie University. Halifax, NS. March 2011.
33. Fernandez CV. Navigating the REB. Academic Skills. Pediatrics and Obstetrics and
Gynecology Residents. IWK Health Centre. Halifax NS. February 2011.
34. Fernandez CV. Consent for research participation. Challenges and considerations. Vision
Research Study Group (PVRSG). IWK Health Centre. Halifax, NS. Platform presentation.
November 2010.
CV – Conrad Fernandez, MD, FRCP(C)
59
35. Fernandez CV. The ethics of bioethics. Unravelling the mysteries of the Research Ethics
Board. Department of Pediatrics Research Day. Halifax, NS. Platform presentation. April
2010.
36. Fernandez CV. Pediatric Oncology Perspectives. Physiotherapy Lecture series. Department
of Physiotherapy. Halifax, NS. April 2010.
37. Marjerrison SL, Fernandez CV, Price VE, Njume E, Hesseling P. Use of Ultrasound in
Diagnosis in endemic Burkitt Lympoma in Cameroon. Department of Pediatrics Research
Day. Halifax, NS. (Marjerrison, presenter, mini-poster talk). April 2010.
38. Gardiner RB, Berman JN, Riddell C, Gaudet M, Fernandez CV, Yhap M, Morash B. The
incidence and prognostic significance of 9p21 abnormalities in pediatric ALL patients - the
IWK experience. Department of Pediatrics Research Day. Halifax, NS. (Gardiner, presenter,
mini-poster talk). April 2010.
39. Fernandez CV and Nicholson D. Navigating the REB. Academic Skills. Pediatrics and
Obstetrics and Gynecology Residents. Halifax, NS. February 2010.
40. Fernandez CV. Consent review. IWK Research Ethics Board Annual Retreat. Halifax, NS.
January 2010.
41. Fernandez CV and Campbell D. Integrated Ethics. Dalhousie University Medical Student
Coffee House Case Discussions. November 2009.
42. Fernandez CV. Error and disclosure in pediatric care. Fellows CANMEDS Academic Rounds.
IWK Health Centre. Halifax, NS. May 2009.
43. Fernandez CV and Diann Nicholson. Navigating the REB. Academic Skills Course. Pediatric
Residents. IWK Health Centre. Halifax, NS. January 2009.
44. Read K, Fernandez CV, Gao J, Strahlendorf C, Pentz R, Barfield R, Baker J, Moghrabi A,
Kodish E, Santor D, Weijer C. Parental decision-making in health research participation.
Interdisciplinary Research Conference. Health Services Research: Evidence Informing
Action. Halifax, NS. November 2008. (K Read, poster presenter)
45. Fernandez CV. Favourable histology Wilms’ tumor. A work in progress. Dept of Pediatrics.
Research Day. Platform presentation. October 2008.
46. Fernandez CV, Vaughn A. Ethics of decision making in children with serious illness. Med I
Panel Discussion. Halifax, NS. September 2008.
47. Parker L, Berman J, Bernstein M, Fernandez CV. Childhood cancer research: zebrafish,
periwinkles, power lines, and ethical dilemmas. Halifax, Nova Scotia. (joint
presentations).Café Scientifique. Halifax, NS. June 2008.
48. Fernandez CV, Hall R, Simpson C. The importance of ethics review. Summer Student
Program. Dalhousie University. Halifax, NS. (Joint presentations.) June 2008.
49. Fernandez CV. REB process. Interdisciplinary Research Program - Research Design Course.
Platform presentation. IWK Health Center. Halifax, Nova Scotia. May 2008.
50. Craig T, Chambers CT, Cummings E, Deacon SH, Gillespie J, Fernandez C, Kay-Raining Bird
E. Expressive and receptive pain language and its relationship to general language
development among children with and without medical conditions: A work in progress. Dept
of Pediatrics Research Day. Platform presentation. (Craig, presenter). May 2008.
51. Cox K, Fernandez C, Chambers CT, Craig T, Bandstra N. Impact on parents of receiving
individualized feedback on research results. Dept of Pediatrics Research Day. Poster. (K
Cox, presenter). May 2008.
CV – Conrad Fernandez, MD, FRCP(C)
60
52. Fernandez CV. Cerebral X-linked adrenoleukodystrophy. Case presentation to visiting
speaker. IWK Health Centre. Halifax, NS. April 2008.
53. Fernandez CV and Diann Nicholson. Navigating the REB. Academic Skills Course. Pediatric
residents. IWK Health Centre. Halifax, NS. February 2008.
54. Fernandez CV. Returning result to research participants. WIPS. Dept of Bioethics. Halifax,
NS. January 2008.
55. Fernandez CV. Returning results to research participants. IWK REB Retreat. Halifax, NS.
January 2008.
56. Fernandez CV. A clinical and research path to integrating bioethics in a career. Med I
Seminar with Drs. Curvin, Kirby and Robinson. Halifax, NS. September 2007.
57. Fernandez CV. Neurosurgery - navigating the REB. Seminar. Neurosurgery Residents.
Halifax, NS. July 2007.
58. Fernandez CV. Guidelines for the ethical conduct of collection of tissue for research purposes.
Works in Progress Seminar. Department of Pediatrics. Halifax, NS. June 2007.
59. Finlay KA, Fernandez CV. Failure to Report and Provide Commentary on Research Ethics
Board Approval and Informed Consent in the Literature. Poster and Platform presentation.
Department of Pediatrics Research Day. (Presenter Finlay) Halifax, NS. April 2007.
60. Kozanczyn C, Collins K, Fernandez CV. Providing Research Results to Study Participants: US
Institutional Review Board Guidance. Poster presentation. Department of Pediatrics Research
Day. (Presenter Kozanczyn) Halifax, NS. April 2007.
61. Kozanczyn C, Collins K, Fernandez CV. Providing Research Results to Study Participants: US
Institutional Review Board Guidance. Poster and Platform presentation. (Presenter,
Kozanczyn). Dalhousie Medical School Research Day. Halifax, NS. February 2007.
62. Fernandez CV. Success stories and challenges in pediatric oncology. Pediatric Residents.
IWK Health Centre. Dalhousie University. Halifax, NS. March 2007.
63. Fernandez CV and Diann Nicholson. Navigating the REB. Academic Skills Course. Pediatric
residents. IWK Health Centre. Halifax, NS. February 2007.
64. Fernandez CV. Success stories and challenges in pediatric oncology. Cancer Research
Training Program. Dalhousie University. Halifax, NS. December 2006.
65. Fernandez CV. Offering to return research results to research participants: Evidence and
questions. Works in Progress session. Department of Bioethics. Dalhousie University. May
2006.
66. A Rowan Legg, Charles Weijer, Jun Gao, Conrad Fernandez. A 10-year follow up study on
the requirement for research ethics board approval prior to publication of human research
results. Dept of Pediatrics Research Day. (Presenter, A. Rowan Legg) May 2006.
67. H Rigby, J Langley, T Mailman, A Higgins, BNA Crooks, CV Fernandez. Utility and cost of
surveillance central line blood cultures in the early detection of asymptomatic bloodstream
infections in pediatric patients following hematopoietic bone marrow transplantation. Dept. of
Pediatrics Research Day. (Presenter, H Rigby) May 2006.
68. Fernandez CV. Navigating the REB. Academic Skills Course. Pediatric residents. IWK
Health Centre. January 2006.
69. Fernandez CV, C Spicer. Infection control procedures for autologous bone marrow transplant
patients. 6N In-patients. IWK Health Centre. July 2005.
CV – Conrad Fernandez, MD, FRCP(C)
61
70. CV Fernandez, T Jurgens, J Brown, E Cooper, L Frankton, A MacLellan, P Milroy, A Otley.
The experience of complementary and alternative health care practitioners caring for children
and youth in Nova Scotia. Dalhousie School of Nursing Annual Research Conference.
(Presenter, J Brown). June 2005.
71. Conway J, Dyack S, Crooks BNA, Fernandez CV. Mixed donor chimerism and low level
iduronidase expression may be adequate for neurodevelopmental protection in Hurler’s
syndrome. Dept. of Pediatrics Research Day. (Presenter, J. Conway). April 2005.
72. Rigby HB, Fernandez CV. A survey of researchers’ practice in returning research results to
research participants. Oral abstracts presented at ASH Annual Meeting 2003. Dept. of
Pediatrics Research Day. (Presenter, H Rigby). April 2005.
73. MacNeil SD, Fernandez CV. Informing research participants of research results: An analysis
of the attitudes of Canadian university-based Research Ethics Board chairs. Dept. of Pediatrics
Research Day. (Presenter, D MacNeil). April 2005.
74. M Lefaivre, CT Chambers, Fernandez CV. Providing parents with individualized feedback on
results of psychological testing conducted for research purposes with children: Ethical issues
and guidelines. Dept. of Pediatrics Research Day. (Presenter, M Lefaivre). April 2005.
75. Fernandez CV. Adolescents/young adults with cancer: An orphan population. QEII Medical
Oncology Grand Rounds (telehealth transmission to Nova Scotia sites). April 2005.
76. Fernandez CV. Pediatric Oncology emergencies. Pediatric Residents. IWK Health Centre.
March 2005.
77. Fernandez CV. Success stories in Pediatric Oncology. Cancer Research Training Program.
Dalhousie University. Halifax, NS. May 2004.
78. Fernandez CV. Pediatric Oncology. Radiotherapy Residents. QEII. Halifax, NS. April 2004.
79. Rigby H, Yu W, Fernandez CV. Lack of efficacy of Gleevic in Pecoma. Poster. Dept of
Pediatrics Research Day. (Rigby - presenter; Fernandez - supervisor). May 2004.
80. Benedict J, Simpson C, Fernandez CV. A survey of parental perceptions of the informed
consent process in pediatric bone marrow transplantation (BMT). Platform presentation. Dept
Pediatrics Research Day. (Benedict - presenter; Fernandez - supervisor). May 2004.
81. MacNeil SD, Kodish ED, Fernandez CV. Informing research participants of research results:
An analysis of pediatric informed consent conferences in randomized controlled trials. Poster.
Dept. of Pediatrics Research Day. (MacNeil - presenter; Fernandez - supervisor). May 2004.
82. Fernandez CV, Taweel S, Kodish ED, Weijer C. Disclosure of research result to research
participants: Needs and attitudes of adolescents and parents. Poster. Dept. of Pediatrics
Research Day. May 2004.
83. Benedict J, Simpson C, Fernandez CV. A survey of parental perceptions of the informed
consent process in pediatric bone marrow transplantation (BMT). Faculty of Medicine Medical
Student Research Day. Poster. (Benedict, presenter; Fernandez, supervisor). December 2003.
84. MacNeil SD, Kodish ED, Fernandez CV. Informing research participants of research results:
An analysis of pediatric informed consent conferences in randomized controlled trials. Faculty
of Medicine Medical Student Research day. Poster. (MacNeil, presenter; Fernandez,
supervisor). December 2003.
85. Macfarlane RJ, McCully BJ, Fernandez CV. Is exchange transfusion or leukopheresis needed
for leukemia patients with hyperleukocytosis when treated with recombinant urate oxidase?
Poster. Dept. of Pediatrics Research Day. (Macfarlane - presenter; Fernandez - supervisor).
June 2003.
CV – Conrad Fernandez, MD, FRCP(C)
62
86. Fernandez CV, Kodish ED, Taweel S, Shurin SB, Weijer C. Disclosure of the right of research
participants to receive research results: An analysis of consent forms in the Children’s
Oncology Group. Platform presentation. Dept. of Pediatrics Research Day. Halifax, Nova
Scotia. June 2003.
87. Fernandez CV, Kodish ED, Shurin SB, Weijer C. Disclosure of the right of research
participants to receive research results: Attitudes and needs of principal investigators in the
Children’s Oncology Group. Poster. Dept of Pediatrics Research Day. Halifax, NS. June
2003
88. Fernandez CV. Error recognition in mortality review. IWK Pediatric Residents. January
2003.
89. Fernandez CV. Pediatric acute lymphoblastic leukemia. Hematology Grand Rounds. QEII.
January 2003.
90. Fernandez CV. Cord blood stem cell transplantation. Family Medicine Grand Rounds. IWK.
November 2002.
91. Fernandez CV. Disclosure of results to research participants. Hematology Grand Rounds.
QEII. November 2002.
92. Fernandez CV. Attitudes of pregnant women to cord blood collection, testing and storage.
Dept. of Pediatrics Research Day. Halifax, NS. May 2001.
93. Fernandez CV. Cytotoxic disasters. Grand Rounds, Dept of Pediatrics. IWK. March 2001.
94. Fernandez CV. Cytotoxic disasters. Hematology Grand Rounds. QEII. June 2001.
95. Fernandez CV. Cord blood stem cell transplantation. Division of Cytogenetics. IWK. October
2001.
96. Fernandez CV. Oncologic emergencies. Pediatric Residents. IWK. 2000.
97. Fernandez CV. Graft vs host disease. Nursing Rounds. IWK. July 1999.
98. Fernandez CV. Cord blood stem cell transplantation. Hematology Grand Rounds. QEII.
February 1999.
99. Fernandez CV. Stem cell transplantation: late complications. Nursing Rounds. IWK.
December 1998.
100. Fernandez CV. Ethics: best interests of child. (Presenter, C. Simpson). Faculty
representative. November 1998.
101. Fernandez CV. Stem cell transplantation: acute complications. Nursing Rounds. IWK.
November 1998.
102. Fernandez CV. Stem cell transplantation. Pediatric Grand Rounds. IWK Health Centre.
October 1998.
103. Fernandez CV. Wilson’s disease - hematological manifestations. Atlantic Provinces Pediatric
Meeting. October 1998.
104. Fernandez CV. Neonatal thrombocytopenia. Pediatric Residents. IWK Health Centre.
October 1998.
105. Fernandez CV. Stem cell transplantation: acute complications. Nursing Rounds. IWK Health
Centre. August 1998.
(Please contact me for a list of local presentations prior to 1998).
CV – Conrad Fernandez, MD, FRCP(C)
63
GRANTS (Peer-reviewed, Awarded):
Date (Start – Finish)
Title Granting Agency Role Total Amt. (Cdn $)
2018-2022 The Pain Squad+ smartphone
app to support real-time pain
management for adolescents
with cancer: a randomized
controlled trial.
CIHR Project Grant Co-investigator
JN Stinson and L
Jibb PI
$573,752
2018-19 Development of Liquid Biopsy
Assays for Wilms Tumor
Translational Pilot
Studies for Solid
Malignancies in the
Children’s Oncology
Group
Co-Investigator
Walz/Crompton PIs
$75,000 US
Jan 2017 –
Jan 2018
Febrile Neutropenia in Atlantic
Canada Pediatric Population, are
we adhering to the Clinical
Guidelines?
TRIC – IWK/NSHA Scientific co-PI $7000.00
June 2016 –
June 2021
The Terry Fox PROFYLE
project
TFRI Ethics Node Lead
Co-PI
(Director Malkin)
$5,000,000.00
Oct 2015-
Sept 2016
Familial Wilms RNA seq
project
Coast to Coast (not
peer reviewed) Co-investigator
K Bedard PI
$10,000.00
Aug 2015-
July 2017
Cancer Pain Assessment and
Management in Children: Using
Social Media to Bridge the Gap
Canadian Cancer
Society Research
Institute
KTA grant
Co-investigator
C Chambers co-PI
C Stinson co-PI
$100,000.00
over 2 years
July – Dec
2015
Sideroblastic Anemia treatment
with Glycine/Folate
Coast to Coast Supervisor $3600.04
July 2014-
June 2016
Canadian Aplastic Anemia and
Myelodysplastic Syndrome
Study (CAMS)
C17 Research
Network
And Alexion
Co-investigator
Y Dror PI
$90,000.00
C17
+$60,000
Alexion
May 2014-
Dec 2014
Parental Involvement to Reduce
Pain in Children with Acute
Lymphoblastic Leukemia
Nursing Research and
Development Fund Co-investigator
Amanda Bettle PI
$3,881.60
2013 - 2018 Canadian Inherited Marrow
Failure Registry - Inherited bone
marrow failure syndromes: from
gene discoveries to pathobiology
CIHR Co-investigator
Y Dror PI
$760,000.00
Mar 2013 –
Mar 2017
(NCE 2018)
Biomarkers and therapeutic
stratification of pediatric
glioblastoma through genomics
and epigenomics
Genome Canada
Large Scale Applied
Research
Co-investigator
Jabado PI
$6,567,000.00
Feb 2013-
Feb 2014
Catastrophizing and Parenting
During Parent-Child Interactions
About Pain and Conflict
Department of
Psychiatry research
fund
Co-investigator
K Birnie PI
$10,000.00
CV – Conrad Fernandez, MD, FRCP(C)
64
Date (Start – Finish)
Title Granting Agency Role Total Amt. (Cdn $)
Sept 2012-
Sept 2014
Canadian Inherited Marrow
Failure Registry - Bone Marrow
Failure-causing Alleles in
Canada and Genotype-
Phenotype
C17 Research
Network
Co-investigator
Dror PI
$200,000.00
July 2011 -
Dec 2014
Identifying New Genes and
Medicines for the Treatment of
Orphan Diseases (IGNITE)
Genome Canada -
Large Scale Applied
Research
Co-Project Leader
McMaster Co-PI
$4,825,936.00 ($2,374,541.00
from GC)
July 2011-
June 2013
Drinking water quality and
cancer risk: Translating
epidemiological evidence into
risk reduction policy
CIHR Co-investigator
Dummer PI
$196,570.00
Mar 2011 -
Mar 2012 The Canadian Pediatric
Cancer Genome Consortium:
Unravelling the genetic basis
of childhood cancer through
next-generation sequencing
Genome Canada -
CIHR Advancing
Technology Innovation
through Discovery
Co-investigator
Sorenson PI
$2,500,000.00
Jan 2011 -Jan
2012
The Canadian Pediatric Genetic
Disorders Sequencing
Consortium (FORGE)
Genome Canada-
CIHR Advancing
Technology Innovation
through Discovery
Collaborator
Boycott PI
$3,000,000.00
July 2010 -
June 2012
Quality of life assessment in a
phase III study of BMT versus
chemotherapy in high risk
relapsed Wilms' tumor.
C17 Research
Network -
Candlelighter’s
Principal
Investigator
$43,397.00
June 2010 -
June 2011 Urinary metabolite profiles in
Wilms’ tumor
IWK Category B Co-investigator
MacLellan PI
$10,250.00
2010 - 2011 Pain Experiences of
Hospitalized Children
IWK Category A Co-investigator
Birnie PI
$4,000.00
2009 - 2014 Cancer Research Training
Program: A research legacy for
Atlantic Canada
CIHR Co-principal
applicant
$1,625,000.00
June 2009 -
June 2010
Pertussis vaccination in BMT
patients.
Canadian Bone
Marrow Transplant
Group
Principal
Investigator
$3,000.00
June 2009 -
2011
Development of the P-SCS: The
Pediatric Supportive Care Scale
C17 Research Network
- Candlelighter’s
Co-Investigator
Zelcer PI
$113,374.00
June 2009-
2012
STOPP- AVN C17 Research
Network
Co-Principal
Investigator
$3900 (IWK support)
June 2009 -
Aug 2009
Parental views on consent, tissue
taking and tissue banking in
pediatric COG populations
IWK Summer
Studentship
Co-investigator
(Supervisor)
McMurter PI
$2,500.00
June 2009 -
Aug 2009
Parental views on Consent,
Tissue Taking and Tissue
Banking in Pediatric COG
populations
IWK Category A Principal
investigator
$492.00
May 2009 -
May 2010
Influence of genetic
polymorphisms for GST on
occurrence of hepatotoxicity in
Wilms’ tumor patients
Hope Hart Johnson
Fund
Principal
Investigator
$4,900.00
CV – Conrad Fernandez, MD, FRCP(C)
65
Date (Start – Finish)
Title Granting Agency Role Total Amt. (Cdn $)
July 2008 -
June 2010
Quality of life assessment in a
phase III study of BMT versus
chemotherapy in high risk
relapsed Wilms' tumor.
Dalhousie Cancer
Research Program
Principal
Investigator
$43,827.00
June 2007 -
June 2008
A Survey of Editorial Practice &
Policy in the Publication of
Ethically Suspect Research.
IWK Category A Co-investigator
(Supervisor)
$2,700.00
June 2006 -
Aug 2006
Informing Research Participants
of Research Results: Analysis of
selected American University-
Based Institutional Review
Boards Policies.
IWK Summer
Studentship Research
Program (joint with grant below)
Co-Investigator
(Supervisor)
$2,125.50
June 2006 -
Aug 2006
Informing Research Participants
of Research Results: Analysis of
selected American University-
Based Institutional Review
Boards Policies.
Dalhousie
Undergraduate
Medical Student
Summer Research
Program
Co-investigator
(Supervisor)
$2,125.50
May 2006 -
Apr 2007
Routine bone marrow
examination in the initial
evaluation of pediatric
Hodgkin’s disease: the Canadian
perspective.
IWK Category A Co-investigator
(15%)
$2,350.00
Jan 2006 -
Jan 2007
Utility and cost of surveillance
central line blood cultures in the
early detection of asymptomatic
bloodstream infections in non-
neutropenic pediatric patients
following hematopoietic stem
cell transplantation.
IWK Category A Co-Investigator
(Supervisor)
$3,800.00
Oct 2005 -
Oct 2006
A 10-year follow-up study on the
requirements for research ethics
board approval prior to
publication of human research
results
IWK Category A Co-Investigator
(Supervisor)
$2,300.00
May 2005 -
May 2006
Expressive and receptive pain
language in healthy children and
children with medical conditions
IWK Category A Co-Investigator $4,000.00
May 2005 -
May 2006
Alternative therapy use in
children with chronic illness
IWK Category A Co-Investigator $4,000.00
Sept 2004 -
Aug 2006
A possible role for hepcidin in
anemia associated with systemic
onset juvenile idiopathic arthritis
(SoJIA)
IWK Category A Co-Investigator $4,932.59
June 2004 -
May 2005
Return of research results to
research participants. ASH
abstracts
HOIC
Summer Studentship
Co-Investigator
(Supervisor)
$3,633.75
Apr 2004 -
Mar 2007
Return of research results to
research participants. Attitudes
and needs of participants
CIHR - Strategic
Initiative - Ethics
Principal
Investigator
$143,587.00
Mar 2004 -
Mar 2005
A survey of parental perceptions
of the informed consent process
in pediatric bone marrow
transplantation Supplemental
funds
Catherine Betts Fund
and Hemat/Oncology
Endowed Fund
Co-Investigator
(Supervisor)
$2,908.78
CV – Conrad Fernandez, MD, FRCP(C)
66
Date (Start – Finish)
Title Granting Agency Role Total Amt. (Cdn $)
Feb 2004 -
Aug 2016
Phase III study of very low, low
and standard risk Wilms Tumor
NCCF
U10 CA98543-02
Principal
Investigator
$14,569.10 Per
yr x 9 yrs
July 2003 -
Dec 2004
Return of research results to
research participants:
1. Attitudes of REB chairs.
2. Canadian REB policies.
IWK Research Office
Category A
Co-Investigator
(Supervisor)
$875.00
July 2003 -
Oct 2003
Population-based survey of care
provided by comple-mentary and
alternative therapists to children
in NS
NSHRF Capacity
Building Grant
Co-Principal
Investigator
$12,000.00
Feb 2003 -
Jan 2004
A survey of parental perceptions
of the informed consent process
in pediatric bone marrow
transplantation
IWK Research Office
- Catherine Betts Fund
Co-Investigator
(Supervisor)
$2,132.50
Jan 2003 -
Dec 2003
Returning research results to
pediatric oncology research
subjects. Focus groups and
questionnaire development
IWK Research Office
- ARG McNaught
Fund
Principal
Investigator
$2,615.12
Dec 2002 -
Nov 2005
Clinical Research Associate for
Registries
IWK Research Office
- ARG McNaught
Fund
Principal
Investigator
$138,850.00
2002 - 2003 Returning research results to
pediatric oncology research
subjects. PI study
Children’s Oncology
Group
Principal
Investigator
Services
in kind
2002 - 2003 A survey of principle investi-
gators - attitudes and institutional
practices in returning research
results to pediatric oncology
research subjects or guardians
IWK Research Office
- Hope-Hart-Johnson
Fund
Principal
Investigator
$5,685.33
2001 - 2002 Use of complementary and
alternative therapies in pediatric
patients presenting to a pediatric
emergency department
IWK Research Office
Category A
Co-Investigator
(Supervisor)
$2,174.00
2001 - 2002 The comprehensive cancer care
project for children: Needs
assessment
IWK Research Office
Category B
Co-Investigator $6,178.83
2001 - 2002 The comprehensive cancer care
project for children: Web page
assessment
Cancer Care Nova
Scotia
Co-Investigator $20,000.00
2000 - 2003 A phase I trial of Temodal using
an extended continuous oral
schedule in pediatric patients
with recurrent brain tumors
Schering Local Principal
Investigator
$4,000.00
1999 - 2001 Attitudes of pregnant women to
cord blood donation, storage and
testing
IWK Research Office
Category B
Principal
Investigator
$14,276.50
1999 - 2001 Hydroxychloroquine as
treatment of immune- mediated
thrombocytopenic purpura
IWK Research Office
Category A
Co-Investigator
(local Principal
Investigator)
$1,980.24
1999 - 2000 Examination of the safety of
abrupt cessation of TPN versus
tapering in pediatric patients
IWK Research Office
Associate Researcher
Principal
Investigator
$7,750.00
1999 Wilms' tumor cytogenetics -
summer studentship
Cancer Care Nova
Scotia
Co-Investigator
(Supervisor)
$5,000.00
CV – Conrad Fernandez, MD, FRCP(C)
67
Date (Start – Finish)
Title Granting Agency Role Total Amt. (Cdn $)
1993 A Cross Canada Survey of
Pediatric House Officers’ Pain
Management Attitudes and
Practices
IWK Research Office
Category A
Co-Investigator $1,800.00
GRANTS (Pending):
Date
(Start –
Finish)
Title Granting Agency Role Total Amt
Applied for
(Cdn $)
Sept 2017 –
August 2020
Diet and the gut microbiome in
immune-mediated complex
medical conditions:
patient-oriented translational
research from table to bench to
bedside’
NSHRF Cahill
Fernandez
(co-investigator)
$147,228.92
2018-2021 Use of Mind-on and Hands-on
Interactive Technologies to
Improve the Quality of Life in
Children with Cancer
CCSRI
(LOI accepted)
Full submission due
1 Nov
Antle/Chambers
CoPI
Fernandez
(co-investigator)
$300,000
2018-2019 Pharmacogenomic Analysis in
Wilms Tumor Patients with
Treatment-Related Severe
Hepatotoxicity
Pablove foundation
(LOI submitted)
Walz PI
Fernandez
(co-investigator)
US$50,000
CV – Conrad Fernandez, MD, FRCP(C)
68
INVITED JOURNAL PEER REVIEW
1. Pediatrics. July 2018. Journal article.
2. J Clinical Oncology. July 2018. Journal article.
3. Pediatric Blood & Cancer. July 2018. Journal article.
4. JNCI. Journal of National Cancer Institute. June 2018. Journal article.
5. Pediatric Blood & Cancer. May 2018. Journal article.
6. JNCCN—Journal of the National Comprehensive Cancer Network. April 2018. Journal article.
7. American Journal of Human Genetics. January 2018. Journal article.
8. Pediatric Blood & Cancer. September 2017. Journal article.
9. European J Cancer. August 2017. Journal article.
10. J Law, Medicine, & Ethics. July 2017. Journal article.
11. Pharmaceutical Medicine. June 2017. Journal article.
12. J Pediatrics. April 2017. Journal article.
13. Pediatric Blood & Cancer. March 2017. Journal article.
14. J Genetic Counselling. February 2017. Journal article.
15. American Journal of Transplantation. January 2017. Journal article.
16. Pediatric Blood & Cancer. November 2016. Journal article.
17. Journal of the National Cancer Institute. October 2016. Journal article.
18. Cancer. September 2016. Journal article.
19. Future Medicine. August 2016. Journal article.
20. Journal of Clinical Oncology. July 2016. Journal article.
21. JAMA. June 2016. Journal article.
22. The Oncologist. May 2016. Journal article.
23. J Genetic Counselling. March 2016. Journal article.
24. Clinical Trials. March 2016. Journal article.
25. Personalized Medicine. February 2016. Journal article.
26. Pediatric Blood & Cancer. January 2016. Journal article.
27. Hasting Center Report. November 2015. Journal article.
28. J Medical Ethics. October 2015. Journal article.
29. CMAJ. September 2015. Journal article.
30. J Adolescent Health. September. 2015. Journal article.
31. Pediatric Blood & Cancer. July 2015. Journal article.
32. Future Oncology. April 2015. Journal article.
33. J Pediatrics. March 2015. Journal article.
34. Current Genomics. March 2015. Journal article (review).
CV – Conrad Fernandez, MD, FRCP(C)
69
35. Pediatric Blood & Cancer. December 2014. Journal article.
36. BMJ Case Reports. December 2014. Journal article.
37. Pediatric Blood & Cancer. September 2014. Journal article.
38. BMC Medical Ethics. July 2014. Journal article.
39. J Genetic Counselling. May 2014. Journal article.
40. Mayo Clinic Proceedings. May 2014. Journal article.
41. European Journal of Cancer. April 2014. Journal article.
42. Emerging Themes in Epidemiology. April 2014. Journal article.
43. Health Expectations. December 2013. Journal article.
44. Translational Pediatrics. December 2013. Journal article.
45. Pediatric Blood & Cancer. October 2013. Journal article.
46. Pediatric Blood & Cancer July 2013. Journal article.
47. Pediatric Blood & Cancer. April 2013. Journal article.
48. Clinical Genetics. April 2013. Journal article.
49. Genetics in Medicine. March 2013. Journal article.
50. J Women’s Health, Issues and Care. January 2013. Journal article.
51. J Genetic Counselling. December 2012. Journal article.
52. Blood Transfusion. December 2012. Journal article.
53. BMC Medical Ethics. November 2012. Journal article.
54. Pediatric Blood & Cancer. September 2012. Journal article (commentary).
55. Pediatric Blood & Cancer. May 2012. Journal article.
56. Journal of Clinical Research and Bioethics. March 2012. Journal article.
57. Pediatric Blood & Cancer. March 2012. Journal article.
58. Genetics in Medicine. November 2011. Journal article.
59. Pediatric Blood & Cancer. October 2011. Journal article.
60. Journal of Pediatric Hematology/Oncology. August 2011. Journal article.
61. Journal of Empirical Research on Human Research Ethics. June 2011. Journal article.
62. Pediatric Blood & Cancer. March 2011. Journal article.
63. Trials. February 2011. Journal article.
64. Expert review of Anticancer Therapy. February 2011. Journal article.
65. BMC Medical Research Methodology. January 2011. Journal article (review major revision).
66. BMC Medical Research Methodology. November 2010. Journal Article.
67. Clinical Trials. November 2010. Journal article.
68. Journal of Pediatric Hematology Oncology. October 2010. Journal article.
69. Trends in Genetics. September 2010. Journal article.
70. Pediatric Health. August 2010. Journal article.
CV – Conrad Fernandez, MD, FRCP(C)
70
71. Trials. June 2010. Journal article.
72. Pediatric Hematology & Oncology. June 2010. Journal article.
73. BMC Medical Ethics. May 2010. Journal article.
74. BMC Health Services. April 2010. Journal article.
75. Public Health Genomics. March 2010. Journal article (review major revision).
76. Cancer Investigation. March 2010. Journal article.
77. CMAJ. January 2010. Journal article.
78. CMAJ. January 2010. Journal article (different from 50).
79. British Journal of Cancer. December 2009. Journal article.
80. Public Health Genomics. December 2009. Journal article.
81. Cancer Investigation. November 2009. Journal article.
82. Pediatric Blood & Cancer. November 2009. Journal article.
83. Pediatrics. November 2009. Review of resubmitted Journal article.
84. Cancer. October 2009. Journal article.
85. Archives of Pediatrics & Adolescent Medicine. October 2009. Journal article.
86. Pediatrics. July 2009. Journal article.
87. Pediatrics. July 2009. Journal article (different from 54).
88. Journal of Clinical Oncology. June 2009. Journal article.
89. Pediatric Blood & Cancer. June 2009. Journal article.
90. Health Expectations. May 2009. Journal article.
91. Pediatric Blood & Cancer. March 2009. Journal article.
92. Accountability in Research. February 2009. Journal article.
93. Expert Review of Anticancer Therapy. February 2009. Journal article.
94. Journal of Pediatric Hematology/Oncology. January 2009. Journal article.
95. Pediatric Blood & Cancer. November 2008. Journal article.
96. Pediatrics. November 2008. Journal article.
97. Journal of Pediatric Hematology Oncology. October 2008. Journal article.
98. Journal of Pediatric Hematology Oncology. September 2008. Journal article.
99. Patient Education and Counseling. September 2008. Journal article.
100. Journal of Pediatric Hematology Oncology. June 2008. Journal article.
101. Pediatric & Child Health. May 2008. Journal article.
102. JAMA. March 2008. Journal article.
103. IRB: Ethics & Human Research. February 2008. Journal article.
104. Journal of Clinical Oncology. December 2007. Journal article.
105. Trials. December 2007. Journal article.
106. Accountability in Research. November 2007. Review of resubmitted Journal article.
CV – Conrad Fernandez, MD, FRCP(C)
71
107. Pediatrics & Child Health. September 2007. Review revised Journal Article.
108. Pediatric Blood & Cancer. September 2007. Journal article.
109. Accountability in Research. July 2007. Journal article.
110. Pediatric Hematology and Oncology. February 2007. Journal article.
111. Journal of Empirical Research on Human Research Ethics. January 2007. Journal article.
112. Journal of Genetic Counseling. September 2006. Journal article.
113. Pediatrics. September 2006. Journal article.
114. Journal of Medical Ethics. July 2006. Journal article.
115. Archives of Pediatrics & Adolescent Medicine. July 2006. Journal article.
116. BMC Urology. May 2006. Journal article.
117. American Journal of Kidney Diseases. April 2006. Journal article.
118. Cancer. March 2006. Journal Article.
119. Pediatric Blood Cancer. January 2006. Journal Article.
120. British Medical Journal. December 2005. Invited editorial - article review.
121. Pediatrics & Child Health. December 2005. Journal Article.
122. Pediatrics & Child Health. November 2005. Journal Articles (x2).
123. American Journal of Kidney Diseases. September 2005. Journal Article.
124. Pediatric Nephrology. July 2005. Journal Article.
125. JAMA. May 2005. Journal Article.
126. Pediatric Blood & Cancer. April 2005. Journal Article.
127. Pediatrics. April 2005. Journal Article.
128. Pediatric Blood & Cancer. March 2005. Journal Article.
129. Pediatrics. January 2005. Journal article.
130. International Journal for Quality in Health Care. December 2004. Journal article.
131. Pediatric Blood & Cancer. July 2004. Journal Article.
132. Canadian Medical Association Journal. October 2003. Journal Article.
133. Journal of Pediatric Hematology/Oncology. November 2002. Journal Article.
134. Journal of Pediatric Hematology/Oncology. April 2002. Journal Article.
135. Expert Review of Anticancer Therapy. November 2001. Journal article.
136. Pediatrics. August 2001. Journal article.
137. Pediatrics. March 2001. Journal article.
138. Pediatric Pain Letter. June 2000. Journal article.
139. Pediatrics. February 2000. Journal article.
140. Science and Social Medicine. February 1999. Journal article.
CV – Conrad Fernandez, MD, FRCP(C)
72
GRANT PEER REVIEW
1. Dutch ZonMw's 'Ethiek en Gezondheid’. External grant reviewer. Netherlands. August 2018.
2. The French Society for Children Cancer and Leukemia (SFCE). Grant reviewer. June 2017.
3. CIHR Project Grant: Fall 2016 competition. Stage II Application panel reviewer (30 grants).
May 2017.
4. CIHR Project Grant: Fall 2016 competition. Stage I Application panel reviewer (8 grants).
Jan – March 2017.
5. The French Society for Children Cancer and Leukemia (SFCE). Grant reviewer. November 2016.
6. MITACs Accelerate Program. Grant review. Reviewer. July 2016.
7. CIHR Project Scheme: 2016 1st Live Pilot. Application panel reviewer. May - June 2016.
8. Dutch ZonMw's 'Ethiek en Gezondheid’. External grant reviewer. Netherlands. October 2015.
9. Beatrice Hunter Cancer Research Institute. Research Committee member. Regular grant
application reviewer. 2013 – present.
10. CIHR Health Professional Awards - Fellowships Committee. Application panel reviewer.
Ottawa, ON. January 2014.
11. CIHR Health Professional Awards Committee. Application panel reviewer. Ottawa, ON. May
2013.
12. National Institutes of Health. Special Emphasis Panel/Scientific Review Group. 2013/10 ZRG1
HDM-V(57) R. Grants panel reviewer. Teleconferenced Bethesda, Md. May 2013.
13. CIHR Fellowship Training Award Committee. Application panel reviewer. Ottawa, ON. January
2013.
14. Dutch ZonMw's national 'Priority Medicines for Children and Elderly Program' programme:
‘Ethical and Legal Aspects of Medicine Research’. External grant reviewer. Netherlands.
October 2011.
15. Pediatric Cancer Outcomes Initiative. Pediatric Oncology Group of Ontario (POGO). 2010/2011
Competition - Outcomes and impacts of Pediatric Cancer. Grants panel reviewer. Toronto,
ON. April 2011.
16. National Institutes of Health. Special Emphasis Panel/Scientific Review Group 2010/10 ZRG1
CRE-B (01) S meeting Research Ethics Study section. Grants panel reviewer. Bethesda, Md.
June 2010.
17. Pediatric Oncology Group of Ontario. Seed funding grant application. External reviewer.
January 2010.
18. C17 Research Network for Pediatric Oncology, Hematology and Hematopoietic Stem Cell
Transplantation. External reviewer. Edmonton, Alberta. January 2010.
19. C17 Research Network for Pediatric Oncology, Hematology and Hematopoietic Stem Cell
Transplantation. External reviewer. Edmonton, Alberta. June 2009.
20. Canadian Institutes of Health Research. Health Ethics, Law & Humanities. Grants Committee.
External Reviewer. May 2009.
21. Research Grants Council Hong Kong. University Grants Committee. External Grant reviewer.
May 2009.
22. Research Grants Council Hong Kong. University Grants Committee. External Grant Reviewer.
March 2009.
CV – Conrad Fernandez, MD, FRCP(C)
73
23. Pediatric Oncology Group Ontario. Seed grant application. External grant reviewer. January
2009.
24. Research Grants Council Hong Kong. University Grants Committee. External Grant Reviewer.
February 2008.
25. Cancer Research UK. Population and Behavioural Sciences Committee. Outline programme
grant application. External grant reviewer. February 2008.
26. National Institutes of Health. Bethesda, Md. Special Emphasis Panel/Scientific Review Group
2008/01 ZRG1 HOP-E (90) S Research Ethics Study section. Grants panel reviewer.
October 2007.
27. Hospital for Sick Children. Toronto. Foundation award. External Grant reviewer. June 2007.
28. Research Grants Council Hong Kong. University Grants Committee. External Grant Reviewer.
May 2007.
29. Nova Scotia Health Research Foundation. External grant reviewer. May 2007.
30. Norah Stephens Oncology Scholar Awards. Halifax. Grants panel reviewer. March 2007.
31. Research Grants Council Hong Kong. University Grants Committee. External Grant Reviewer.
February 2007.
32. Research Grants Council Hong Kong. University Grants Committee. External Grant Reviewer.
January 2007.
33. Diabetes UK. London, UK. External Grant Reviewer. October 2006.
34. Norah Stephens Oncology Scholar Awards. Halifax. Grants panel reviewer. March 2006.
35. Research Grants Council Hong Kong. University Grants Committee. External Grant Reviewer.
May 2006.
36. Hospital for Sick Children. Toronto. Foundation award. External Grant reviewer. October 2005.
37. Anemia Institute AIRE research grant competition. Grant review requested. Declined: conflict
of interest. February 2004.
38. Medical Research Council of Canada. April 2000. Grant application reviewer.
39. CIHR. Grant review requested. Declined: conflict of interest. April 2003. Grant.
40. Alberta Cancer Board. October 1999. Foundation grant application reviewer.
PROMOTION AND OTHER PEER REVIEW
1. Expert Review of Wilms Tumour information for cancer.ca. Canadian Cancer Society. 30 March
2018.
2. Moderator Best poster presentation. Solid Non-Brain Tumors II. SIOP. Washington DC 13
October 2017.
3. Ann & Robert H. Lurie Children's Hospital of Chicago Feinberg School of Medicine
Northwestern University. Chicago, Ill. External reviewer for promotion to Assistant Professor.
October 2017.
4. Wilms tumor staging. Canadian Cancer Society. Content development. 25 July 2017.
5. Adolescents and Young Adults with cancer (AYA) Review Panel. Document development.
Canadian Partnership Against Cancer. External reviewer. December 2016.
CV – Conrad Fernandez, MD, FRCP(C)
74
6. Wilms Tumor. PDQ Pediatric Treatment Editorial Board, Office of Cancer Content Management
Office of Communications and Education, National Cancer Institute. External Reviewer. May
2016.
7. BC Children’s Hospital. Reviewer for Child & Family Research Institute (CFRI) five-year
Investigator Salary Award. January 2015.
8. Canadian Cancer Encyclopedia. Canadian Cancer Society. Wilms tumor treatment. External
expert reviewer content. May 2014.
9. Expert Panel on Therapeutic Products for infants, children, and youth. Report on the assessment
of medicines for children. Council of Canadian Academies. External Expert Reviewer.
January 2014.
10. Wilms Tumor. PDQ Pediatric Treatment Editorial Board, Office of Cancer Content Management
Office of Communications and Education, National Cancer Institute. External Reviewer.
August 2013.
11. Hospital for Sick Children. Promotions Committee. External Reviewer for Associate
Professorship. December 2012 (RZS).
12. Children’s Oncology Group Bioethics Committee review of the Presidential Commission for the
Study of Bioethical Issues report: Privacy and Progress. November 2012.
13. University of Western Ontario. Children’s Hospital. Promotions Committee. Reviewer for
Associate Professorship. June 2012 (SZ).
14. Promotion & Tenure Committee. Department of Bioethics. Dalhousie University. Member.
October 2011.
15. Oxford University Press Canada. The Higher Education Division. Proposed Undergraduate
Textbook: The Canadian Bioethics Companion. Expert reviewer. April 2010.
16. Hospital for Sick Children. Care of Infants and Children with Life-limiting Conditions. Policy
review. Expert reviewer. December 2009.
17. Hospital for Sick Children. Promotions Committee. Reviewer for Associate Professorship.
October 2009 (AG).
18. Wilms’ tumor chapter. Canadian Cancer Encyclopedia. Expert reviewer. Canadian Cancer
Society Information Service. December 2008.
19. IWK Health Centre. Promotions Committee. Reviewer for CAPR application. September 2008.
20. Dalhousie University. Promotion & Tenure Committee. Department of Bioethics. Dalhousie
University. Member. October 2007.
21. IWK Health Centre. Promotions Committee. Reviewer for CAPR application. September 2006.
22. IWK Health Centre. Promotions Committee. Reviewer for Associate Professorship application.
October 2003.
23. Hospital for Sick Children. Promotions Committee. Reviewer for Associate Professorship.
October 2003 (JD).
24. Hospital for Sick Children. Promotions Committee. Reviewer for Associate Professorship.
October 2000.
25. University of British Columbia Research Ethics Board. Bone marrow transplant study. External
expert reviewer. March 2000.
26. Canadian Cancer Encyclopedia. Long Term Effects. Reviewer. October. 1998.
CV – Conrad Fernandez, MD, FRCP(C)
75
SUPERVISOR - Electives (primary supervisor):
(In addition to 4-6 pediatric residents per year on the hematology/oncology service):
Michael Mackley: Medical student – Med I RIM. November 2017 – present.
Meghan Pike: Pediatric Resident – research elective. July 2017 - present
Douglas Iaboni: Medical student – Med I RIM student. November 2015 – June 2017.
Marissa Leblanc: Medical student – Med II elective. January – April 2015.
Marissa Leblanc: Medical student – Med I RIM student. January 2014- June 2016.
Berit Dool: Medical Student – NOMS, Ontario. Elective. July 2014.
Ashley Geerlinks: Pediatrics resident – research elective. June 2014 – June 2016.
Sarah Sampson: Medical student – Med I elective. Planned Jan-May 2013.
Pier Glaude: Pediatrics resident – research elective. December 2012 – June 2015.
Rachel Shaw: Medical student - Med I elective. Jan 2011 – May 2011.
Bernice Duan: Medical student - Med I elective. Sept - Dec 2010.
Stacey Marjerrison: Pediatrics resident - research elective. July 2009 - June 2010.
Britney McMurter: Kinesiology Student. IWK Summer Studentship. June - August 2009.
Katherine Quackenbush: Medical Student - Med I elective. October 2008 - May 2009.
Rosie Ashton: Medical Student - Med I elective. October 2008 – May 2009.
Kate Read: Medical Student - research elective. April 2008 - August 2009.
Christa Kozanczyn: Medical Student - research elective. September 2006 - August 2008.
Kelly Cox: Pediatric Resident - research elective. November 2006 - June 2011
Katy Adair Finlay: Medical Student - elective. October 2006 - June 2007.
Carla Angelski: Pediatric Resident - research elective. May 2006 - 2008.
Christa Kozanczyn: Medical Student - summer student. May 2006 - September 2006
Heather Rigby: Medical Student - elective. October 2005 - September 2006.
(Dr. J Donald Hatcher Research Prize for outstanding research in undergraduate medicine. 2007)
Anne Rowan-Legg: Pediatric Resident - research elective. May 2005 - June 2007.
Jennifer Conway: Pediatric Resident - research elective. September 2004 - October 2005.
Heather Rigby: Medical Student - summer student. June - August 2004.
Heather Rigby: Medical Student - hematology/oncology elective. September 2003 - May 2004
Danielle McNeil: Medical Student. BSc Med program. September 2002 - June 2006.
(Dr. J. Donald Hatcher Research Prize for outstanding research in undergraduate medicine. 2006)
Jan Benedict: Medical Student - hematology/oncology elective. September 2002 - September 2004
Robyn McFarlane: Medical Student - hematology oncology elective. September 2002 - June 2003
Elizabeth Shouldice: Medical Student - hematology/oncology elective. September 2001 - April 2002
Sara McDonald: Medical Student - hematology/oncology elective. September 2000 - April 2001
Julia Wildish: Cancer Care Nova Scotia Summer Studentship. May - August 2000.
CV – Conrad Fernandez, MD, FRCP(C)
76
Julia Wildish: Medical Student - hematology/oncology elective. September 99 - April 2000
Jennifer Gillis: Medical Student - hematology/oncology elective. September 99 - April 2000
Chrystal Todd: Medical Student - hematology/oncology elective. September 99 - April 2000
Amanda Kim: Medical Student - hematology/oncology elective. September 98 - April 99
GRADUATE STUDENT SUPERVISION:
Perri Tutelman. PhD. Committee member. October 2017 – present.
Melissa Richardson. MSc. Committee member. STAG2 in EWS. Sept 2016- June 2018.
Succesful defense. 15 June 2018. .
Amanda Bettle: Masters of Nursing Committee member. Pain in pediatric oncology patients. December
2013 – 2015. Successful defense July 2015.
Victoria Bentley MSc Pathology. Committee member. PI3K/AKT/NOTCH signaling in T-Cell Acute
Lymphoblastic Leukemia (T-ALL). August 2012 – July 2014. Successful defense July 2014.
Katie Birnie: PhD Psychology. Dissertation Committee Member. Pain and parent/child
catastrophizing. January 2011- Sept 2015. Successful defense Sept 2015.
Tessa Craig: MA Committee member. Pain expression in children. May 2007 - August 2009.
Successful defense.
Holly Richardson: Interdisciplinary PhD. Spirituality in cancer children. Committee Member. June
2005 - 2013. Successful defense June 2013.
Marie Josee Faivre: Psychology student comprehensive. Returning results in psychology studies. Co-
supervisor. June 2004 - May 2005. Successful defense.
Victoria Seavilleklein: PhD Candidate Philosophy. AMS Bioethics Internship. Clinical Supervisor.
May 2004 - August 2006.
Christy Simpson: PhD Candidate Ethics - Clinical Elective. October 1998
GRANT review (tracked starting 2017)
Jason Berman – Neuroblastoma TME grant September 2017.
Ketan Kulkarni – BHCRI new investigator support award Oct 2017.
Jason Berman – Schwachman Diamond syndrome. Leukemia and Lymphoma Society. Feb 2018.
CV – Conrad Fernandez, MD, FRCP(C)
77
TEACHING/EDUCATION (see Teaching Dossier for full details):
1. Pediatric Residents. Exam preparation. 2 hr. 9 August 2018.
2. Master’s student (T Huynh). External examiner. Dalhousie University. 9 August 2018.
3. Med 3. Anemia and Thrombosis cases x 1.5 hr. 24 July 2018.
4. Pediatric Residents. Seminar. Bone Marrow Transplant. 1 hr. 31 October 2017.
5. Royal College History and Physical Exam Skills Assessment. IWK Health Centre. 19 May
2017.
6. Practice OSCE. Pediatric Hematology Oncology Fellow. 17 May 2017.
7. Ethics cases discussion. Royal College of Physicians and Surgeons. Fellow academic half day.
12 May 2017.
8. OSCE case writing. Royal College practice exams. Subspecialty resident training program
Pediatric Hematology Oncology. Submitted Jan 2017.
9. Pediatric Residents. Journal Club. Late mortality in cancer patients. 1 hr. 16 January 2017.
10. Pediatric Residents. Seminar. Aplastic Anemia 1 hr. 16 January 2017.
11. Pediatric Hematology Oncology Academic Half Day. Ethics. 2 December 2016.
12. Pediatric Residents. Exam preparation. 1.5 hrs. 11 October 2016. (solid tumors)
13. MCQ Question creation for Med students. X2. Submitted. May 2016
14. Pediatric Hematology Oncology Academic Half Day. Hepatoblastoma. 20 May 2016
15. Clinical Investigator Program. Expert facilitator. GCP and clinical trials. 18 May 2016.
16. Pediatric Hematology Oncology Academic Half Day. Wilms tumor. 11 Dec 2015
17. Med 3. Anemia and Thrombosis cases x 1.5 hr. 3 February 2016
18. Renal tumors. Half day teaching (2 hours). 11 December 2015.
19. Neonatal-perinatal Half day teaching (1.5 hours). WBC. 2 December 2015.
20. Pediatric Residents. Exam preparation. 1 hr. 30 November 2015
21. Pediatric Residents. Exam preparation. 1 hr. 27 October 2015.
22. Grade 9 Education telephone interview re: Pediatric Oncology. 28 April 2015.
23. Med 3. Anemia and Thrombosis cases x 1.5 hr. 4 February 2015
24. Pediatric Residents. Exam preparation x 1.5 hrs. 30 October 2014
CV – Conrad Fernandez, MD, FRCP(C)
78
25. OSCE teaching pediatrics residents. Breaking bad news. 9 June 2014.
26. Judge. Department of Pathology Research Trainee Day. 1 May 2014.
27. Pediatric Residents. Moral distress seminar. IWK Health Centre. 25 February 2014
28. Emergency Department Student teaching. Solid tumor presentations. IWK Health Centre. 19
Feb 2014.
29. Neonatal Perinatal Medicine Fellow teaching. WBC. IWK Health Centre. 12 Feb 2014
30. Royal College History and Physical Exam Skills Assessment. IWK Health Centre. 15 Nov
2013.
31. Royal College History and Physical Exam Skills Assessment. IWK Health Centre. October
2012.
32. Royal College History and Physical Exam Skills Assessment. IWK Health Centre. April 2010.
33. CARMS pediatric resident applications. Review committee member. December 09 - February
10.
34. Med I Dalhousie University. Patient-doctor skills. Interviewee for ethics assignment.
December 2009.
35. Ethics consultation. Therapeutic misconception and study design. NovelTech Ethics. Baylis
and MacQuarrie. November 2009.
36. CIHR Canadian Child Health Clinician Scientist Training Program. Facilitator. Ethics of
Database Use. November 2009.
37. Royal College History and Physical Exam Skills Assessment. IWK Health Centre. March
2008.
38. Med I Dalhousie University. Patient-doctor skills. Interviewee for ethics assignment (2
groups). November 2007.
39. Royal College History and Physical Exam Skills Assessment. IWK Health Centre. March
2007.
40. Canadian Child Health Clinician Scientist Program. Case discussion. Expert resource - ethics.
December 2006.
41. Pediatric Resident Journal Club. March 2006.
42. OSCE examiner/case writer. Pediatric residents. November 2005.
43. Case development. Bioethics Education Project. Royal College of Physicians and Surgeons of
Canada. Case writer. November 2005.
44. COPS case writer. Skin, Glands and Blood Unit. Hematology case. September 2005.
45. Medical Student Multiple Choice question writer. August 2005.
46. Medical Student Admissions Interviews. February 2005.
47. OSCE examiner. Medical School III Exams. March 2004.
48. Dalhousie Faculty Research Ethics Workshop. Case writer. February 2004.
49. Royal College of Physician Examination Board in Hematology. SAQ - Case writer. February
2004.
50. Canadian Child Health Clinician Scientist Program - Core Curriculum for Research Ethics and
Integrity. Unit: Consideration of Risk in Research Involving Children. November 2003.
Online January 2004.
CV – Conrad Fernandez, MD, FRCP(C)
79
51. Medical Student Admissions Interviews. January 2004.
52. Pediatric Resident Journal Club. February 17, 2003.
53. COPS Curriculum. Human Body Unit. August - September 2001.
54. Royal College of Physicians and Surgeons. Site Examiner. 2000 - present.
55. Royal College of Physicians and Surgeons. SAQ Writer. 2000 - present.
56. Medical students and Residents. Dalhousie University and external university electives (4-8 per
year). 1998 - present.
57. Pediatric Senior Resident Examination preparation. 1998 - present (1-2 hour preparation
sessions given 2-3 times per year).
58. Medical Student Hematology tutorials. 1998 - present (5-6 per year).
HOSTED VISITING PROFESSORS:
Dr. Nathaniel Treister. Associate Professor of Oral Medicine at Harvard School of Dental Medicine.
Associate Surgeon in the Division of Oral Medicine and Dentistry at Brigham and Women's
Hospital. Hematology, Oncoloyg and Pediatric Academic Rounds and trainee seminar. June 21-
22. 2018.
Dr. Torunn Yock, Associate Professor. Massachusetts General Hospital. Invited lecturer for Pediatric
Grand Rounds, Radiation Oncology teaching and seminar. May 5-6. 2015.
Dr. David Malkin, Professor. Hospital for Sick Children. Invited seminars. Key note speaker Trainee
Research Day. April 29-30, 2015.
Dr. Stephen Sallan, Professor, DFCI. Invited lecture Pediatric Grand Rounds. Adult Hematology Grand
rounds and seminars. February 6-8, 2013.
Dr. Steve Joffe, Associate Professor, Harvard and DFCI. Invited lecturer for Pediatric Grand Rounds,
Medical Oncology Grand rounds and several seminars. October 24, 25th. 2012
EDUCATIONAL MATERIAL PREPARATION:
1. IWK Tumor board Brochure. 2013. Parents.
2. Stem Cell Transplantation Binder. Guidelines 2000. Physicians/Nursing. Full revision 2003.
3. Video - Graft Versus Host Disease. 2000. Nursing.
4. Royal College of Physicians and Surgeons. MCQ Development. 2000.
5. Video - Stem Cell Transplantation: Late Complications. 1999. Nursing.
6. Video - Alternative therapies in Pediatric Oncology. 1999. Nursing.
7. Late Effects after Pediatric Oncology Treatment - Candlelighters News Letter. 1999. Parents.
8. Video - Stem Cell Transplantation: Acute Complications. 1998. Nursing.
CV – Conrad Fernandez, MD, FRCP(C)
80
NEWS MEDIA:
Dyna Rochmyaningsih. Freelance writer. Nature. July 2018.
Fredericton Daily Gleaner. Rare cancer. July 2017.
CTV Atlantic. Atlantic New. House calls. Oncofertility in AYA patients. May 2017. http://ctv.news/4EkFWf
Global TV. Global News at 6. #KidsCancerPain project. August 2016.
Global TV. Breakfast Show. #KidsCancerPain. July 2016.
Chronicle Herald. Izaak Magazine. IGNITE and orphan diseases. September 2013.
Canadian Institutes of Health Research. “Show me the Evidence”. September 2013. Return of results in
the age of genomics.
CTV News. April 2013. Bone marrow transplant in a child.
Science - January 2011. Return of Results from GWAS Studies.
USA Today - December 2008. Returning research results to participants.
CBC Radio - May 2008. Michael Enright’s Sunday Edition. Panel discussion: consent in children.
CIHR - May 2006. Return of investment in research. Summary for Members of Parliament.
Medical Post - April 2006. Adolescents and young adults with cancer.
Chronicle Herald - March 2006. Adolescents and young adults with cancer.
IRB Advisor (journal) - October 2005. Returning research results to participants.
Chronicle Herald - November 2004 - newspaper article: HLA types in registries for BMT.
CBC Television - November 2004 - The National: Cord blood transplantation.
CKDU - September 2004 - Radio interview: Cord blood transplantation.
Chronicle Herald - October 2003: Infection post bone marrow transplant.
ATV - July 2003 - TV interview: Cord blood transplantation.
Chronicle Herald - June 2003 - newspaper article interview: Fanconi’s anemia and BMT.
CBC French - TV interview: Hurler’s syndrome.
Globe and Mail - newspaper article interview: Complementary and alternative therapies.
Chronicle Herald - newspaper article interview: Hurler’s syndrome.
QUALIFICATIONS/ TRAINING:
MEDIDATA PI COURSE.FEB 2016.
TCPS 2 CORE - course on research ethics May 2014.
Health Canada Division 5 Training. April 2014.
Merck Consent Process e-Learning Course 15 March 2014
Merck Adverse Experience Reporting course 15 March 2014
Merck ICH/GCP Course 15 March 2014
Pediatric Advanced Life Support, Instructor Course 1993.
Pediatric Advanced Life Support, Instructor Course 1993.
CV – Conrad Fernandez, MD, FRCP(C)
81
PROFESSIONAL MEMBERSHIPS:
Canadian Medical Association
Canadian Society for Clinical Investigation
Children’s Oncology Group
American Society of Clinical Oncology
American Society of Pediatric Hematology/Oncology
American Society of Hematology
Nova Scotia Medical Society
Royal College of Physician and Surgeons of Canada (FRCPC)
International Society of Pediatric Oncology (SIOP)
INTERESTS:
Sports: ice hockey, kayaking, golf.
Birding.
COMMUNITY:
Assistant Coach. Halifax Hawks Hockey Association. (2004 - 2007)
Board of Directors (member) German Language Heritage School. (2005 - 2007)